0001898766 2023-11-01 2024-07-31 0001898766 dei:BusinessContactMember 2023-11-01 2024-07-31 0001898766 2024-07-31 0001898766 2023-10-31 0001898766 us-gaap:RelatedPartyMember 2024-07-31 0001898766 us-gaap:RelatedPartyMember 2023-10-31 0001898766 2022-10-31 0001898766 TPET:OperatorsMember 2023-10-31 0001898766 TPET:OperatorsMember 2022-10-31 0001898766 us-gaap:NonrelatedPartyMember 2023-10-31 0001898766 us-gaap:NonrelatedPartyMember 2022-10-31 0001898766 us-gaap:RelatedPartyMember 2022-10-31 0001898766 2024-05-01 2024-07-31 0001898766 2023-05-01 2023-07-31 0001898766 2022-11-01 2023-07-31 0001898766 2022-11-01 2023-10-31 0001898766 2021-11-01 2022-10-31 0001898766 us-gaap:CommonStockMember 2024-04-30 0001898766 TPET:ShareSubscriptionReceivablesMember 2024-04-30 0001898766 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0001898766 us-gaap:RetainedEarningsMember 2024-04-30 0001898766 2024-04-30 0001898766 us-gaap:CommonStockMember 2023-10-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2023-10-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001898766 us-gaap:RetainedEarningsMember 2023-10-31 0001898766 us-gaap:CommonStockMember 2023-04-30 0001898766 TPET:ShareSubscriptionReceivablesMember 2023-04-30 0001898766 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001898766 us-gaap:RetainedEarningsMember 2023-04-30 0001898766 2023-04-30 0001898766 us-gaap:CommonStockMember 2022-10-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2022-10-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001898766 us-gaap:RetainedEarningsMember 2022-10-31 0001898766 us-gaap:CommonStockMember 2021-10-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2021-10-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001898766 us-gaap:RetainedEarningsMember 2021-10-31 0001898766 2021-10-31 0001898766 us-gaap:CommonStockMember 2024-05-01 2024-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2024-05-01 2024-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2024-05-01 2024-07-31 0001898766 us-gaap:RetainedEarningsMember 2024-05-01 2024-07-31 0001898766 us-gaap:CommonStockMember 2023-11-01 2024-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2023-11-01 2024-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-07-31 0001898766 us-gaap:RetainedEarningsMember 2023-11-01 2024-07-31 0001898766 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2023-05-01 2023-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001898766 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001898766 us-gaap:CommonStockMember 2022-11-01 2023-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2022-11-01 2023-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-07-31 0001898766 us-gaap:RetainedEarningsMember 2022-11-01 2023-07-31 0001898766 us-gaap:CommonStockMember 2022-11-01 2023-10-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2022-11-01 2023-10-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-10-31 0001898766 us-gaap:RetainedEarningsMember 2022-11-01 2023-10-31 0001898766 us-gaap:CommonStockMember 2021-11-01 2022-10-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2021-11-01 2022-10-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2021-11-01 2022-10-31 0001898766 us-gaap:RetainedEarningsMember 2021-11-01 2022-10-31 0001898766 us-gaap:CommonStockMember 2024-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2024-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2024-07-31 0001898766 us-gaap:RetainedEarningsMember 2024-07-31 0001898766 us-gaap:CommonStockMember 2023-07-31 0001898766 TPET:ShareSubscriptionReceivablesMember 2023-07-31 0001898766 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001898766 us-gaap:RetainedEarningsMember 2023-07-31 0001898766 2023-07-31 0001898766 TPET:SouthSalinasProjectMember TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2024-07-31 0001898766 TPET:AcquisitionOfSouthSalinasProjectMember TPET:TrioLLCMember 2023-04-30 0001898766 TPET:SouthSalinasProjectMember TPET:TrioLLCMember 2023-10-31 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-09-30 2021-09-30 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-09-30 0001898766 TPET:TrioLLCMember 2021-09-30 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2023-10-31 0001898766 us-gaap:IPOMember 2023-04-20 2023-04-20 0001898766 TPET:TrioLLCMember TPET:McCoolRanchPurchaseAgreementMember 2023-10-31 0001898766 TPET:HeavySweetOilMember TPET:ARLOAgreementMember 2023-11-01 2023-11-30 0001898766 TPET:HeavySweetOilMember TPET:ARLOAgreementMember 2023-11-30 0001898766 TPET:ARLOAgreementMember 2023-12-01 2023-12-31 0001898766 TPET:ARLOAgreementMember 2024-01-01 2024-01-31 0001898766 TPET:HeavySweetOilMember TPET:ARLOAgreementMember 2024-01-01 2024-01-31 0001898766 TPET:SouthSalinasProjectMember TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-09-14 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-09-13 2021-09-14 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-12-17 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-12-16 2021-12-17 0001898766 TPET:TrioLLCMember 2021-09-14 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2023-04-30 0001898766 TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2022-10-31 0001898766 TPET:SouthSalinaProjectMember TPET:TrioLLCMember 2021-09-14 0001898766 TPET:SouthSalinaProjectMember TPET:TrioLLCMember 2023-04-30 0001898766 TPET:TrioLLCMember 2021-09-13 2021-09-14 0001898766 TPET:TrioLLCMember 2024-07-31 0001898766 TPET:TrioLLCMember 2023-10-31 0001898766 TPET:SouthSalinasProjectMember TPET:TrioLLCMember 2021-09-14 0001898766 TPET:SouthSalinasProjectMember TPET:TrioLLCMember 2023-04-30 0001898766 TPET:TrioLLCMember 2022-10-31 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-12-01 2023-12-31 0001898766 srt:ChiefExecutiveOfficerMember 2024-03-01 2024-03-31 0001898766 us-gaap:InvestorMember 2024-03-01 2024-03-31 0001898766 us-gaap:InvestorMember us-gaap:ConvertibleNotesPayableMember 2024-04-01 2024-04-30 0001898766 us-gaap:InvestorMember us-gaap:ConvertibleNotesPayableMember 2024-05-01 2024-07-31 0001898766 us-gaap:InvestorMember us-gaap:ConvertibleNotesPayableMember 2024-03-01 2024-03-31 0001898766 2023-10-31 2023-10-31 0001898766 TPET:ThreeInvestorsMember 2023-10-31 0001898766 TPET:TwoTranchesMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 TPET:FirstTrancheMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 us-gaap:IPOMember 2023-04-20 0001898766 2023-04-20 2023-04-20 0001898766 us-gaap:OverAllotmentOptionMember 2023-04-20 0001898766 TPET:OilSalesMember 2024-05-01 2024-07-31 0001898766 TPET:OilSalesMember 2023-05-01 2023-07-31 0001898766 TPET:OilSalesMember 2023-11-01 2024-07-31 0001898766 TPET:OilSalesMember 2022-11-01 2023-07-31 0001898766 TPET:OilAndNaturalGasRevenueMember TPET:OnePurchaserMember us-gaap:CustomerConcentrationRiskMember 2023-11-01 2024-07-31 0001898766 TPET:FirstLeaseMember 2022-05-27 0001898766 TPET:SecondLeaseMember 2024-07-31 0001898766 TPET:GroupOneMember 2023-03-31 0001898766 TPET:GroupOneMember 2023-02-28 0001898766 TPET:GroupTwoMember 2023-02-28 0001898766 TPET:GroupTwoMember 2023-03-31 0001898766 TPET:TrioLLCMember 2023-10-31 0001898766 TPET:McCoolRanchPurchaseAgreementMember 2023-10-01 2023-10-31 0001898766 TPET:McCoolRanchPurchaseAgreementMember 2023-10-31 0001898766 TPET:ParcelOneMember TPET:McCoolRanchOilFieldMember 2024-07-31 0001898766 TPET:ParcelTwoMember TPET:McCoolRanchOilFieldMember 2024-07-31 0001898766 TPET:ParcelOneAndTwoMember TPET:McCoolRanchOilFieldMember 2024-07-31 0001898766 TPET:OptionPayTwoInitialPaymentMember 2023-10-01 2023-10-31 0001898766 TPET:FinalSubsequentPaymentMember 2023-10-01 2023-10-31 0001898766 2023-10-01 2023-10-31 0001898766 2024-01-01 2024-01-31 0001898766 TPET:FinalSubsequentPaymentMember 2024-01-01 2024-01-31 0001898766 TPET:ARLOAgreementMember 2023-11-10 2023-11-10 0001898766 TPET:ARLOAgreementMember 2023-11-10 0001898766 srt:MinimumMember TPET:ARLOAgreementMember 2023-11-10 2023-11-10 0001898766 TPET:AmendedARAgreementMember 2023-12-29 0001898766 TPET:AmendedARLOAgreementMember 2023-12-29 2023-12-29 0001898766 TPET:AmendedARLOAgreementMember 2023-11-01 2024-07-31 0001898766 srt:ScenarioForecastMember TPET:AmendedARLOAgreementMember 2024-10-01 2024-10-10 0001898766 srt:ScenarioForecastMember TPET:AmendedARLOAgreementMember 2024-10-10 0001898766 TPET:SouthSalinasProjectMember 2022-11-01 2023-10-31 0001898766 TPET:McCoolRanchOilFieldMember 2022-11-01 2023-10-31 0001898766 2022-05-27 0001898766 TPET:SecondAforementionedMember 2023-10-31 0001898766 2022-12-22 2022-12-22 0001898766 TPET:McCoolRanchOilFieldMember TPET:TrioLLCMember 2022-12-22 0001898766 TPET:KenFronFieldMember TPET:TrioLLCMember 2022-12-22 0001898766 TPET:UnionAveFieldMember TPET:TrioLLCMember 2022-12-22 0001898766 TPET:UnionAveFieldMember 2023-05-12 0001898766 TPET:TrioLLCMember TPET:KenFronFieldMember 2023-10-16 0001898766 2023-10-16 2023-10-16 0001898766 TPET:TrioLLCMember 2023-04-01 2023-04-30 0001898766 TPET:TrioLLCMember 2023-04-30 0001898766 TPET:SouthSalinasProjectMember 2023-11-01 2024-07-31 0001898766 TPET:TrioLLCMember TPET:McCoolRanchPurchaseAgreementMember 2023-10-16 0001898766 TPET:McCoolRanchPurchaseAgreementMember 2023-10-16 2023-10-16 0001898766 TPET:McCoolRanchPurchaseAgreementMember 2023-10-16 0001898766 TPET:OperatorsMember TPET:McCoolRanchPurchaseAgreementMember 2024-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-09-02 2023-09-02 0001898766 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-09-02 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2024-06-19 2024-06-19 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2024-06-19 2024-06-19 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2024-06-19 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2024-05-01 2024-07-31 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-11-01 2024-07-31 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-31 0001898766 TPET:MrFrankIngriselliMember us-gaap:RestrictedStockUnitsRSUMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2022-02-28 0001898766 TPET:MrGregOverholtzerMember us-gaap:RestrictedStockUnitsRSUMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2022-02-28 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2022-02-01 2022-02-28 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2022-02-28 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2022-10-01 2022-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2024-05-01 2024-07-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2023-11-01 2024-07-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2024-07-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2023-05-01 2023-07-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2022-11-01 2023-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2023-05-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2023-05-01 2023-05-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2023-11-01 2024-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2024-05-01 2024-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2024-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2023-05-01 2023-07-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember TPET:SixEmployeeAgreementMember 2022-11-01 2023-07-31 0001898766 TPET:MichaelLPetersonMember 2023-10-23 2023-10-23 0001898766 TPET:MichaelLPetersonMember 2023-10-23 0001898766 TPET:MrPetersonMember us-gaap:RestrictedStockMember 2023-10-23 2023-10-23 0001898766 TPET:MrPetersonMember us-gaap:RestrictedStockMember 2023-10-23 0001898766 TPET:MrPetersonMember us-gaap:RelatedPartyMember 2024-03-26 0001898766 TPET:MrPetersonMember us-gaap:RestrictedStockMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2024-03-26 2024-03-26 0001898766 TPET:MrPetersonMember 2024-05-01 2024-07-31 0001898766 TPET:MrPetersonMember 2023-11-01 2024-07-31 0001898766 TPET:MrPetersonMember 2024-07-11 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2024-07-11 2024-07-11 0001898766 TPET:MrRobinRossMember 2024-07-11 2024-07-11 0001898766 TPET:MrRobinRossMember 2024-07-11 0001898766 TPET:MrRobinRossMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-11 2024-07-11 0001898766 TPET:MichaelLPetersonMember 2024-03-26 0001898766 TPET:MichaelLPetersonMember 2024-03-26 2024-03-26 0001898766 TPET:MrPetersonMember us-gaap:RestrictedStockMember TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2024-03-26 0001898766 TPET:SouthSalinasProjectMember 2022-11-01 2023-10-31 0001898766 TPET:SouthSalinasProjectMember 2023-10-31 0001898766 TPET:SouthSalinasProjectMember 2022-10-31 0001898766 TPET:OptionedAssetsRelatedPartyMember 2022-12-22 2022-12-22 0001898766 TPET:TrioLLCMember TPET:HangmanHollowFieldAssetMember TPET:OptionedAssetsRelatedPartyMember 2022-12-22 0001898766 TPET:TrioLLCMember TPET:KenFronFieldMember TPET:OptionedAssetsRelatedPartyMember 2022-12-22 0001898766 TPET:TrioLLCMember TPET:UnionAveFieldMember TPET:OptionedAssetsRelatedPartyMember 2022-12-22 0001898766 TPET:TrioLLCMember TPET:AdditionalWorkingInterestSouthSalinasProjectMember 2023-04-01 2023-04-30 0001898766 TPET:TrioLLCMember TPET:AdditionalWorkingInterestSouthSalinasProjectMember 2023-04-30 0001898766 TPET:TrioLLCMember TPET:PurchaseAndSaleAgreementMember 2021-09-14 0001898766 srt:MinimumMember TPET:NotesPayableRelatedPartyMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 srt:MaximumMember TPET:NotesPayableRelatedPartyMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 TPET:NotesPayableRelatedPartyMember us-gaap:IPOMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 us-gaap:RelatedPartyMember 2022-11-01 2023-10-31 0001898766 us-gaap:RelatedPartyMember 2021-11-01 2022-10-31 0001898766 TPET:FiveOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-10 2022-07-11 0001898766 TPET:FiveOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-11 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-10-31 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2021-11-01 2022-10-31 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-10-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-10-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2021-11-01 2022-10-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2023-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2022-11-01 2023-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2021-11-01 2022-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockUnitsRSUMember TPET:RestrictedShareIssuedToExecutivesAndEmployeesMember 2023-10-31 0001898766 TPET:SixEmployeeAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2023-05-31 0001898766 TPET:SixEmployeeAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2023-05-01 2023-05-31 0001898766 TPET:SixEmployeeAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2021-11-01 2022-10-31 0001898766 TPET:SixEmployeeAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-10-31 0001898766 TPET:SixEmployeeAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2023-10-31 0001898766 TPET:MrIngriselliMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-20 2023-07-20 0001898766 TPET:MrIngriselliMember us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-07-31 0001898766 TPET:MichaelLPetersonMember 2023-10-16 2023-10-16 0001898766 TPET:MichaelLPetersonMember 2023-10-16 0001898766 TPET:MrPetersonMember us-gaap:RestrictedStockUnitsRSUMember 2023-10-23 2023-10-23 0001898766 2023-10-23 0001898766 TPET:MrPetersonMember 2022-11-01 2023-10-31 0001898766 TPET:MrPetersonMember 2023-10-31 0001898766 TPET:ConsultingAgreementRelatedPartyMember 2023-10-16 2023-10-16 0001898766 TPET:FirstAforementionedMember TPET:UnprovedPropertyLeaseMember 2024-07-31 0001898766 TPET:FirstAforementionedMember TPET:UnprovedPropertyLeaseMember 2022-10-31 0001898766 TPET:SecondAforementionedMember TPET:UnprovedPropertyLeaseMember 2024-07-31 0001898766 TPET:ParcelOneMember 2024-07-31 0001898766 TPET:ParcelTwoMember 2024-07-31 0001898766 TPET:LeaseholdMember 2024-07-31 0001898766 TPET:FirstGroupMember TPET:UnprovedPropertyLeaseMember 2023-02-28 0001898766 TPET:FirstGroupMember TPET:UnprovedPropertyLeaseMember 2023-03-31 0001898766 TPET:SecondGroupMember TPET:UnprovedPropertyLeaseMember 2023-02-28 0001898766 TPET:SecondGroupMember TPET:UnprovedPropertyLeaseMember 2023-03-31 0001898766 TPET:AmendedARLOAgreementMember 2024-07-31 2024-07-31 0001898766 srt:DirectorMember 2022-07-09 2022-07-11 0001898766 TPET:BoardCommitteeMember 2022-07-09 2022-07-11 0001898766 us-gaap:IPOMember 2024-05-01 2024-07-31 0001898766 us-gaap:IPOMember 2023-11-01 2024-07-31 0001898766 us-gaap:IPOMember 2023-05-01 2023-07-31 0001898766 us-gaap:IPOMember 2022-11-01 2023-07-31 0001898766 TPET:AdvisorsMember 2022-07-28 0001898766 TPET:AdvisorsMember 2022-07-27 2022-07-28 0001898766 us-gaap:WarrantMember 2023-04-20 2023-04-20 0001898766 us-gaap:WarrantMember 2023-04-20 0001898766 TPET:AdvisorsMember 2023-10-04 2023-10-04 0001898766 TPET:AdvisorsMember 2023-10-04 0001898766 TPET:AdvisorsMember 2023-12-29 0001898766 2024-02-26 0001898766 TPET:FirstAforementionedMember TPET:UnprovedPropertyLeaseMember 2023-10-31 0001898766 TPET:SecondAforementionedMember TPET:UnprovedPropertyLeaseMember 2023-10-31 0001898766 us-gaap:IPOMember 2022-11-01 2023-10-31 0001898766 us-gaap:IPOMember us-gaap:WarrantMember 2023-04-20 2023-04-20 0001898766 TPET:TrioLLCMember 2022-05-01 2022-05-01 0001898766 TPET:PromissoryNoteMember 2024-07-31 0001898766 TPET:PromissoryNoteMember 2023-10-31 0001898766 TPET:InvestorsMember 2023-10-31 0001898766 TPET:InvestorsMember 2022-10-31 0001898766 us-gaap:BridgeLoanMember 2023-10-31 0001898766 us-gaap:BridgeLoanMember 2022-10-31 0001898766 us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-10-04 0001898766 us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 us-gaap:MeasurementInputExercisePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 2023-10-04 0001898766 us-gaap:MeasurementInputDiscountRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-10-04 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-12-18 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-12-29 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-01-12 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-01-12 2024-01-12 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-12-18 2023-12-18 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-12-29 2023-12-29 0001898766 2023-12-18 0001898766 2023-12-29 0001898766 2024-01-12 0001898766 TPET:ConvertibleNotesPayableOneMember 2023-12-18 2023-12-18 0001898766 TPET:ConvertibleNotesPayableOneMember 2023-12-29 2023-12-29 0001898766 TPET:ConvertibleNotesPayableOneMember 2024-01-12 2024-01-12 0001898766 srt:MinimumMember TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 srt:MaximumMember TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputSharePriceMember 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-12-29 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-29 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-29 2023-12-29 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputSharePriceMember 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-12-29 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-29 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-29 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-12-29 0001898766 TPET:NewModifiedTermsMember us-gaap:WarrantMember 2023-12-29 2023-12-29 0001898766 us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 us-gaap:MeasurementInputExercisePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 us-gaap:MeasurementInputDiscountRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-01 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-16 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-03-22 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-04-02 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-04-02 2024-04-02 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-01 2024-02-01 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-16 2024-02-16 0001898766 TPET:FirstTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-03-22 2024-03-22 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-02-01 2024-02-01 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-02-16 2024-02-16 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-03-22 2024-03-22 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-04-02 2024-04-02 0001898766 2024-02-01 0001898766 2024-02-16 0001898766 2024-03-22 0001898766 2024-04-02 0001898766 TPET:ConvertibleNotesPayableOneMember 2024-02-01 2024-02-01 0001898766 TPET:ConvertibleNotesPayableOneMember 2024-02-16 2024-02-16 0001898766 TPET:ConvertibleNotesPayableOneMember 2024-03-22 2024-03-22 0001898766 TPET:ConvertibleNotesPayableOneMember 2024-04-02 2024-04-02 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-04-02 0001898766 TPET:FirstTrancheMember 2024-02-01 2024-02-01 0001898766 TPET:FirstTrancheMember 2024-04-15 2024-04-15 0001898766 TPET:FirstTrancheMember 2024-02-01 0001898766 TPET:FirstTrancheMember 2024-04-15 0001898766 2024-02-05 2024-02-05 0001898766 srt:MaximumMember 2024-02-05 0001898766 srt:MinimumMember 2024-02-05 0001898766 TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-02 0001898766 TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-05 0001898766 TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-05 2024-02-05 0001898766 TPET:SecondTrancheMember us-gaap:ConvertibleNotesPayableMember 2024-02-02 2024-02-02 0001898766 TPET:SecondTrancheMember 2024-02-02 2024-02-02 0001898766 TPET:SecondTrancheMember 2024-02-05 2024-02-05 0001898766 TPET:SecondTrancheMember 2024-02-02 0001898766 TPET:SecondTrancheMember 2024-02-05 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-07-31 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-10-31 0001898766 us-gaap:ConvertibleNotesPayableMember 2023-11-01 2024-07-31 0001898766 us-gaap:ConvertibleNotesPayableMember 2022-11-01 2023-10-31 0001898766 TPET:TrioLLCMember TPET:KenFronFieldMember TPET:McCoolRanchPurchaseAgreementMember 2023-10-16 0001898766 TPET:McCoolRanchPurchaseAgreementMember 2023-11-01 2024-07-31 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-03-27 2024-03-27 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-03-27 0001898766 srt:ScenarioForecastMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-09-30 0001898766 srt:ScenarioForecastMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-10-30 0001898766 srt:ScenarioForecastMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-11-30 0001898766 srt:ScenarioForecastMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-12-30 0001898766 srt:ScenarioForecastMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2025-01-30 0001898766 srt:MinimumMember TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-03-27 0001898766 srt:MaximumMember 2024-03-27 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-07-31 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2023-10-31 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2024-05-01 2024-07-31 0001898766 TPET:MarchTwoThousandTwentyFourDebtFinancingMember 2023-11-01 2024-07-31 0001898766 srt:ChiefExecutiveOfficerMember 2024-03-26 0001898766 2024-03-26 0001898766 srt:ChiefExecutiveOfficerMember 2024-03-26 2024-03-26 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-24 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-24 2024-04-24 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember TPET:CommitmentSharesMember 2024-04-24 2024-04-24 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember us-gaap:CommonStockMember 2024-04-24 0001898766 srt:MinimumMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember us-gaap:CommonStockMember 2024-04-24 0001898766 srt:MinimumMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-24 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-05-01 2024-07-31 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2023-11-01 2024-07-31 0001898766 2024-04-24 2024-04-24 0001898766 srt:MinimumMember 2024-04-24 2024-04-24 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember 2024-04-24 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-05-31 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-05-31 2024-05-31 0001898766 TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-07-31 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember 2024-06-27 2024-06-27 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputSharePriceMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 us-gaap:MeasurementInputExercisePriceMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 us-gaap:MeasurementInputExpectedTermMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputOptionVolatilityMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputExpectedDividendRateMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputDiscountRateMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember 2024-07-31 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember 2023-10-31 0001898766 TPET:JuneTwoThousandTwentyFourDebtFinancingMember 2023-11-01 2024-07-31 0001898766 TPET:SouthSalinasProjectMember us-gaap:RelatedPartyMember TPET:PurchaseAndSaleAgreementMember TPET:TrioLLCMember 2021-09-14 0001898766 srt:MinimumMember us-gaap:RelatedPartyMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 srt:MaximumMember us-gaap:RelatedPartyMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 us-gaap:RelatedPartyMember us-gaap:IPOMember TPET:TrioLLCMember 2022-05-26 2022-05-27 0001898766 TPET:InvestorsMember 2022-01-26 2022-01-28 0001898766 TPET:InvestorsMember TPET:JanuaryTwoThousandAndTwentyTwoNotesMember 2022-01-28 0001898766 TPET:InvestorsMember 2022-01-28 0001898766 srt:MaximumMember TPET:InvestorsMember 2022-01-28 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2022-01-26 2022-01-28 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2022-01-28 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2023-10-31 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2022-10-31 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2022-11-01 2023-10-31 0001898766 TPET:InvestorsMember us-gaap:IPOMember 2021-11-01 2022-10-31 0001898766 us-gaap:BridgeLoanMember 2022-09-01 2022-09-30 0001898766 us-gaap:BridgeLoanMember 2022-09-30 0001898766 us-gaap:BridgeLoanMember us-gaap:IPOMember 2022-09-30 0001898766 srt:MaximumMember us-gaap:BridgeLoanMember 2022-09-30 0001898766 TPET:InvestorsMember us-gaap:BridgeLoanMember 2023-10-31 0001898766 TPET:InvestorsMember us-gaap:BridgeLoanMember 2022-10-31 0001898766 us-gaap:BridgeLoanMember 2022-11-01 2023-10-31 0001898766 us-gaap:BridgeLoanMember 2021-11-01 2022-10-31 0001898766 TPET:VotingAgreementsMember 2023-10-04 0001898766 2023-10-04 0001898766 us-gaap:CommonStockMember 2023-11-11 2023-11-11 0001898766 TPET:VendorMember us-gaap:CommonStockMember 2023-11-11 2023-11-11 0001898766 TPET:VendorMember us-gaap:CommonStockMember 2023-11-11 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-02-01 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-02-16 0001898766 us-gaap:ConvertibleNotesPayableMember 2024-03-22 0001898766 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2024-02-01 2024-02-01 0001898766 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2024-04-15 2024-04-15 0001898766 2024-04-15 0001898766 2024-02-01 2024-02-01 0001898766 2024-04-15 2024-04-15 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-03-20 2024-03-20 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-03-20 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-03-26 2024-03-26 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-01-01 2024-01-31 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-03-26 0001898766 TPET:InvestorsMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-16 2024-04-16 0001898766 TPET:InvestorsMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-24 2024-04-24 0001898766 TPET:InvestorsMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-16 0001898766 TPET:InvestorsMember TPET:AprilTwoThousandTwentyFourDebtFinancingMember 2024-04-24 0001898766 TPET:ConsultantsMember us-gaap:CommonStockMember TPET:MarketingServicesAgreementMember 2024-04-29 2024-04-29 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-04-29 2024-04-29 0001898766 TPET:ConsultantsMember TPET:MarketingServicesAgreementMember 2024-04-29 0001898766 TPET:FirstTrancheMember TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputExercisePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:FirstTrancheMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:SecondTrancheMember TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExercisePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 2023-12-29 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2023-12-29 0001898766 TPET:SecondTrancheMember TPET:SeniorSecuredConvertiblePromissoryNoteMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputSharePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExercisePriceMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 2024-01-02 0001898766 TPET:SecondTrancheMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ConvertibleNotesPayableMember TPET:OctoberTwoThousandTwentyThreeSPAMember 2024-01-02 0001898766 TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 us-gaap:MeasurementInputExercisePriceMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputSharePriceMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 us-gaap:MeasurementInputExpectedTermMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputOptionVolatilityMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputExpectedDividendRateMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 2024-06-27 0001898766 us-gaap:MeasurementInputDiscountRateMember TPET:JuneTwoThousandTwentyFourSPAMember 2024-06-27 0001898766 TPET:ConsultantMember us-gaap:EmployeeStockOptionMember 2023-08-15 2023-08-15 0001898766 TPET:ConsultantMember us-gaap:EmployeeStockOptionMember 2023-08-15 0001898766 TPET:InvestorsMember us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-01-31 0001898766 us-gaap:WarrantMember 2022-01-28 0001898766 TPET:GPLVenturesLLCMember 2022-04-28 2022-04-28 0001898766 TPET:GPLVenturesLLCMember 2022-04-28 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-10 2022-07-11 0001898766 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-11 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockMember 2022-10-17 2022-10-17 0001898766 TPET:InvestorsMember 2022-10-17 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockMember 2021-11-01 2022-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockMember 2022-11-01 2023-10-31 0001898766 TPET:ExecutivesMember us-gaap:RestrictedStockMember 2023-10-31 0001898766 us-gaap:CommonStockMember 2022-12-01 2022-12-31 0001898766 us-gaap:CommonStockMember 2022-12-31 0001898766 us-gaap:IPOMember 2023-04-01 2023-04-30 0001898766 us-gaap:IPOMember 2023-04-30 0001898766 us-gaap:CommonStockMember 2023-04-20 2023-04-20 0001898766 us-gaap:CommonStockMember 2023-04-20 0001898766 TPET:ConsultantsMember 2023-04-20 2023-04-20 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2023-05-01 2023-05-01 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2023-05-01 0001898766 TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2022-11-01 2023-10-31 0001898766 TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2021-11-01 2022-10-31 0001898766 TPET:TwoThousandTwentyTwoEquityIncentivePlanMember 2023-10-31 0001898766 us-gaap:CommonStockMember 2023-05-02 2023-05-02 0001898766 us-gaap:CommonStockMember 2023-06-23 2023-06-23 0001898766 us-gaap:CommonStockMember 2023-07-11 2023-07-11 0001898766 us-gaap:CommonStockMember 2023-07-11 0001898766 us-gaap:CommonStockMember 2023-05-02 0001898766 us-gaap:CommonStockMember 2023-06-23 0001898766 TPET:ConsultantsMember 2023-05-02 2023-05-02 0001898766 TPET:ConsultantsMember 2023-06-23 2023-06-23 0001898766 TPET:ConsultantsMember 2023-07-11 2023-07-11 0001898766 TPET:MarcumLlpMember us-gaap:CommonStockMember 2023-06-30 2023-06-30 0001898766 TPET:MarcumLlpMember us-gaap:CommonStockMember 2023-06-30 0001898766 2023-06-30 2023-06-30 0001898766 TPET:MrFrankIngriselliMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-20 2023-07-20 0001898766 TPET:MrFrankIngriselliMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-20 0001898766 TPET:FourOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-02 2023-09-02 0001898766 TPET:FourOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-02 0001898766 TPET:FourOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-10-31 0001898766 TPET:FourOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2021-11-01 2022-10-31 0001898766 TPET:FourOutsideDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-10-31 0001898766 2023-10-16 0001898766 us-gaap:WarrantMember 2022-01-31 0001898766 2022-01-31 0001898766 us-gaap:MeasurementInputOptionVolatilityMember 2022-01-31 0001898766 us-gaap:MeasurementInputExercisePriceMember 2022-01-31 0001898766 us-gaap:WarrantMember 2023-07-10 2023-07-10 0001898766 TPET:NewModifiedTermsMember 2023-07-10 0001898766 TPET:OriginalIssueTermsMember 2023-07-10 0001898766 us-gaap:WarrantMember 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputSharePriceMember 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-07-10 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-07-10 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-07-10 2023-07-10 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputSharePriceMember 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-07-10 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-07-10 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-07-10 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-07-10 0001898766 TPET:NewModifiedTermsMember us-gaap:WarrantMember 2023-07-10 2023-07-10 0001898766 us-gaap:WarrantMember 2023-09-20 2023-09-20 0001898766 us-gaap:WarrantMember 2023-09-21 2023-09-21 0001898766 TPET:OriginalIssueTermsMember 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputSharePriceMember 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-09-20 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-09-20 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-20 2023-09-20 0001898766 TPET:OriginalIssueTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-09-20 0001898766 TPET:NewModifiedTermsMember 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputSharePriceMember 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExercisePriceMember 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedTermMember 2023-09-20 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-09-20 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-20 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:MeasurementInputDiscountRateMember 2023-09-20 0001898766 TPET:NewModifiedTermsMember us-gaap:WarrantMember 2023-09-20 2023-09-20 0001898766 us-gaap:CommonStockMember TPET:TwoAccreditedInvestorsMember 2022-12-31 0001898766 us-gaap:OverAllotmentOptionMember 2022-12-31 0001898766 us-gaap:IPOMember 2022-12-31 0001898766 us-gaap:WarrantMember 2023-10-31 0001898766 us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 us-gaap:WarrantMember 2024-07-31 0001898766 2020-11-01 2021-10-31 0001898766 TPET:ExercisePriceRangeOneMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeOneMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeFourMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeFourMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeSixMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeSixMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeSevenMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeSevenMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeEightMember us-gaap:WarrantMember 2024-07-31 0001898766 TPET:ExercisePriceRangeEightMember us-gaap:WarrantMember 2023-11-01 2024-07-31 0001898766 TPET:ExercisePriceRangeOneMember us-gaap:WarrantMember 2023-10-31 0001898766 TPET:ExercisePriceRangeOneMember us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 TPET:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2023-10-31 0001898766 TPET:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 TPET:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2023-10-31 0001898766 TPET:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 TPET:ExercisePriceRangeFourMember us-gaap:WarrantMember 2023-10-31 0001898766 TPET:ExercisePriceRangeFourMember us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2023-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2020-11-01 2021-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2020-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2023-11-01 2024-07-31 0001898766 us-gaap:EmployeeStockOptionMember 2024-07-31 0001898766 us-gaap:EmployeeStockOptionMember 2021-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2021-11-01 2022-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2022-10-31 0001898766 us-gaap:EmployeeStockOptionMember 2022-11-01 2023-10-31 0001898766 us-gaap:EmployeeStockOptionMember TPET:ExercisePriceRangeOneMember 2024-07-31 0001898766 us-gaap:EmployeeStockOptionMember TPET:ExercisePriceRangeOneMember 2023-11-01 2024-07-31 0001898766 us-gaap:EmployeeStockOptionMember TPET:ExercisePriceRangeOneMember 2023-10-31 0001898766 us-gaap:EmployeeStockOptionMember TPET:ExercisePriceRangeOneMember 2022-11-01 2023-10-31 0001898766 us-gaap:SubsequentEventMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2024-08-01 2024-08-01 0001898766 us-gaap:SubsequentEventMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2024-08-01 0001898766 srt:ScenarioForecastMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2025-01-30 0001898766 srt:ScenarioForecastMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2025-02-28 0001898766 srt:ScenarioForecastMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2025-03-30 0001898766 srt:ScenarioForecastMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2025-04-30 0001898766 srt:ScenarioForecastMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2025-05-30 0001898766 us-gaap:SubsequentEventMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2024-08-06 2024-08-06 0001898766 us-gaap:SubsequentEventMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2024-08-06 0001898766 srt:ScenarioForecastMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2025-01-30 0001898766 srt:ScenarioForecastMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2025-02-28 0001898766 srt:ScenarioForecastMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2025-03-30 0001898766 srt:ScenarioForecastMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2025-04-30 0001898766 srt:ScenarioForecastMember TPET:AugustSixTwoThousandTwentyFourSPAMember 2025-05-30 0001898766 us-gaap:SubsequentEventMember TPET:AugustOneTwoThousandTwentyFourSPAMember 2024-08-06 0001898766 us-gaap:SubsequentEventMember 2024-08-16 0001898766 TPET:TwoClassOneDirectorsMember us-gaap:SubsequentEventMember 2024-08-15 2024-08-15 0001898766 us-gaap:SubsequentEventMember 2024-08-15 2024-08-15 0001898766 srt:MinimumMember us-gaap:SubsequentEventMember 2024-08-15 0001898766 srt:MaximumMember us-gaap:SubsequentEventMember 2024-08-15 0001898766 TPET:SeniorSecuredConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember 2023-11-11 0001898766 TPET:CommonWarrantMember us-gaap:SubsequentEventMember 2023-11-11 0001898766 TPET:PlacementAgentWarrantMember us-gaap:SubsequentEventMember 2023-11-11 0001898766 us-gaap:SubsequentEventMember TPET:ARAgreementMember 2023-11-10 2023-11-10 0001898766 us-gaap:SubsequentEventMember TPET:AmendedARAgreementMember 2023-12-29 0001898766 us-gaap:SubsequentEventMember TPET:AmendedARAgreementMember 2023-12-29 2023-12-29 0001898766 us-gaap:SubsequentEventMember TPET:AmendedARAgreementMember TPET:HeavySweetOilLLCMember 2023-12-29 2023-12-29 0001898766 us-gaap:SubsequentEventMember 2023-12-28 0001898766 us-gaap:SubsequentEventMember 2023-12-29 0001898766 us-gaap:SubsequentEventMember TPET:AmendmentToOctoberTwentyTwentyThreeSPAMember 2023-12-29 0001898766 us-gaap:SubsequentEventMember TPET:AmendmentToSecondTrancheFinancingMember 2024-01-02 2024-01-02 0001898766 us-gaap:SubsequentEventMember TPET:AmendmentToSecondTrancheFinancingMember 2024-01-02 0001898766 us-gaap:WarrantMember us-gaap:SubsequentEventMember TPET:AmendmentToSecondTrancheFinancingMember 2024-01-02 0001898766 us-gaap:WarrantMember 2022-11-01 2023-10-31 0001898766 us-gaap:WarrantMember 2021-11-01 2022-10-31 0001898766 TPET:ConvertibleNotesMember 2022-11-01 2023-10-31 0001898766 TPET:ConvertibleNotesMember 2021-11-01 2022-10-31 0001898766 TPET:CommitmentSharesMember 2022-11-01 2023-10-31 0001898766 TPET:CommitmentSharesMember 2021-11-01 2022-10-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2022-11-01 2023-10-31 0001898766 us-gaap:RestrictedStockUnitsRSUMember 2021-11-01 2022-10-31 0001898766 TPET:SecuritiesPurchaseAgreementMember TPET:GPLVenturesLLCMember 2022-11-01 2023-10-31 0001898766 us-gaap:IPOMember 2023-10-31 iso4217:USD shares iso4217:USD shares utr:acre utr:sqft pure true 0001898766 S-1/A

P5Y

P3Y

Amendment No. 2 Trio Petroleum Corp. DE 87-1968201 5401 Business Park Suite 115 Bakersfield CA 93309 (661) 324-3911 Robin Ross 5401 Business Park South Suite Bakersfield CA 93309 (661) 324-3911 Non-accelerated Filer true true false

293107

1561924

324603

133417

617710

1695341

11083285

9947742

11700995

11643083

1435521

609360

2778

1217597

18633 21651

1319890

254589

154002

402725

3588138

1851386

50397

48313

50397

48313

3638535

1899699

0.0001

500000

0.0001

24500000

2516419

1552328

252

155

10010

26445654

20200121

-18373436

-10446882

8062460

9743384

11700995

11643083

63052

135975

8054

199637

132871

225052

1321961

1171256

3744914

2215775

238322

785962

1150852

896947

695

2084

1569032

2157550

5030721

3339858

-1505980

-2157550

-4894746

-3339858

668381

1810370

746930

13051 10500 13051 1196306 1125000

4210

14632

-672591

-13051

-3031808

-1884981

-2178571

-2170601

-7926554

-5224839

-2178571

-2170601

-7926554

-5224839

-0.87

-1.63

-3.84

-5.04

2516419

1327839

2061704

1037442

2516419

252

-10010

25949631

-16194865

9745008

257701

238322

-2178571

2516419

252

-10010

26445654

-18373436

8062460

1552328

155

-10010

20200121

-10446882

9743384

95000

694490

694500

409191

816681

3323505

3323587

75000 8 667492 667500 22590 3 3

1150852

-7926554

2516419

252

-10010

26445654

-18373436

8062460

1239961

124

-10010

16754953

-6956694

9788373

122474

1812623

1812635

2400

80159

35000

-4

59993 6 -6

21250

785960

785962

-2170601

1481078

148

-10010

19433685

-9127295

10296528

848640

-10010

6635505

-3902456

2723124

848640

-10010

6635505

-3902456

2723124

20000

371998

372000

251946

5164850

5164875

18750 2 1124998 1125000 100000 10 3342616 3342626

4000

122474

1812623

1812635

2400

80160

35000

-4

59993 6 -6

21875

896945

896947

-5224839

1481078

148

-10010

19433685

-9127295

10296528

1481078

148

-10010

19433685

-9127295

10296528

-7926554

-5224839

694500

3323587

25000

2084

1125000 129589

1803758

432693

-250876

1150852

896947

191186

114290

826161

315045

556727

118642

-2542360

1135543

249520

2959580

-3018

1405050

-1138561

-1804050

452160

2550000

1836880

125000

550000

1472512

6000000

210778

1812635

1013493

-248898

5778790

-1268817

1432380

1561924

73648

293107

1506028

409191 667500

134550

120 4000

NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS Company Organization Trio Petroleum Corp. (“Trio Petroleum”, the “Company” or “TPET”) is a California-based oil and gas exploration and development company headquartered in Bakersfield, California, with its principal executive offices located at 5401 Business Park South, Suite 115, Bakersfield, California 93309, and with operations in Monterey County, California, and Uintah County, Utah. The Company was incorporated on July 19, 2021, under the laws of Delaware to acquire, fund, and operate oil and gas exploration, development and production projects, initially focusing on one major asset in California, the South Salinas Project (“South Salinas Project”). The Company has since acquired interests in the McCool Ranch Oil Field in Monterey County, California, and in the Asphalt Ridge Project in Uintah County, Utah. The Company has had revenue-generating operations since the McCool Ranch Oil Field was restarted on February 22, 2024, and recognized its first revenues in the fiscal quarter ended April 30, 2024, and received the proceeds from these operations in June 2024. Acquisition of South Salinas Project The Company was initially formed to acquire from Trio Petroleum LLC (“Trio LLC”) an approximate <span id="xdx_905_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_pid_dp_uPure_c20240731__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember_z3qLMJVAVX4k" title="Business acquisition percentage">82.75% working interest (which was subsequently increased to an approximate <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230430__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--AcquisitionOfSouthSalinasProjectMember_zmdzJ7vD01jc" title="Business acquisition percentage of working interest">85.775% working interest in April 2023), in the large, approximately 9,300-acre South Salinas Project that is located in Monterey County, California, and subsequently partner with certain members of Trio LLC’s management team to develop and operate those assets. In September 2021, the Company entered into a Purchase and Sale Agreement (“Trio LLC PSA”) with Trio LLC to acquire the purchased percentage of the South Salinas Project’s leases, wells and inventory in exchange for $<span id="xdx_906_eus-gaap--PaymentsToAcquireBusinessesGross_c20210930__20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zE1Elf48QE49" title="Payments to acquire businesses net of cash acquired">300,000 cash, a non-interest-bearing note payable of $<span id="xdx_904_eus-gaap--AccountsPayableInterestBearingCurrentAndNoncurrent_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zdRFB2vYWOB3" title="Non interest bearing notes payable">3,700,000 and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210930__20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zyrLMSsOE44h" title="Number of shares issued">245,000 shares of the Company’s $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zX8RnsddvJth" title="Common stock price per share">0.0001 par value common stock (which constituted 45% of the total number of issued shares of the Company at that time). The Company accounted for the purchase as an asset acquisition, as prescribed in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 – Business Combinations. The assets and associated asset retirement obligations (“ARO”) were recorded based on relative fair value at the estimated fair value of the consideration paid. The Company holds an approximate <span id="xdx_906_ecustom--PurchaseOfAdditionalOfRoyaltiesInterestPercentage_iI_dp_uPure_c20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zbXZG1Mju2vg" title="Purchase of additional of royalties interest percentage">68.62% interest after the application of royalties (“net revenue interest”) in the South Salinas Project, while Trio LLC holds an approximate <span id="xdx_904_ecustom--PurchaseOfAdditionalInterestPercentage_iI_dp_uPure_c20210930__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zrYokypyUBq6" title="Working interest percentage">3.8% working interest in the South Salinas Project; the Company and Trio LLC are separate and distinct companies. There are two contiguous areas of notable oil/gas accumulations in the South Salinas Project; the first is the Humpback Area that occurs in the northern part of the project and the second is the Presidents Area (“Presidents Oil Field”) that occurs in the southern part of the project. As of July 31, 2024 and October 31, 2023, there were no proved reserves attributable to the approximate <span id="xdx_909_eus-gaap--AreaOfLand_iI_usqft_c20231031__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zv6xMtHrMAT3" title="Area of land">9,300 acres of the property. Since it was returned to production in March 2024, the HV-3A well at the South Salinas Project has been producing oil with a generally favorable oil-water ratio; the Company expects to take steps to improve oil production from this well in the third or fourth calendar quarter of 2024 and expects to receive the first revenue from oil produced from the well in the third calendar quarter of 2024. Initial Public Offering The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold 100,000 shares of its common stock for total gross proceeds of $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zYmVXqdTrRLa" title="Sale of stock, consideration received on transaction">6,000,000, which is described more fully in Note 4. Additional Acquisitions - McCool Ranch Oil Field & Asphalt Ridge Leasehold In October 2023, the Company entered into an agreement (“McCool Ranch Purchase Agreement”) with Trio LLC for purchase of a <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231031__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember_ziu79ohqFIhj" title="Business acquisition, percentage of voting interests acquired">21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project; the Company initially began refurbishment operations with respect to a water disposal well. After refurbishment was successfully accomplished, the Company restarted production operations on the assets (see Note 5 for further information). In <span id="xdx_909_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20231101__20231130__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zeVlcSjpfdO9" title="Business acquisition, description of acquired entity">November 2023, the Company entered into a leasehold acquisition and development option agreement (“ARLO Agreement”) with Heavy Sweet Oil, LLC (“HSO”), which gave the Company a 9-month option for the exclusive right to acquire up to a <span id="xdx_909_ecustom--PercentageOfProductionShare_pid_dp_uPure_c20231101__20231130__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zqWzh0qwbLGf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Percentage of production share">20% interest in a <span id="xdx_90D_eus-gaap--AreaOfLand_iI_uAcre_c20231130__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zaTqDnEUtuD2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Area of land">960-acre drilling and production program in the Asphalt Ridge leases for $<span id="xdx_908_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231101__20231130__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zfzSgKHMPgdj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Payment for acquisition, loan and lease, held-for-investment">2,000,000. In December 2023, the Company amended the agreement and funded $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231201__20231231__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zjOAQ2USbgWa" title="Business combination, consideration transferred">200,000 in exchange for an immediate <span id="xdx_903_ecustom--FinanceLeaseInterestPercentage_pid_dp_uPure_c20231201__20231231__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zUif4hmNA765" title="Finance lease interest percentage">2% interest in the leases; subsequently, in January 2024, the Company funded an additional $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240101__20240131__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_z4a3hZG6XSMd" title="Business combination, consideration transferred">25,000 resulting in a total <span id="xdx_906_ecustom--FinanceLeaseInterestPercentage_pid_dp_uPure_c20240101__20240131__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zruqtgY1LjA7" title="Finance lease interest percentage">2.25% working interest in the leases. Such funds are to be used for the building of roads and related infrastructure in furtherance of the development of the leases; at present, the Company has until February 10, 2025 to pay HSO an additional approximate $<span id="xdx_903_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_pn3n6_c20240101__20240131__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zrvG6NJcTUE" title="Payment for acquisition, loan and lease, held-for-investment">1.775 million to exercise the option for the remaining <span id="xdx_90D_ecustom--PercentageOfProductionShare_pid_dp_uPure_c20240101__20240131__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HeavySweetOilMember_zZOPKAWx8Vzc" title="Percentage of production share">17.75% interest in the leases (see Note 6 for further information). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

0.8275

0.85775

9300

300000

3700000

245000

0.0001

0.45 0.6862 0.038

9300

100000

6000000

0.21918315

November 2023, the Company entered into a leasehold acquisition and development option agreement (“ARLO Agreement”) with Heavy Sweet Oil, LLC (“HSO”), which

0.20

960

2000000

200000

0.02

25000

0.0225

1775000

0.1775

NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Amounts presented in the balance sheet as of October 31, 2023 are derived from our audited financial statements as of that date. The unaudited condensed financial statements as of and for the three- and nine-month periods ended July 31, 2024 and 2023 have been prepared in accordance with U.S. GAAP and the interim reporting rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report on Form 10-K/A filed with the SEC on June 13, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, accounts receivable, bad debt expense, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates. Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers” (“Topic 606”) requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services; refer to Note 5 – Revenue from Contracts with Customers for additional information. The Company’s revenue is comprised of revenue from exploration and production activities to produce oil. The Company’s oil is sold to one customer who is a marketer, and payment is received in the month following delivery. The Company recognizes sales revenues from oil when control transfers to the customer at the time of delivery. Revenue is measured based on the contract price, which may include adjustments for market differentials and downstream costs incurred by the customer, including gathering, transportation or short load fees. Revenues are recognized for the sale of the Company’s percentage of working interest, adjusted for any incoming and outstanding expenses and oil and gas assessments. Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of July 31, 2024 and October 31, 2023, the Company recorded $210,778 and $350,320 in debt issuance costs, respectively. Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in exploration and/or early production stages and the Company began generating revenue from its operations during the quarterly period ended April 30, 2024. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of July 31, 2024 and October 31, 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization. Unproved oil and natural gas properties Unproved oil and natural gas properties have unproved lease acquisition costs, which are capitalized until the lease expires or otherwise until the Company specifically identifies a lease that will revert to the lessor, at which time the Company charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of July 31, 2024 and October 31, 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization; see further discussion in Note 6. Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties. Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project (“SSP”) acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the SSP acquisition in future exploration, production and/or disposal (i.e., disposal of produced water or CO2 by injection) activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetRetirementObligation_iS_c20231101__20240731_zMMrfdRyWN8h" style="width: 16%; text-align: right" title="ARO, beginning balance">51,091</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accretion expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccretionExpense_c20231101__20240731_zDGYtLRnhXMf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion expense">2,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – July 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetRetirementObligation_iE_c20231101__20240731_zWOHw1oJKEWc" style="text-align: right" title="ARO, ending balance">53,175</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: ARO – current</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetRetirementObligationCurrent_iI_c20240731_zHOPYzaAPqKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20240731_zOprNemfn1C" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">50,397</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210914__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinaProjectMember_zHCBnxmMJSia" title="Business acquisition, percentage of voting interests acquired">82.75% working interest (which was subsequently increased to an <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230430__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinaProjectMember_z7XsNs4IkxOf" title="Business acquisition, percentage of voting interests acquired">85.775% working interest as of April 2023) in the SSP from Trio LLC in exchange for cash, a note payable to Trio LLC and the issuance of 245,000 shares of common stock. As of the date of the acquisition, Trio LLC owned 45% of the outstanding shares of the Company and was considered a related party. As of July 31, 2024 and October 31, 2023, Trio LLC owned less than <span id="xdx_90B_ecustom--BusinessAcquisitionOfOutstandingSharesPercentage_iI_pid_dp_uPure_c20240731__dei--LegalEntityAxis__custom--TrioLLCMember_zBfuPYYq0zW" title="Business acquisition of outstanding shares percentage">1% and <span id="xdx_90D_ecustom--BusinessAcquisitionOfOutstandingSharesPercentage_iI_pid_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember_zUqeVOKsPYP1" title="Business acquisition of outstanding shares percentage">1%, respectively, of the outstanding shares of the Company. Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degrees by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Amounts presented in the balance sheet as of October 31, 2023 are derived from our audited financial statements as of that date. The unaudited condensed financial statements as of and for the three- and nine-month periods ended July 31, 2024 and 2023 have been prepared in accordance with U.S. GAAP and the interim reporting rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report on Form 10-K/A filed with the SEC on June 13, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, accounts receivable, bad debt expense, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates.

Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers” (“Topic 606”) requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services; refer to Note 5 – Revenue from Contracts with Customers for additional information. The Company’s revenue is comprised of revenue from exploration and production activities to produce oil. The Company’s oil is sold to one customer who is a marketer, and payment is received in the month following delivery. The Company recognizes sales revenues from oil when control transfers to the customer at the time of delivery. Revenue is measured based on the contract price, which may include adjustments for market differentials and downstream costs incurred by the customer, including gathering, transportation or short load fees. Revenues are recognized for the sale of the Company’s percentage of working interest, adjusted for any incoming and outstanding expenses and oil and gas assessments.

Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of July 31, 2024 and October 31, 2023, the Company recorded $210,778 and $350,320 in debt issuance costs, respectively.

210778

350320

Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in exploration and/or early production stages and the Company began generating revenue from its operations during the quarterly period ended April 30, 2024. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of July 31, 2024 and October 31, 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization.

Unproved oil and natural gas properties Unproved oil and natural gas properties have unproved lease acquisition costs, which are capitalized until the lease expires or otherwise until the Company specifically identifies a lease that will revert to the lessor, at which time the Company charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of July 31, 2024 and October 31, 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization; see further discussion in Note 6.

Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties.

Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project (“SSP”) acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the SSP acquisition in future exploration, production and/or disposal (i.e., disposal of produced water or CO2 by injection) activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetRetirementObligation_iS_c20231101__20240731_zMMrfdRyWN8h" style="width: 16%; text-align: right" title="ARO, beginning balance">51,091</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accretion expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccretionExpense_c20231101__20240731_zDGYtLRnhXMf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion expense">2,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – July 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetRetirementObligation_iE_c20231101__20240731_zWOHw1oJKEWc" style="text-align: right" title="ARO, ending balance">53,175</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: ARO – current</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetRetirementObligationCurrent_iI_c20240731_zHOPYzaAPqKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20240731_zOprNemfn1C" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">50,397</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Components of the changes in ARO are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetRetirementObligation_iS_c20231101__20240731_zMMrfdRyWN8h" style="width: 16%; text-align: right" title="ARO, beginning balance">51,091</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accretion expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccretionExpense_c20231101__20240731_zDGYtLRnhXMf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion expense">2,084</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – July 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetRetirementObligation_iE_c20231101__20240731_zWOHw1oJKEWc" style="text-align: right" title="ARO, ending balance">53,175</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: ARO – current</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetRetirementObligationCurrent_iI_c20240731_zHOPYzaAPqKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20240731_zOprNemfn1C" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">50,397</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

51091

2084

53175

2778

50397

Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210914__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinaProjectMember_zHCBnxmMJSia" title="Business acquisition, percentage of voting interests acquired">82.75% working interest (which was subsequently increased to an <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230430__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinaProjectMember_z7XsNs4IkxOf" title="Business acquisition, percentage of voting interests acquired">85.775% working interest as of April 2023) in the SSP from Trio LLC in exchange for cash, a note payable to Trio LLC and the issuance of 245,000 shares of common stock. As of the date of the acquisition, Trio LLC owned 45% of the outstanding shares of the Company and was considered a related party. As of July 31, 2024 and October 31, 2023, Trio LLC owned less than <span id="xdx_90B_ecustom--BusinessAcquisitionOfOutstandingSharesPercentage_iI_pid_dp_uPure_c20240731__dei--LegalEntityAxis__custom--TrioLLCMember_zBfuPYYq0zW" title="Business acquisition of outstanding shares percentage">1% and <span id="xdx_90D_ecustom--BusinessAcquisitionOfOutstandingSharesPercentage_iI_pid_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember_zUqeVOKsPYP1" title="Business acquisition of outstanding shares percentage">1%, respectively, of the outstanding shares of the Company.

0.8275

0.85775

245000

0.45 0.01 0.01

Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degrees by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

NOTE 3 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of July 31, 2024, the Company had $293,107 in its operating bank account and a working capital deficit of $2,970,428. To date, the Company has been funding operations through proceeds from the issuance of common stock, financing through certain investors, the consummation of its IPO in April 2023 (see Note 4), and convertible note financing under two tranches in October 2023 and December 2023, pursuant to which it raised total gross proceeds of $2,371,500. Additionally, the Company received funds in the amount of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_c20240301__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zJsBui1N2RAg" title="Proceeds from issuance of unsecured debt">125,000 from an unsecured promissory note from its CEO (see Note 9), as well as gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_c20240301__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zPaA0lFF6kY5" title="Proceeds from issuance of unsecured debt">184,500 from a promissory note with an investor in March 2024 (see Note 9) and gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20240401__20240430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zSEKqY8ziK6c">720,000 from convertible debt financing with two investors in April 2024 (see Note 9). As of the end of the third fiscal quarter, the Company received gross proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_c20240501__20240731__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zqgWtPkQXCmj" title="Proceeds from convertible debt">720,000 from convertible note financing with the same April 2024 investors (see Note 9) and subsequent to the quarter, secured a financing with gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromConvertibleDebt_c20240301__20240331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zDpVNQpc0wr7" title="Proceeds from convertible debt">134,000 from the March 2024 investor (see Note 13). The Company also expects to receive additional funding from a public offering on Form S-1, an amendment to which was filed with the Securities and Exchange Commission (“SEC”) on August 8, 2024. The accompanying condensed financial statements have been prepared on the basis that the Company will continue as a going concern over the next twelve months from the date of issuance of these condensed financial statements, which assumes the realization of assets and the satisfaction of liabilities in the normal course of business. As of July 31, 2024, the Company has an accumulated deficit of $18,373,436 and has experienced losses from continuing operations. Based on the Company’s cash balance as of July 31, 2024 and projected cash needs for the twelve months following the issuance of these condensed financial statements, management estimates that it will need to generate sufficient sales revenue and/or raise additional capital to cover operating and capital requirements. Management will need to raise the additional funds by issuing additional shares of common stock or other equity securities or obtaining additional debt financing. Although management has been successful to date in raising necessary funding and obtaining financing through investors, there can be no assurance that any required future financing can be successfully completed on a timely basis, on terms acceptable to the Company, or at all. Based on these circumstances, management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these condensed financial statements. Accordingly, the accompanying condensed financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

293107

2970428

2371500

125000

184500

720000

134000

-18373436

NOTE 4 – INITIAL PUBLIC OFFERING The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6KMNA2Mlqib" title="Sale of stock, number of shares issued in transaction">100,000 shares of common stock at a public offering price of $60.00 per share for gross proceeds of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zo41HKWJ5xL4" title="Proceeds from issuance initial public offering">6,000,000. After deducting the underwriting commissions, discounts and offering expenses payable by the Company, it received net proceeds of approximately $4,940,000. The Company’s common stock is listed on the NYSE American under the symbol TPET. The Company also issued warrants to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3H5iihm0no" title="Class of warrant or right, number of securities called by warrants or rights">5,000 shares of common stock to the underwriters at an exercise price of $66.00 per share (110% of public offering price), the cost of which was offset to additional paid-in capital upon IPO.

100000

60.00

6000000

4940000

5000

66.00

1.10

NOTE 5 – REVENUE FROM CONTRACTS WITH CUSTOMERS Disaggregation of Revenue from Contracts with Customers The following table disaggregates revenue by significant product type for the three- and nine-month periods ended July 31, 2024 and 2023: SCHEDULE OF DISAGGREGATES REVENUE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_49D_20240501__20240731_zeVT7xQx067i" style="text-align: center">Three Months Ended</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" id="xdx_49C_20230501__20230731_zgnL0I7Rrxcl" style="text-align: center">Three Months Ended</td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20231101__20240731_zv2Isn6c8TOi" style="font-weight: bold; text-align: center">Nine Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20221101__20230731_ze5zOhFG366a" style="text-align: center; font-weight: bold">Nine Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">July 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OilSalesMember_zdh6TC1xl1wb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1.5pt">Oil sales</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">63,052</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">135,975</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"> -</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zyuMcqd88SLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total revenue from customers</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">63,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135,975</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> There were no significant contract liabilities or transaction price allocations to any remaining performance obligations as of July 31, 2024 or 2023. Significant concentrations of credit risk For the three and nine months ended July 31, 2024, the Company has only one purchaser, which accounts for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20231101__20240731__srt--ProductOrServiceAxis__custom--OilAndNaturalGasRevenueMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--OnePurchaserMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNKv6wyCV5ui">10% or more of the Company’s total oil and natural gas revenue for these periods.

The following table disaggregates revenue by significant product type for the three- and nine-month periods ended July 31, 2024 and 2023: SCHEDULE OF DISAGGREGATES REVENUE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_49D_20240501__20240731_zeVT7xQx067i" style="text-align: center">Three Months Ended</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" id="xdx_49C_20230501__20230731_zgnL0I7Rrxcl" style="text-align: center">Three Months Ended</td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20231101__20240731_zv2Isn6c8TOi" style="font-weight: bold; text-align: center">Nine Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20221101__20230731_ze5zOhFG366a" style="text-align: center; font-weight: bold">Nine Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">July 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OilSalesMember_zdh6TC1xl1wb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1.5pt">Oil sales</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">63,052</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">135,975</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"> -</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zyuMcqd88SLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total revenue from customers</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">63,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135,975</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

63052

135975

63052

135975

0.10

NOTE 6 – OIL AND NATURAL GAS PROPERTIES The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20240731_zmjN222lyp44" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20231031_zWQNorxajlS" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">October 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OilAndGasPropertyFullCostMethodGross_iI_zknITJlfgRbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Oil and gas properties – not subject to amortization</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">11,083,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,947,742</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OilAndGasPropertyFullCostMethodDepletion_iI_zxMG8q25zYk6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated impairment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OilAndGasPropertyFullCostMethodNet_iI_z1wTsnR0of77" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Oil and gas properties – not subject to amortization, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,083,285</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,947,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the three and nine months ended July 31, 2024, the Company incurred aggregated exploration costs of $8,054 and $132,871, respectively; these expenses were exploratory, geological and geophysical costs and were expensed on the statement of operations during the applicable periods. For capitalized costs, the Company incurred approximately $1.1 million for the nine months ended July 31, 2024; these expenses were related to drilling exploratory wells and acquisition costs, both of which were capitalized and reflected in the balance of the oil and gas property as of July 31, 2024. During the three and nine months ended July 31, 2023, the Company incurred aggregated exploration costs of $199,637 and $225,052, respectively; these expenses were exploratory, geological and geophysical costs and were expensed on the statement of operations during the applicable periods. For capitalized costs, the Company incurred approximately $3.2 million for the nine months ended July 31, 2023; these costs were related to drilling exploratory wells and acquisition costs, both of which were capitalized and reflected in the balance of the oil and gas property as of July 31, 2023. Leases South Salinas Project As of July 31, 2024, the Company holds interests in various leases related to the unproved properties of the South Salinas Project (see Note 8); two of the leases are held with the same lessor. The first lease, which covers 8,417 acres, was amended on May 27, 2022 to provide for an extension of then-current force majeure status for an additional, uncontested twelve months, during which the Company would be released from having to evidence to the lessor the existence of force majeure conditions. As consideration for the granting of the lease extension, the Company paid the lessor a one-time, non-refundable payment of $252,512; this amount was capitalized and reflected in the balance of the oil and gas property as of October 31, 2022. The extension period commenced on June 19, 2022 and currently, the “force majeure” status has been extinguished by the drilling of the HV-1 well. The ongoing operations and oil production at the HV-3A well maintains the validity of the lease. The second lease covers 160 acres of the South Salinas Project; it is currently held by delay rental and is renewed every three years. Until drilling commences, the Company is required to make delay rental payments of $30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the delay rental payment for the period from October 2023 through October 2024. During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers 360 acres and has a term of 20 years; the Company is required to make rental payments of $25/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period February 2024 through February 2025. The second group of leases covers 307.75 acres and has a term of 20 years; the Company is required to make rental payments of $30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period from March 2024 through March 2025. McCool Ranch Oil Field In October 2023, the Company entered into the McCool Ranch Purchase Agreement with Trio LLC for purchase of a 21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project; the Company initially recorded a payment of $100,000 upon execution of the McCool Ranch Purchase Agreement, at which time Trio LLC began refurbishment operations with respect to the San Ardo WD-1 water disposal well (the “WD-1”) to determine if it was capable of reasonably serving the produced water needs for the assets. With refurbishment successfully accomplished, the Company is obligated to pay an additional $400,000 per the McCool Ranch Purchase Agreement; it has paid approximately $<span id="xdx_90C_ecustom--PaymentForRestartingProductionOperation_c20231001__20231031__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember_z489fjLxylZi" title="Payment for restarting production operation">270,000 to date for restarting production operations on the assets and has recorded a liability of approximately $<span id="xdx_900_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_c20231031__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember_zraGC0DBguXc" title="Purchase obligation, to be paid, remainder of fiscal year">130,000 for the remainder as of the end of the period. These additional costs are capitalized costs and are reflected in the balance of the oil and gas property as of July 31, 2024. The Company holds interests in various leases related to the unproved properties of the McCool Ranch Oil Field; these leases occur in two parcels, “Parcel 1” and “Parcel 2”. Parcel 1 comprises ten leases and approximately 480 acres, which are held by delay rental payments that are paid-up and current. Parcel 2 comprises one lease and approximately 320 acres, which is held by production. The total leasehold comprises approximately 800 gross and net acres. Optioned Assets – Old Man Prospect In October 2023, the Company and Lantos Energy entered into an option agreement, whereby the Company has the option to pay two initial payments of $<span id="xdx_90C_eus-gaap--LongTermPurchaseCommitmentAmount_c20231001__20231031__us-gaap--TypeOfArrangementAxis__custom--OptionPayTwoInitialPaymentMember_zQBwrOl9Cm8k" title="Long-term purchase commitment, amount">12,500 each and a final subsequent payment of $<span id="xdx_90F_eus-gaap--LongTermPurchaseCommitmentAmount_c20231001__20231031__us-gaap--TypeOfArrangementAxis__custom--FinalSubsequentPaymentMember_zuxnUQ4H5Ia7" title="Long-term purchase commitment, amount">175,000, for a total of $200,000 within 120 days of the effective date for exclusive rights to the option to purchase 80% of the 100% Before Project Payout Working Interest (“BPPWI”) in Lantos’ oil and gas leasehold interests in Solano County, California (referred to as the Old Man Prospect). As of January 31, 2024, the Company has paid approximately $25,000 towards the purchase of this option. Due to technical risks identified during due diligence and due to other considerations, the Company did not make the final $175,000 payment and as a result the 120-day option period has expired. Optioned Assets – Asphalt Ridge Leasehold Acquisition & Development Option Agreement On November 10, 2023, the Company entered into the ARLO Agreement with HSO for a term of nine months which gives the Company the exclusive right to acquire up to a <span id="xdx_90B_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zeiZDuHSYmNb" title="Percentage of interest to acquire in leases">20% interest in a 960 acre drilling and production program in the Asphalt Ridge leases for $<span id="xdx_90C_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zYckFv4ANQj8" title="Payments to acquire loans and lease">2,000,000, which may be invested in tranches by the Company, with an initial tranche closing for an amount no less than $<span id="xdx_909_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__srt--RangeAxis__srt--MinimumMember_zyvrJUxePPs1" title="Payments to acquire loans and lease">500,000 and paid within seven days subsequent to HSO providing certain required items to the Company. On December 29, 2023, the Company entered into an amendment to the ARLO Agreement, whereby the Company funded $200,000 of the $500,000 payable by the Company to HSO at the Initial Closing, in advance of HSO satisfying certain required items for a 2% interest in the leases; such funds are to be used by HSO solely for the building of roads and related infrastructure in furtherance of the development of the leases. As of July 31, 2024, the Company has paid a total of $225,000 to HSO in costs related to infrastructure and has obtained a 2.25% interest in the leases; such costs are capitalized costs and are reflected in the balance of the oil and gas property as of July 31, 2024. The Company has until February 10, 2025 to pay HSO an additional $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20241001__20241010__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z4uRSFmmkdF7" title="Stock issued during period, value, stock options exercised">1,775,000 to exercise an option for the remaining <span id="xdx_905_ecustom--GasAndOilWorkingInterestPercentage_pid_dp_uPure_c20241001__20241010__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z8zer90amqc9">17.75% working interest in the initial 960 acres of the Asphalt Ridge Leases. If the Company raises sufficient funds in its current public offering (for which an amendment to its Form S-1 was filed with the SEC on August 8, 2024), it plans to use $<span id="xdx_908_eus-gaap--ProceedsFromStockOptionsExercised_c20241001__20241010__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z9LTn9VKj2N8" title="Proceeds from stock options exercised">1,775,000 of the net proceeds received to exercise the remaining <span id="xdx_90F_ecustom--GasAndOilWorkingInterestPercentage_pid_dp_uPure_c20241001__20241010__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zWppwF6GXH6g">17.75% working interest in the Asphalt Ridge Leases. If this option is not exercised on or before such date, the Company will forfeit any further right to acquire this additional <span id="xdx_900_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20241001__20241010__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z887zVBIi2r5">17.75% working interest in the initial 960 acres.

The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20240731_zmjN222lyp44" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20231031_zWQNorxajlS" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">October 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OilAndGasPropertyFullCostMethodGross_iI_zknITJlfgRbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Oil and gas properties – not subject to amortization</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">11,083,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,947,742</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OilAndGasPropertyFullCostMethodDepletion_iI_zxMG8q25zYk6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated impairment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OilAndGasPropertyFullCostMethodNet_iI_z1wTsnR0of77" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Oil and gas properties – not subject to amortization, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,083,285</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,947,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

11083285

9947742

11083285

9947742

8054

132871

1100000

199637

225052

3200000

8417

252512

160

360

P20Y

307.75

P20Y

30 30

0.21918315

100000

400000

270000

130000

480

320

800

12500

175000

200000

the effective date for exclusive rights to the option to purchase 80% of the 100% Before Project Payout Working Interest

25000

175000 0.20

960

2000000

500000

200000 500000 0.02

225000

0.0225

1775000

0.1775

960

1775000

0.1775 0.1775

960

NOTE 7 – RELATED PARTY TRANSACTIONS South Salinas Project – Related Party Upon its formation, the Company acquired from Trio LLC a majority working interest in the South Salinas Project and engaged the services of certain members of Trio LLC to manage the Company’s assets (see Note 1 and Note 6). Trio LLC operates the South Salinas Project on behalf of the Company, and as operator, conducts and has full control of the operations within the constraints of the Joint Operating Agreement, and acts in the capacity of an independent contractor. Trio LLC currently holds a 3.8% working interest in the South Salinas Project and the Company holds an 85.775% working interest. The Company provides funds to Trio LLC to develop and operate the assets in the South Salinas Project; such funds are classified in the short-term asset/liability section of the balance sheet as Advance to Operators/Due to Operators, respectively. As of July 31, 2024 and October 31, 2023, the balance of the Due to Operators account is $18,633 and $21,651, respectively. McCool Ranch Oil Field Asset Purchase – Related Party On October 16, 2023, the Company entered into the McCool Ranch Purchase Agreement with Trio LLC for purchase of a <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231016__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember_zxsOqhFrHln7">21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project (see Note 6); the Assets are situated in what is known as the “Hangman Hollow Area” of the McCool Ranch Oil Field. The Company initially recorded a payment of $100,000 upon execution of the McCool Ranch Purchase Agreement, at which time Trio LLC began refurbishment operations with respect to the San Ardo WD-1 to determine if it was capable of reasonably serving the produced water needs for the assets. With refurbishment successfully accomplished, the Company is obligated to pay an additional $400,000 per the McCool Ranch Purchase Agreement; it has paid approximately $270,000 during the year for restarting production operations on the assets and has a liability of approximately $<span id="xdx_908_eus-gaap--NotesPayable_iI_c20240731__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OperatorsMember_zlKQiVBfKUs8">130,000 to Trio LLC as a note payable – related parties on the balance sheet as of July 31, 2024. Restricted Stock Units (“RSUs”) issued to Directors Pursuant to the 2022 Equity Incentive Plan (“the Plan”), on September 2, 2023, the Company issued an aggregate <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230902__20230902__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLTJRi8iHuTk">21,250 shares of its $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230902__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVGpdCujdc1l">0.0001 par common stock to four outside directors with a fair value of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8BQnGMOZZW8">12.80 per share for a grant date value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230902__20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzSuqg1G62Df">273,275. The shares, or RSUs, vested as of February 28, 2024. On June 19, 2024, the Company agreed to award <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240619__20240619__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z3R2KkPr2Yq">50,000 restricted stock units to a newly appointed director under the Plan; as there were only 22,750 shares remaining for issuance under the Plan, 22,500 RSUs were awarded immediately with a fair value of $6.00 per share for a grant date value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20240619__20240619__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z9jIQb28rjAg" title="Stock issued during period, value, restricted stock award, gross">134,550 and the remaining 27,500 RSUs will be awarded to the director if and when the number of shares available under the Plan have been increased, with shareholder approval, and there are a sufficient number of shares available for such additional award of RSUs. With regards to vesting, <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20240619__20240619__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zNX347WuPi46">25% of the RSUs vest six months after the date of issuance and the remaining RSUs will vest in equal amounts quarterly thereafter. For the three and nine months ended July 31, 2024, the Company recognized stock-based compensation for these awards in the amount of $7,720 and $184,980, respectively, within stock-based compensation expenses on the income statement, with $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zkyYumfgRjD7">126,830 of unrecognized expense as of the period ended July 31, 2024. Restricted Shares issued to Executives and Employees In February 2022, the Company entered into employee agreements with Frank Ingriselli (former Chief Executive Officer) and Gregory L. Overholtzer (Chief Financial Officer or “CFO”) which, among other things, provided for the grant of restricted shares in the amounts of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrFrankIngriselliMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zNtPeffnKISh">50,000 and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrGregOverholtzerMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zSGRuNcGVIK2">5,000, respectively, pursuant to the Plan. Per the terms of the employee agreements, subject to continued employment, the restricted shares vest over a two-year period, under which <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20220201__20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_z0XiXsWzLewa">25% will vest upon the earlier of three months after the IPO or six months after the grant date. After this date, the remainder vest in equal tranches every six months until fully vested. As the Plan was not adopted until October 17, 2022, these shares will be recorded as of that date at a fair value of $<span id="xdx_90F_eus-gaap--SharePrice_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zmlbFcxhQClc">5.88 per share; such value was calculated via a third-party valuation performed using income and market methods, as well as a discounted cash flow method, with the terminal value using a market multiples method, adjusted for a lack of marketability. As of October 31, 2022, the Company recorded <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221001__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_znV9qu8eECcc">55,000 restricted shares at a fair value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221001__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zaUHICi5YKai">323,400, and for the three and nine months ended July 31, 2024, the Company recognized stock-based compensation of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20240501__20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zbqSmlD3HDde">40,757 and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zKXxQZPeDrIg">120,943, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zwkmnQFqlSI8">34,555 as of July 31, 2024. For the three and nine months ended July 31, 2023, the Company recognized stock-based compensation of $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zGpXeJ9qj2qf">40,757 and $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20221101__20230731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zDr1o26hTah6">120,943, respectively, within stock-based compensation expenses on the income statement. In May 2023, the Company entered into six employee agreements which, among other things, provided for the grant of an aggregate of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zDc4rq8vC3t7">35,000 restricted shares pursuant to the Plan. Per the terms of the employee agreements, subject to continued employment, the restricted shares vest as follows: <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20230501__20230531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_z7KocUuhL8x7">25% of the shares vested five months after the issuance date, after which the remainder vest in equal tranches every six months until fully vested. The shares were recorded on the date of issuance at a fair value of $43.00 per share for an aggregate fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zImbtGiJW2Ml">1,505,000, and for the three and nine months ended July 31, 2024, the Company recognized stock-based compensation of $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20240501__20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zBBiOMPt9sQa">189,845 and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zbU8DpQqrpqc">563,343, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_z34xrsnq0ztj">501,437 as of the period ended July 31, 2024. For the three and nine months ended July 31, 2023, the Company recognized stock-based compensation of $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zaAtKP0KLEOe">226,242 and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20221101__20230731__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TypeOfArrangementAxis__custom--SixEmployeeAgreementMember_zYnVsl4VAPQb">226,242, respectively, within stock-based compensation expenses on the income statement. On October 16, 2023, the Company and Michael L. Peterson entered into an employment agreement (the “Peterson Employment Agreement”), effective as of October 23, 2023, pursuant to which Mr. Peterson will serve as Chief Executive Officer of the Company, replacing Mr. Ingriselli. Pursuant to the Peterson Employment Agreement, Mr. Peterson will be paid an annual base salary of $350,000. In addition, Mr. Peterson is entitled to receive, subject to his continuing employment with the Company on the applicable date of the bonus payout, an annual target discretionary bonus of up to 100% of his annual base salary, payable at the discretion of the Compensation Committee of the Board based upon the Company’s and Mr. Peterson’s achievement of objectives and milestones to be determined on an annual basis by the Board. Pursuant to the Peterson Employment Agreement, the Company issued Mr. Peterson a grant of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zDlPIHKgIBza">50,000 shares of restricted stock pursuant to the Company’s Omnibus Incentive Compensation Plan (the “Plan”) at a fair value of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zWKm8UOzqUn1">5.40 per share for a grant date fair value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zRcJ1bvgLTrh" title="Stock issued during period, value, restricted stock award, gross">271,000. The restricted stock grant vests over a period of two years, with <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zzgMvh3wjxZk">25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement. On March 26, 2024, the Company borrowed $<span id="xdx_902_eus-gaap--ShortTermBorrowings_iI_c20240326__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zAvD2Qd7zPyb">125,000 from Mr. Peterson (the “Peterson Loan”), in connection with which the Company delivered to Mr. Peterson an Unsecured Subordinated Promissory Note in the principal amount of $125,000 (the “Peterson Note”). As additional consideration for the Peterson Loan, the Company accelerated the vesting of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20240326__20240326__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zY6eH4IxHyCk">50,000 shares of restricted stock awarded to Mr. Peterson under the Company’s 2022 Equity Incentive Plan. For the three and nine months ended July 31, 2024, the Company recognized stock-based compensation of $233,505 and $267,659, respectively, within stock-based compensation expenses on the income statement, with no unrecognized expense as of the period ended July 31, 2024. On the same date as Mr. Peterson’s resignation as the Company’s Chief Executive Officer on July 11, 2024, the Company and Mr. Peterson entered into a three-month consulting agreement, which includes a monthly cash fee of $10,000 and an award of 50,000 RSUs pursuant to the Plan. The RSUs will be issued on such date as there are a sufficient number of shares available under the Plan for the award of such RSUs, and will fully vest sixty days after their issuance. On July 11, 2024, the Company entered into an employment agreement with Mr. Robin Ross, pursuant to which Mr. Ross will serve as Chief Executive Officer of the Company, replacing Mr. Peterson. Pursuant to the Ross Employment Agreement, Mr. Ross will be paid an annual base salary of $300,000. In addition, Mr. Peterson is entitled to receive, subject to his continuing employment with the Company on the applicable date of the bonus payout, an annual target discretionary bonus of up to 100% of his annual base salary, payable at the discretion of the Compensation Committee of the Board based upon the Company’s and Mr. Ross’ achievement of objectives and milestones to be determined on an annual basis by the Board. Pursuant to the Ross Employment Agreement, the Company awarded Mr. Ross <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240711__20240711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrRobinRossMember_zqjnaBATdtOl">100,000 RSUs pursuant to the Plan; the RSUs will be issued on such date as there are a sufficient number of shares available under the Plan for the award of such RSUs. With regards to vesting, <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20240711__20240711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrRobinRossMember_zIe7GKQg1cr8">25% of the RSUs vest six months after the award is made to Mr. Ross, with the remainder vesting in equal tranches each three months thereafter, until either the restricted shares have been fully vested or Mr. Ross’s continuous service ends, whichever occurs first. Note Payable – Related Party On March 26, 2024, the Company borrowed $125,000 from its Chief Executive Officer, Michael L. Peterson, in connection with which the Company delivered to Mr. Peterson an Unsecured Subordinated Promissory Note in the principal amount of $125,000. The Note is payable on or before September 26, 2024 (the “Peterson Note Maturity Date”), upon which date the principal balance and interest accruable at a rate of 10% per annum is due and payable to Mr. Peterson by the Company. The Company may prepay the Peterson Note at any time prior to the Peterson Note Maturity Date, in whole or in part, without premium or penalty. The Company is also required to prepay the Peterson Note, in full, prior to the Peterson Note Maturity Date from the proceeds of any equity or debt financing received by the Company of at least $1,000,000. As additional consideration for the Peterson Loan, the Company accelerated the vesting of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240326__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_z8F8dKESG9zb">50,000 shares of restricted stock awarded to Mr. Peterson under the Company’s 2022 Equity Incentive Plan. The Peterson Note also provides for acceleration of payment of the outstanding principal balance and all accrued and unpaid interest in the case of an Event of Default (as such term is defined in the Peterson Note), where there is either a payment default or a bankruptcy event.

0.038 0.85775 18633 21651

0.21918315

100000

400000

270000

130000

21250

0.0001

12.80

273275

50000

22750

22500

6.00

134550

27500

0.25

7720

184980

126830

50000

5000

0.25

5.88

55000

323400

40757

120943

34555

40757

120943

35000

0.25

43.00

1505000

189845

563343

501437

226242

350000 1

50000

5.40

271000

0.25

125000

50000

233505

267659

10000

50000

300000 1

100000

0.25

125000

0.10

1000000

50000

NOTE 8 – COMMITMENTS AND CONTINGENCIES From time to time, the Company is subject to various claims that arise in the ordinary course of business. Management believes that any liability of the Company that may arise out of or with respect to these matters will not materially adversely affect the financial position, results of operations, or cash flows of the Company. Unproved Property Leases The Company holds interests in various leases related to the unproved properties of the South Salinas Project (see Note 6); two of the leases are held with the same lessor. The first lease, which covers <span id="xdx_904_eus-gaap--AreaOfLand_iI_uAcre_c20240731__us-gaap--LeaseContractualTermAxis__custom--FirstAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zYCDJrccbbAg" title="Area of land">8,417 acres, was amended on May 27, 2022 to provide for an extension of then-current force majeure status for an additional, uncontested twelve months, during which the Company would be released from having to evidence to the lessor the existence of force majeure conditions. As consideration for the granting of the lease extension, the Company paid the lessor a one-time, non-refundable payment of $<span id="xdx_908_ecustom--NonRefundablePayment_iI_c20221031__us-gaap--LeaseContractualTermAxis__custom--FirstAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zINSSvSuw3t8" title="Non refundable payment">252,512; this amount was capitalized and reflected in the balance of the oil and gas property as of October 31, 2022. The extension period commenced on June 19, 2022 and currently, the “force majeure” status has been extinguished by the drilling of the HV-1 well. The ongoing operations and oil production at the HV-3A well maintains the validity of the lease. The second lease covers <span id="xdx_900_eus-gaap--AreaOfLand_iI_uAcre_c20240731__us-gaap--LeaseContractualTermAxis__custom--SecondAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zvIpq6zmI2hf" title="Area of land">160 acres of the South Salinas Project; it is currently held by delay rental and is renewed every three years. Until drilling commences, the Company is required to make delay rental payments of $<span id="xdx_90A_ecustom--DelayRentalPayments_iI_uAcre_c20240731__us-gaap--LeaseContractualTermAxis__custom--SecondAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zLYJUS4yb3oa" title="Delay rental payments">30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the delay rental payment for the period from October 2023 through October 2024. The Company holds interests in various leases related to the unproved properties of the McCool Ranch Oil Field. These leases occur in two parcels, “Parcel 1” and “Parcel 2”. Parcel 1 comprises ten leases and approximately 480 acres, which are held by delay rental payments that are paid-up and current. Parcel 2 comprises one lease and approximately 320 acres, which is held by production. The total leasehold comprises approximately 800 gross and net acres. During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers <span id="xdx_909_eus-gaap--AreaOfLand_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zyiwt46CNfVb" title="Area of land"><span id="xdx_90E_eus-gaap--AreaOfLand_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zJuX5d37h1Mf" title="Area of land">360 acres and has a term of <span id="xdx_901_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230228__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zGNzbrsdJ6Hg" title="Lease, term"><span id="xdx_904_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230331__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zZKnToLlthad" title="Lease, term">20 years; the Company is required to make rental payments of $<span id="xdx_909_eus-gaap--NetRentableArea_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_ztuZ6l87l9f4" title="Payments for rent"><span id="xdx_902_eus-gaap--NetRentableArea_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zxmab0aP2uK7" title="Payments for rent">25/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period February 2024 through February 2025. The second group of leases covers <span id="xdx_90B_eus-gaap--AreaOfLand_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zMjTsCDriCM3" title="Area of land"><span id="xdx_90E_eus-gaap--AreaOfLand_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zeYnCOdFglca" title="Area of land">307.75 acres and has a term of <span id="xdx_901_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zT8s3pGPT0oi" title="Lease, term"><span id="xdx_90D_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zZuHAzl4gkg8" title="Lease, term">20 years; the Company is required to make rental payments of $<span id="xdx_90F_ecustom--DelayRentalPayments_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zMYxrtYpHOA5" title="Payments for rent"><span id="xdx_90C_ecustom--DelayRentalPayments_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zRIsOqMN550c" title="Payments for rent">30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period from March 2024 through March 2025. On November 10, 2023, the Company entered into the ARLO Agreement with HSO for a term of nine months which allows the Company the exclusive right to acquire up to a <span id="xdx_90D_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_zNWziUfFFnB" title="Percentage of interest to acquire in leases">20% interest in a 960 acre drilling and production program in the Asphalt Ridge leases for $<span id="xdx_907_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember_znUQ3MvwiL97" title="Payments to acquire loans and lease">2,000,000, which may be invested in tranches by the Company, with an initial tranche closing for an amount no less than $<span id="xdx_903_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARLOAgreementMember__srt--RangeAxis__srt--MinimumMember_zBDmbcWOZmsb" title="Payments to acquire loans and lease">500,000 and paid within seven days subsequent to HSO providing certain required items to the Company. On December 29, 2023, the Company entered into an amendment to the ARLO Agreement, whereby the Company funded $200,000 of the $500,000 payable by the Company to HSO at the Initial Closing, in advance of HSO satisfying certain required items for a 2% interest in the leases; such funds are to be used by HSO solely for the building of roads and related infrastructure in furtherance of the development of the leases. As of July 31, 2024, the Company has paid a total of $225,000 to HSO in costs related to infrastructure and has obtained a <span id="xdx_901_ecustom--PercentageOfInterestToAcquireInfrastructure_pid_dp_uPure_c20240731__20240731__us-gaap--TypeOfArrangementAxis__custom--AmendedARLOAgreementMember_z4Ab6v1Jt0C4" title="Percentage of interest to acquire infrastructure">2.25% interest in the leases; such costs are capitalized costs and are reflected in the balance of the oil and gas property as of July 31, 2024. Board of Directors Compensation On July 11, 2022, the Company’s Board of Directors approved compensation for each of the non-employee directors of the Company, which would be effective upon the consummation of the IPO. Such compensation is structured as follows: an annual retainer of $50,000 cash plus an additional $10,000 for each Board committee upon which the Director serves, each paid quarterly in arrears. Payment for this approved compensation commenced upon successful completion of the Company’s IPO in April 2023; for the three and nine months ended July 31, 2024, the Company has recognized $55,000 and $165,000, respectively, in directors’ fees, and for the three and nine months ended July 31, 2023, the Company has recognized $78,132 and $78,132, respectively, in directors’ fees. Agreements with Advisors On July 28, 2022, the Company entered into a placement agent agreement with the Placement Agent with Spartan Capital Securities, LLC (“Spartan”), whereby Spartan agreed to serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company for a one-year term. The agreement provided for a $25,000 non-refundable advance upon execution of the agreement and completion of a bridge offering to be credited against the accountable expenses incurred by the Placement Agent upon successful completion of the Company’s initial public offering (“IPO”), a cash fee of 7.5%, warrants to purchase a number of common shares equal to 5% of the aggregate number of common shares placed in the IPO and reimbursement of other expenses. On April 20, 2023, pursuant to this agreement, the Company issued representative warrants to Spartan to purchase up to an aggregate of 5,000 shares of common stock; such warrants have a five-year term with an exercise price of $66.00 and can be exercised any time after the IPO date. On October 4, 2023 and December 29, 2023, the Company entered into additional placement agent agreements with Spartan, whereby Spartan would serve as the exclusive placement agent in connection with the closing of private placements. The agreements provided the agent with i) a cash fee 7.5% of the aggregate proceeds raised in the sale and ii) warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche; warrants to purchase 4,167 and 2,750 common shares with exercise prices of $26.40 and $11.00 for the first and second tranches, respectively, were issued to Spartan as of January 31, 2024. Such warrants may be exercised beginning 6 months after issuance until four- and one-half years thereafter. Compliance with NYSE American On February 26, 2024, the Company received written notice from the NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Section 1003(f)(v)”) because the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) have been selling for a substantial period of time at a low price per share. The Notice has no immediate effect on the listing or trading of the Company’s Common Stock and the Common Stock will continue to trade on the NYSE American under the symbol “TPET” with the designation of “. BC” to indicate that the Company is not in compliance with the NYSE American’s continued listing standards. Additionally, the Notice does not result in the immediate delisting of the Company’s Common Stock from the NYSE American. Pursuant to Section 1003(f)(v), the NYSE American staff (the “Staff”) determined that the Company’s continued listing is predicated on effecting a reverse stock split of its Common Stock or demonstrating sustained price improvement within a reasonable period of time, which the Staff determined to be no later than August 26, 2024. On May 1, 2024, the NYSE American notified the Company that it had regained compliance with the NYSE American listing requirements with respect to Section 1003(f)(v) of the NYSE American Company Guide due to its shares of common stock demonstrating sustained price improvement.

8417

252512

160

480

320

800

360

P20Y

307.75

P20Y

30 30 0.20

960

2000000

500000

200000 500000 0.02

225000

0.0225

50000

10000

55000 165000 78132 78132 25000 the Company’s initial public offering (“IPO”), a cash fee of 7.5%, warrants to purchase a number of common shares equal to 5% of the aggregate number of common shares placed in the IPO and reimbursement of other expenses.

5000

66.00

i) a cash fee 7.5% of the aggregate proceeds raised in the sale and ii) warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche; warrants to purchase

4167

2750

26.40

11.00

0.0001

NOTE 9 – NOTES PAYABLE Notes payable as of July 31, 2024 and October 31, 2023 consisted of the following: SCHEDULE OF NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240731_zLlkuyxxlS57" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20231031_ztvQ0TyyNOQd" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">October 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--ConvertibleNotesPayableCurrent_iI_zJwJmSoiAATd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Convertible note, net of discounts</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,217,597</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_hsrt--TitleOfIndividualAxis__custom--PromissoryNoteMember_zPRJ6MEiDiLe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Promissory notes, net of discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,319,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zxAjyBfhwWRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Notes payable – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">254,589</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iI_zT0NuRwB3SZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,574,541</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,217,597</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Convertible note – investors (October 2023 SPA) On October 4, 2023, the Company entered into a securities purchase agreement (the “October 2023 SPA”) with an investor; the October 2023 SPA provides for loans in an aggregate principal amount of up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zNSygcoV2ye3" title="Debt instrument face amount">3.5 million under two tranches, with first and second tranche fund amounts of $<span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--DebtInstrumentAxis__custom--FirstTrancheMember_zj6is5MzeCpk" title="Proceeds from convertible note">2.0 million and $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--DebtInstrumentAxis__custom--SecondTrancheMember_zv4049eVqZ79" title="Proceeds from convertible note">1.5 million, respectively. In consideration for the investor’s funding of the first tranche, the Company issued i) a senior secured convertible promissory note in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_znasO02xcTHb">2,000,000 (the “Note”) and ii) a warrant to purchase up to <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zzqDzOIYv2Ab">43,336 shares of Common Stock at an initial exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zoMrrGaxn2Si">24.00 per share of Common Stock, subject to certain adjustments (the “Common Warrant”). The Note was initially convertible into shares of Common Stock at conversion price of $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zcobOfsYwNe9">24.00, subject to certain adjustments (the “Conversion Price”), provided that the Conversion Price shall not be reduced below $<span id="xdx_90C_ecustom--DebtInstrumentFloorPrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zzsq7OqhGDd6">7.00 (the “Floor Price”). The Note did not bear any interest and matured on April 4, 2025. Upon the initial funding on October 4, 2023, the Company recorded gross proceeds of approximately $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zMcK1B6rKe5f">2.0 million, a <span id="xdx_900_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zviToXQSpdxi">7% original issue discount of $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zLaOjlXg1ocb">140,000 and debt issuance costs of $<span id="xdx_901_eus-gaap--PaymentsOfDebtIssuanceCosts_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zuL4MHtQ5PX6">350,320, for net proceeds of approximately $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z2ItzFMTrifa">1.5 million. The Company also issued a warrant to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zabC9vt1s3Lb">43,336 shares of common stock with an aggregate relative fair value of $<span id="xdx_906_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zsH6CI46Lg6b">332,630; the factors used to determine fair value were a share price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zI9Q6eSYqh65">11.00, an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_znhGD6Gm7AUb">24.00, an expected term of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zlBfduNRH8e4">5 years, annualized volatility of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zVK7jmdguwbg">137.10%, a dividend rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zqRaCdsWkc7h">zero percent and a discount rate of <span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zi8tdZcMRxG2">4.72%. On December 18, 2023, December 29, 2023 and January 12, 2024, the Company made principal payments towards the first tranche in the amounts of $125,000, $125,000, and $125,000, respectively, which it converted into shares at 103% for conversion amounts of $128,750, $128,750 and $128,750, respectively. Conversion shares were issued numbering 18,393, <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zcLnm9nqu2Y1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,393 and 18,393, respectively, at fair values per share of $6.80, $6.20 and $5.80, respectively, for total amounts of $125,072, $114,036 and $105,575, with cash payments of $36,698, $35,837 and $49,935 made to the investor for the difference between the monthly conversion price and the floor price listed in the most recent amendment to the agreement. Additionally, losses in the amounts of $36,770, $24,873 and $30,510, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. On December 29, 2023, the Company entered into an amendment to the Second Tranche Note of the October 2023 SPA, which reduced the conversion price of note and exercise price of warrant from $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember__srt--RangeAxis__srt--MinimumMember_zKcb1ECxVrn9">24.00 to $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember__srt--RangeAxis__srt--MaximumMember_z4M5M9zD5xak">10.00; the Company accounted for the amendment as a warrant modification, whereby the effect of the modification is measured as the difference in its relative fair value immediately before the modification and after the modification, and any increase to the relative fair value is recognized as an equity issuance cost. To assess for the change in relative fair value, the Company performed a Black Scholes Option Model calculation to quantify the fair value of the common warrants under their original terms as of the modification date using the following assumptions: a share price of $<span id="xdx_90F_eus-gaap--SharePrice_iI_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zTp7LbKIUSSd">6.20, an exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zQQpKp2ze6nc">24.00, an expected term of <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zv5KuLnfsvyf">5.0 years, volatility of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zUIV4SOrw8Cg">137.1%, a dividend rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_z8FSrGvzjJz1">0% and a discount rate of <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zt37ChN8C2Ge">3.84%. The Company then performed a Black Scholes Option Model calculation to quantify the fair value of the common warrants with their new modified terms as of the modification date using the following assumptions: a share price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zqdrAYANujrd">6.20, an exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zIECe5fyHYSh">10.00, an expected term of <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_z7nDVmHUrGnb">5.0 years, volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zLJzzHxEPwQg">137.1%, a dividend rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20231229__20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zrAbOwCPyc8e">0% and a discount rate of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20231229__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zJNL6UrZ2qsj">3.84%. The aggregate difference of approximately $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zlzIRhICzSIj">0.1 million between the two calculated amounts was recorded as an equity issuance cost within equity during the period to account for the change in relative fair value. On January 2, 2024, the second tranche of the October 2023 SPA was funded, and the Company recorded gross proceeds of approximately $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zgitG6z3bLa8">550,000, a <span id="xdx_908_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zwdxcpBM6xNc">7% original issue discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z153ooMPuTok">38,500 and debt issuance costs of $<span id="xdx_909_eus-gaap--PaymentsOfDebtIssuanceCosts_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zhPc3QfPNzu9">90,978, for net proceeds of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfDebt_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zMTj9RkPu9Xa">421,000. The Company also issued warrants to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zRokQBvxf0i">22,279 shares of common stock with an aggregate relative fair value of $<span id="xdx_905_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zD4BQ5N2dFRe">98,708; the factors used to determine fair value were a share price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zNveZTkcI8a">6.40, an exercise price of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zq1sN2zBrA38">10.00, an expected term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zzptZUaIPUWg">5 years, annualized volatility of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_z6OsMgQy6Jse">137.10%, a dividend rate of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zWkplt13BZof">zero percent and a discount rate of <span id="xdx_90B_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zsYa1RGHfnVa">3.93%. On February 1, 2024, February 16, 2024, March 22, 2024 and April 2, 2024, the Company made principal payments towards the first tranche in the amounts of $625,000, $125,000, $125,000, and $750,000, respectively, which it converted into shares at <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240402__20240402__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zbceCgZxwM61">103% for conversion amounts of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240201__20240201__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zyedBvdVzfOk">643,750, $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240216__20240216__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_z7wVd35gNwH1">128,750, $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zmF7T7WjFXaa">128,750 and $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240402__20240402__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zhWA4AtdEjQ4">772,500, respectively. Conversion shares were issued numbering 91,965, 42,917, 42,917 and 257,500, respectively, at fair values per share of $4.80, $2.60, $2.00 and $3.40, respectively, for total amounts of $441,428, $113,300, $84,117 and $881,165, with a cash payment of $32,247 made to the investor for the difference between the monthly conversion price and the floor price listed in the most recent amendment to the agreement for the February 16, 2024 conversion. Additional shares of 119,796 and 17,576, respectively, were issued on February 1, 2024 and April 15, 2024, respectively, at fair values of $4.80 and $12.60, respectively, for total amounts of $574,779 and $221,449, respectively; these share issuances were made in lieu of additional cash payments related to the February 1, 2024 and March 22, 2024 principal payment conversions. Additionally, losses in the amounts of $<span id="xdx_904_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240201__20240201__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zrtnD3DzI9t6">391,447, $<span id="xdx_90A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240216__20240216__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_z1QIKwI3yIyl">20,547, $<span id="xdx_904_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240322__20240322__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zekHSLirs2O8">180,566 and $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240402__20240402__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_z3r8JO6Toaa2">131,165, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. On February 5, 2024, the Company entered into the first amendment to the First Tranche Note of the October 2023 SPA; such amendment provides for i) a reduction of the floor price of the conversion price from $7.00 to $3.00, ii) the issuance of additional 119,796 shares of common stock (as noted above) to the investor in lieu of the Company’s obligation to pay cash installments under the First Tranche Note, and iii) a new obligation of the Company to request acceleration of monthly payments in installments of $250,000 as soon as possible to repay the remaining $1,000,000 principal balance of the First Tranche Note, with the investor converting and selling shares subject to a) the beneficial ownership limitation of 4.99% and b) market prices of the Company’s common stock being at or above the floor price of $3.00. On February 2, 2024 and February 5, 2024, the Company made principal payments towards the second tranche in the amounts of $275,000 and $275,000, respectively, which it converted into shares at <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240205__20240205__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zBVTWS9VOwUl">103% for conversion amounts of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240202__20240202__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zlGzgBEuWpk5">283,250 and $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240205__20240205__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zPorr8deKISb">283,250, respectively. Conversion shares were issued numbering 94,417 and 94,417, respectively, at fair values per share of $3.40 and $3.60, respectively, for total amounts of $323,094 and $339,334, respectively. Additionally, losses in the amounts of $48,094 and $64,334, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. As of April 2024, both tranches of the October 2023 SPA were fully repaid, and as of July 31, 2024 and October 31, 2023, the balance of the convertible notes, net of discounts, was $0 and $1,217,597, respectively, with non-cash interest expense related to discounts recognized in the amounts of $1,063,372 and $40,547, respectively. Note Payable – Related Party (McCool Ranch) On October 16, 2023, the Company entered into the McCool Ranch Purchase Agreement with Trio LLC for purchase of a <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231016__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--TypeOfArrangementAxis__custom--McCoolRanchPurchaseAgreementMember__us-gaap--RegulatoryAssetAxis__custom--KenFronFieldMember_zGohLnTkX42j">21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project (see Note 6); the Assets are situated in what is known as the “Hangman Hollow Area” of the McCool Ranch Oil Field. The Company initially recorded a payment of $100,000 upon execution of the McCool Ranch Purchase Agreement, at which time Trio LLC began refurbishment operations with respect to the San Ardo WD-1 to determine if it was capable of reasonably serving the produced water needs for the assets. With refurbishment successfully accomplished, the Company is obligated to pay an additional $400,000 per the McCool Ranch Purchase Agreement; it has paid approximately $270,000 during the year for restarting production operations on the assets and has a liability of approximately $130,000 to Trio LLC as a note payable – related parties on the balance sheet as of July 31, 2024. March 2024 Debt Financing The Company executed a Securities Purchase Agreement, dated March 27, 2024 (the “SPA”) with an institutional investor (the “March 2024 Investor”), which March 2024 Investor signed and funded on April 5, 2024, and pursuant to which the Company raised gross proceeds of $184,500 and received net proceeds of $164,500, after payment of offering expenses (the “March 2024 Debt Financing”). The SPA contains certain representations and warranties by the March 2024 Investor and the Company and customary closing conditions. In connection with the March 2024 Debt Financing, the Company issued an unsecured promissory note to the March 2024 Investor, dated March 27, 2024, in the principal amount of $211,500, having an original issue discount of $27,000 or approximately 13% (the “March 2024 Investor Note”). Interest accrues on the March 2024 Investor Note at a rate of 12% per annum and the maturity date of the March 2024 Investor Note is January 30, 2025 (the “March 2024 Investor Note Maturity Date”). The March 2024 Investor Note provides for five payments of principal and accrued interest which are payable: (i) $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNBB82WXgV5e">118,440 on September 30, 2024; (ii) $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20241030__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z85V9Nb72jUb">29,610 on October 30, 2024; (iii) $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zPPdw9nY3oN2">29,610 on November 30, 2024; (iv) $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20241230__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYye5dg6IMXj">29,610 on December 30, 2024; and (v) $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20250130__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYuZd7ifDLw">29,610 on January 30, 2025. The Company may prepay the March 2024 Investor Note, in full and not in part, any time during the 180 day period after the issuance date of the Investor Note at a <span id="xdx_90D_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240327__us-gaap--ShortTermDebtTypeAxis__custom--MarchTwoThousandTwentyFourDebtFinancingMember__srt--RangeAxis__srt--MinimumMember_zoBRt97VAT98">3% discount to the outstanding amount of principal and interest due and payable; provided, that in the event of a prepayment, the Company will still be required to pay the full amount of interest that would have been payable through the term of the March 2024 Investor Note, in the amount of $25,380. The Investor Note contains provisions constituting an Event of Default (as such term is defined in the March 2024 Investor Note) and, upon an Event of Default, the March 2024 Investor Note will be accelerated and become due and payable in an amount equal to 150% of all amounts due and payable under the March 2024 Investor Note with interest at a default rate of 22% per annum. In addition, upon an Event of Default, the March 2024 Investor has the right to convert all or any outstanding amount of the March Investor Note into shares of the Company’s common stock at a conversion price equal to the greater of (i) 75% of the Market Price (as such term is defined in the March 2024 Investor Note) or (ii) the conversion floor price, which is $1.42340 (the “Floor Price”); provided, however, that the Floor Price shall not apply after October 5, 2024, and thereafter, the conversion price will be 75% of the Market Price. Issuance of shares of common stock to the March 2024 Investor is subject to certain beneficial ownership limitations and not more than 19.99% of the shares of common stock outstanding on March 29, 2024 may be issued upon conversion of the March 2024 Investor Note. The conversion price is also subject to certain adjustments or other terms in the event of (i) mergers, consolidations or recapitalization events or (ii) certain distributions made to holders of shares of common stock. As of July 31, 2024 and October 31, 2023, the balance of the promissory note, net of discounts, was $194,014 and $0, respectively, with non-cash interest expense related to discounts recognized in the amounts of $21,550 and $29,514 for the three- and nine-month periods ended July 31, 2024. Note Payable – Related Party On March 26, 2024, the Company borrowed $125,000 from its Chief Executive Officer, Michael L. Peterson, in connection with which the Company delivered to Mr. Peterson an Unsecured Subordinated Promissory Note in the principal amount of $125,000. The Note is payable on or before September 26, 2024, upon which date the principal balance and interest accruable at a rate of 10% per annum is due and payable to Mr. Peterson by the Company. The Company may prepay the Peterson Note at any time prior to the Peterson Note Maturity Date, in whole or in part, without premium or penalty. The Company is also required to prepay the Peterson Note, in full, prior to the Peterson Note Maturity Date from the proceeds of any equity or debt financing received by the Company of at least $1,000,000. As additional consideration for the Peterson Loan, the Company accelerated the vesting of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20240326__20240326__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zNcTkz8S74Dc">50,000 shares of restricted stock awarded to Mr. Peterson under the Company’s 2022 Equity Incentive Plan. The Peterson Note also provides for acceleration of payment of the outstanding principal balance and all accrued and unpaid interest in the case of an Event of Default (as such term is defined in the Peterson Note), where there is either a payment default or a bankruptcy event. As of July 31, 2024 and October 31, 2023, the Company has accrued interest on the loan in the amounts of $4,384 and $0, respectively. April 2024 Convertible Debt Financings On April 24, 2024, the Company entered into an Amended and Restated Securities Purchase Agreement (the “A&R SPA”), pursuant to which two institutional investors (the “April 2024 Investors”) provided an aggregate of $720,000 in financing on April 17, 2024 and April 24, 2024 (the “April 2024 Financings’) resulting in net proceeds to the Company, after offering expenses, of $664,000. The Company also issued to the April 2024 Investors an aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240424__20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__us-gaap--StatementEquityComponentsAxis__custom--CommitmentSharesMember_zTS1wy7PRus5">75,000 shares of common stock, as and for a commitment fee in connection with the April 2024 Financings (the “Commitment Shares”). The commitment shares were issued separately in two amounts of 37,500 common shares at fair values of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzDTq6zXKTP">9.80 per share and $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zG9kzbs5yKP1">8.00 per share for values totaling $366,000 and $301,500, respectively; such amounts are debt issuance costs and were recorded as debt discounts to be amortized over the life of the agreement. For the three and nine months ended July 31, 2024, the Company amortized $503,361 and $560,189, respectively, in noncash interest expense related to the commitment shares. Pursuant to the provisions of the A&R SPA, the Company granted “piggy-back registration rights” to the April 2024 Investors for the registration for resale of the Commitment Shares and the Conversion Shares (defined hereafter). Additionally, until 18 months after the later of (i) August 16, 2024 or the full repayment of the April 2024 Investors Notes (defined hereafter), the Company provided the April 2024 Investors with the right to jointly participate in future financings in an amount up to 100% of any debt financing and up to 45% of any other type of financing. Further, the Company is prohibited from entering into any variable rate transactions for as long as the April 2024 Investors hold any of the Commitment Shares; provided, however, that the Company is permitted to enter into At-the-Market offerings with a nationally recognized broker-dealer. The Company has also agreed to use commercially reasonable efforts to consummate a reverse stock split of its shares of common stock, in the event that it is required in order to maintain the listing of its common stock on the NYSE American. In connection with the April 2024 Financings, the Company issued Senior Secured Convertible Promissory Notes to the April 2024 Investors in the aggregate principal amount of $800,000 (the “April 2024 Investors Notes”), having an aggregate original issue discount of $80,000, or 10% of the aggregate principal amount of the April Notes. There is no interest payable on the outstanding balance of the April 2024 Investors Notes, unless an Event of Default has occurred, in which case interest will accrue on the outstanding balance of the April 2024 Investors Notes at a rate of 15% per annum until cured (the “Default Interest”). The Company may prepay all or any portion of the April 2024 Investors Notes at any time, provided that it also makes an equal prepayment, with respect to each of the April 2024 Investors Notes, and must prepay both of the April 2024 Investors Notes in full from the proceeds of any debt or equity financing of the Company generating, in a single transaction or a series of related transactions, gross proceeds of not less than $1,000,000, during any time that either of the April 2024 Investors Notes remain outstanding. In May 2024, the April 2024 Investors have provided limited waivers to the Company, which waivers require the Company to only pay 50% of the outstanding balance of the April 2024 Investors Notes upon any equity or debt financing generating less than $5,000,000 in gross proceeds if such financing takes place before June 30, 2024. The maturity date of both April 2024 Investors Notes is August 16, 2024. The Company also incurred debt issuance costs of $56,000 in connection with the issuance of the April 2024 Investor Notes; the values of such costs and the original issue discount noted above (which total $136,000) are recorded as debt discounts and amortized as the life of the April 2024 Investors Notes; as of July 31, 2024, the balance of April 2024 Investor Notes, net of discounts, was $671,836 and the Company amortized $102,557 and $115,148 in noncash interest expense related to these debt discounts for the three and nine months ended July 31, 2024, respectively. The April 2024 Investors Notes are convertible into shares common stock of the Company (the “Conversion Shares”) at a per share conversion price of $5.00, subject to certain adjustments. The April 2024 Investors Notes also contain certain beneficial ownership limitations prohibiting the April 2024 Investors from converting the April 2024 Investors Notes, if any such conversion would result in an April 2024 Investor’s ownership of shares in excess of the applicable beneficial ownership limitation. The April 2024 Investors Notes also contain customary provisions constituting an Event of Default (as such term is defined in the April 2024 Investors Notes) and, in addition to the requirement to pay Default Interest upon an Event of Default, after an Event of Default has existed for at least 15 days without being cured, the April 2024 Investors Notes may be accelerated by the April 2024 Investors, in which case they will become immediately due and payable. The Company also granted to the April 2024 Investors a senior security interest in and to all of the Company’s assets and non-real estate properties, subject to certain exceptions, securing repayment of the April 2024 Investors Notes as set forth in an Amended and Restated Security Agreement, dated April 24, 2024, between the Company and the April 2024 Investors (the “A&R Security Agreement”). June 2024 Convertible Debt Financings On June 27, 2024, the Company entered into a securities purchase agreement (the “June 2024 SPA”) with the same April 2024 Investors (the “June 2024 Investors”). Pursuant to the terms and conditions of the June 2024 SPA, each June 2024 Investor provided financing of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourDebtFinancingMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember_z9qyvBza1tra">360,000 to the Company (net of a <span id="xdx_90B_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourDebtFinancingMember_zIbQrKqFTeN3">10% original issuance discount as described below) in the form of the June 2024 Notes (as defined below) for aggregate gross proceeds in the amount of $720,000 (the “June 2024 Financing”) and net proceeds to the Company, after offering expenses, of $676,200. In consideration of the June 2024 Investors’ funding under the June 2024 SPA, on June 27, 2024, the Company issued and sold to each June 2024 Investor: (A) a Senior Secured <span id="xdx_908_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember_zeloXf1vYbRb">10% Original Issue Discount Convertible Promissory Note in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember_zqMCkLvNjHe5">400,000 (the “June 2024 Notes”) and (B) a warrant to purchase 37,231 shares (the “June 2024 Warrant Shares”) of the company’s Common Stock, at an initial exercise price of $7.90500 per share of Common Stock, subject to certain adjustments (the “June 2024 Warrants”). The June 2024 Warrants (which are for the purchase of an aggregate 74,461 common shares) were recorded as equity warrants with an aggregate relative fair value of $257,701; the factors used to determine fair value were a share price of $<span id="xdx_905_eus-gaap--SharePrice_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zO3OPxe5hE5g">6.00, an exercise price of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zE77buIEueUf">7.90500, an expected term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240627__20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zco0C9niNQJe">5 years, annualized volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240627__20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zFCYXkCwTkX4">132.52%, a dividend rate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20240627__20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zp2Fmx62AEjg">zero percent and a discount rate of <span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z3LxsTTrjsLj">4.29%. <span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20240627__20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourDebtFinancingMember_z0cPBqPU2mz3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The June 2024 Notes are initially convertible into shares of Common Stock (the “June 2024 Conversion Shares”) at a conversion price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourDebtFinancingMember_zbak3CGpgIU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.90500 per share, subject to certain adjustments (the “June 2024 Notes Conversion Price”), provided that the June 2024 Conversion Price shall not be reduced below $<span id="xdx_901_ecustom--DebtInstrumentFloorPrice_iI_c20240627__us-gaap--ShortTermDebtTypeAxis__custom--JuneTwoThousandTwentyFourDebtFinancingMember_zpSnkMThgTUj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40 (the “June 2024 Floor Price”), and provided further that, subject to the applicable rules of the NYSE American, the Company may lower the June 2024 Floor Price at any time upon written notice to the June 2024 Investors. The June 2024 Notes do not bear any interest, except in the case of an Event of Default (as such term is defined in the June 2024 Notes), and the June 2024 Notes mature on June 27, 2025. Upon the occurrence of any Event of Default, interest shall accrue on the June 2024 Notes at a rate equal to 10% per annum or, if less, the highest amount permitted by law. Commencing on the 90th day following the original issue date of the June 2024 Notes, the Company is required to pay to the June 2024 Investors the outstanding principal balance under the June 2024 Notes in monthly installments, on such date and each one (1) month anniversary thereof, in an amount equal to 103% of the total principal amount under the June 2024 Notes multiplied by the quotient determined by dividing one by the number of months remaining until the maturity date of the June 2024 Notes, until the outstanding principal amount under the June 2024 Notes has been paid in full or, if earlier, upon acceleration, conversion or redemption of the June 2024 Notes in accordance with their terms. All monthly payments are payable by the Company in cash, provided that under certain circumstances, as provided in the June 2024 Notes, the Company may elect to pay in shares of Common Stock. The Company may repay all or any portion of the outstanding principal amount of the June 2024 Notes, subject to a 5% pre-payment premium; provided that (i) the Equity Conditions (as such term is defined in the June 2024 Notes) are then met, (ii) the closing price of the Common Stock on the trading day prior to the date that a prepayment notice is provided by the Company is not below the then June 2024 Conversion Price, and (iii) a resale registration statement registering June 2024 Conversion Shares and June Financing Warrant Shares has been declared effective by SEC. If the Company elects to prepay the June 2024 Notes, the June 2024 Investors have the right to convert all of the principal amount of the June 2024 Notes at the applicable June 2024 Conversion Price into June 2024 Conversion Shares. As of July 31, 2024 and October 31, 2023, the balance of the June 2024 Notes was $454,040 and $0, respectively, with noncash interest expense recognized for the amortization of debt discounts of $35,537 for the both the three and nine months ended July 31, 2024.

Notes payable as of July 31, 2024 and October 31, 2023 consisted of the following: SCHEDULE OF NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240731_zLlkuyxxlS57" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20231031_ztvQ0TyyNOQd" style="font-weight: bold; text-align: center">As of</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">October 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--ConvertibleNotesPayableCurrent_iI_zJwJmSoiAATd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Convertible note, net of discounts</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,217,597</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_hsrt--TitleOfIndividualAxis__custom--PromissoryNoteMember_zPRJ6MEiDiLe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Promissory notes, net of discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,319,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zxAjyBfhwWRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Notes payable – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">254,589</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iI_zT0NuRwB3SZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,574,541</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,217,597</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1217597

1319890

254589

1574541

1217597

3500000

2000000.0

1500000

2000000

43336

24.00

7.00

2000000.0

0.07

140000

350320

1500000

43336

332630

11.00

24.00

P5Y

1.3710

4.72

125000

1.03

128750

18393

6.80

6.20

5.80

125072

114036

105575

36698 35837 49935

36770

24873

30510

24.00

10.00

6.20

24.00

P5Y

1.371

3.84

6.20

10.00

P5Y

1.371

3.84

100000

550000

0.07

38500

90978

421000

22279

98708

6.40

10.00

P5Y

1.3710

3.93

625000

125000

750000

1.03

643750

128750

772500

91965

42917

257500

4.80

2.60

2.00

3.40

441428

113300

84117

881165

32247

119796

17576

4.80

12.60

574779

221449

391447

20547

180566

131165

i) a reduction of the floor price of the conversion price from

7.00

3.00

275000

1.03

283250

94417

3.40

3.60

323094

339334

48094

64334

1217597

1063372

40547

0.21918315

100000

400000

270000

130000

184500

164500

211500

27000

0.13

0.12

118440

29610

0.03

25380

The Investor Note contains provisions constituting an Event of Default (as such term is defined in the March 2024 Investor Note) and, upon an Event of Default, the March 2024 Investor Note will be accelerated and become due and payable in an amount equal to 150% of all amounts due and payable under the March 2024 Investor Note with interest at a default rate of 22% per annum. In addition, upon an Event of Default, the March 2024 Investor has the right to convert all or any outstanding amount of the March Investor Note into shares of the Company’s common stock at a conversion price equal to the greater of (i) 75% of the Market Price (as such term is defined in the March 2024 Investor Note) or (ii) the conversion floor price, which is

1.42340

194014

21550

29514

125000

0.10

1000000

50000

4384

720000

664000

75000

37500

9.80

8.00

366000

301500

503361

560189

0.45

800000

80000

0.10

0.15

1000000

0.50

5000000

2024-08-16

56000

136000

671836

102557

115148

5.00

360000

0.10

720000

676200

0.10

400000

37231

7.90500

74461

257701

6.00

7.90500

P5Y

1.3252

4.29

The June 2024 Notes are initially convertible into shares of Common Stock (the “June 2024 Conversion Shares”) at a conversion price of $

7.90500

2.40 1.03 0.05

454040

35537

NOTE 10 – STOCKHOLDERS’ EQUITY Common Shares On November 11, 2023, the Company entered into an agreement with a vendor to provide marketing and distribution services for a period of six months, with compensation in the form of 10,000 shares. The Company issued the vendor <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231111__20231111__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--VendorMember_zpwVeEq4TXwa">10,000 common shares at a fair market value price of $9.60 per share for a total amount of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20231111__20231111__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--VendorMember_zrVCqX3eAI2l">95,200; this amount was recognized as marketing fees in the first and second quarters of 2024. On December 18, 2023, December 29, 2023 and January 12, 2024, the Company issued conversion shares which numbered 18,393, 18,393 and 18,393, respectively, at fair values per share of $6.80, $6.20 and $5.80, respectively, for total amounts of $125,072, $114,036 and $105,575, with cash payments of $36,698, $35,837 and $49,935 made to the investor for the difference between the monthly conversion price and the floor price listed in the most recent amendment to the agreement (see Note 9). Additionally, losses in the amounts of $36,770, $24,873 and $30,510, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. On February 1, 2024, February 16, 2024, March 22, 2024 and April 2, 2024, the Company issued conversion shares numbering 91,965, 42,917, 42,917 and 257,500, respectively, at fair values per share of $4.80, $2.60, $2.00 and $3.40, respectively, for total amounts of $441,428, $113,300, $84,117 and $881,165, with a cash payment of $32,247 made to the investor for the difference between the monthly conversion price and the floor price listed in the most recent amendment to the agreement for the February 16, 2024 conversion (see Note 9). Additional shares of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240201__20240201__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQEPgN05kH8b">119,796 and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240415__20240415__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztLy6lr7Ak7f">17,576, respectively, were issued on February 1, 2024 and April 15, 2024, respectively, at fair values of $4.80 and $12.60, respectively, for total amounts of $574,779 and $221,449, respectively; these share issuances were made in lieu of additional cash payments related to the February 1, 2024 and March 22, 2024 principal payment conversions. Additionally, losses in the amounts of $391,447, $20,547, $180,566 and $131,165, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. On February 2, 2024 and February 5, 2024, the Company made principal payments towards the second tranche in the amounts of $275,000 and $275,000, respectively, which it converted into shares at <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240205__20240205__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_z0K7MmQZo7B2">103% for conversion amounts of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240202__20240202__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zi2lk7y1tx61">283,250 and $<span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240205__20240205__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zwv6oflG8shf">283,250, respectively. Conversion shares were issued numbering 94,417 and 94,417, respectively, at fair values per share of $3.40 and $3.60, respectively, for total amounts of $323,094 and $339,334, respectively. Additionally, losses in the amounts of $<span id="xdx_909_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240202__20240202__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zsiEqnUjoM4d">48,094 and $<span id="xdx_905_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240205__20240205__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zHp3C2tvg5Hd">64,334, respectively, were recognized for the difference between the value of the shares issued and the principal payment amounts. On March 20, 2024, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240320__20240320__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zwOPEj4cSNIc">5,000 shares of common stock to a consultant as a settlement for non-performed marketing services per an agreement dated November 2021; such shares were issued at a fair value of $2.20 per share for a total value of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240320__20240320__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zkRRUtMlHRll">10,500. On March 26, 2024, the Company entered into an agreement with consultants to provide marketing services; the agreement has an effective date of April 26, 2024 and a term from April 1, 2024 through June 30, 2024. The terms provide for a one-time cash payment of $<span id="xdx_90F_eus-gaap--MarketingExpense_c20240326__20240326__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zy12r1Zygiwh">100,000 or, in lieu of a cash payment, the Company may elect to complete a one-time equity issuance in the form of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240326__20240326__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zMt17wrqoBv1">50,000 shares of common stock, as well as three monthly cash payments totaling $<span id="xdx_904_eus-gaap--MarketingExpense_c20240101__20240131__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zwqiGJRmNsUl">30,000 to be paid in the first fiscal half of 2024. The Company issued 50,000 shares of common stock at a fair value of $7.40 per share for a total amount of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240326__20240326__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zcdT2ampsoF">368,000. On April 16, 2024 and April 24, 2024, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240416__20240416__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zcU2yi7gC3d4">37,500 shares of common stock and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240424__20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zB2kqv6y0mmj">37,500 shares of common stock respectively, to the April 2024 Investors as and for a commitment fee in connection with the April 2024 Financings. The commitment shares were issued at fair values of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240416__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zNrjPqgpRfpg">9.80 per share and $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zRFYagTWUgUf">8.00 per share, respectively, for values totaling $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240416__20240416__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z2IA0vE1m4S4">366,000 and $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240424__20240424__us-gaap--ShortTermDebtTypeAxis__custom--AprilTwoThousandTwentyFourDebtFinancingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zAqYStnWg80d">301,500, respectively. On April 29, 2024, the Company entered an agreement with consultants to provide marketing services; the agreement has a term from April 29, 2024 through October 29, 2024. The terms provide for a $<span id="xdx_90D_eus-gaap--MarketingExpense_c20240429__20240429__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpUyDXSxhhWh">30,000 cash payment and the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240429__20240429__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zOxlRKqUJbLj">30,000 shares of common stock. The Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240429__20240429__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zcKq9gfGn9b4">30,000 shares of common stock at a fair value of $7.40 per share for a total amount of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240429__20240429__us-gaap--TypeOfArrangementAxis__custom--MarketingServicesAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zokmjWRZRYid">220,800. Warrants October 2023 SPA with Warrants On October 4, 2023 and December 29, 2023, the Company entered into placement agent agreements with Spartan (see Note 8 for further information) for their role in connection with the two tranche fundings related to the October 2023 SPA; among other things, the agreements provide the agent with equity-classified warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche. For the first tranche, the Company issued to Spartan warrants to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zMknUpj8vGWc">4,167 shares of common stock with a fair value of $<span id="xdx_906_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zbkTh3Dnf9Hj">38,029; the factors used to determine fair value were a share price of $<span id="xdx_901_eus-gaap--SharePrice_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zK1qZEi6Npmb">11.00, an exercise price of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zslhyPpe7nF4">26.40, an expected term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_z1sGDuUEKWA8">5 years, annualized volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zK2ag66Zg9ag">137.10%, a dividend rate of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_z8tPKTvN0OAf">zero percent and a discount rate of <span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--AwardTypeAxis__custom--FirstTrancheMember_zPJB6WxzXQI2">4.72%. For the second tranche, the Company issued to Spartan warrants to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_znT5zfg4PrUk">2,750 common shares of common stock with a fair value of $<span id="xdx_900_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_z4KU9tsJwUPi">14,753; the factors used to determine fair value were a share price of $<span id="xdx_908_eus-gaap--SharePrice_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_z5YXKSJGpZG1">6.40, an exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zvCXvaCUgHF5">11.00, an expected term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zfIxZ8548lq1">5 years, annualized volatility of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zWdniGi933mk">137.10%, a dividend rate of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20231229__20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zBpr1rxA4qk6">zero percent and a discount rate of <span id="xdx_909_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20231229__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zh75XEluMZr8">3.93%. On January 2, 2024, the second tranche of the October 2023 SPA was funded (see Note 9 for further information); in connection with this funding, the Company issued to the investor equity warrants to purchase up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zudR9yyJUjrk">22,279 shares of common stock with an aggregate relative fair value of $<span id="xdx_908_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_z6sMPrz8Ypid">98,708; the factors used to determine fair value were a share price of $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zJJYoHnnDhO6">6.40, an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zzLnjshQgKde">10.00, an expected term of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zkuw7gS2GOpb">5 years, annualized volatility of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zYAZXCRSjTAd">137.10%, a dividend rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20240102__20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zDjqh7SCVBC8">zero percent and a discount rate of <span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240102__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--AwardTypeAxis__custom--SecondTrancheMember_zetZavTwhSx6">3.93%. June 2024 SPA with Warrants On June 27, 2024, the Company entered into the June 2024 SPA with the June 2024 Investors (see Note 9 above); pursuant to the terms and conditions of the agreement, in consideration for providing financing, the Company issued to each June 2024 Investor a warrant to purchase 37,231 shares of the Company’s common stock, at an initial exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zfiFHsmmbts9">7.90500 per share. The June 2024 Warrants (which are for the purchase of an aggregate 74,461 common shares) were recorded as equity warrants with an aggregate relative fair value of $257,701; the factors used to determine fair value were a share price of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zc58E1E1hB3g">6.00, an exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zzg6oeyWqLHj">7.90500, an expected term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240627__20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z9wwVPtbPid8">5 years, annualized volatility of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240627__20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zOyLLFDT6aDj">132.52%, a dividend rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20240627__20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zecurdq3AmWl">zero percent and a discount rate of <span id="xdx_906_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240627__us-gaap--TypeOfArrangementAxis__custom--JuneTwoThousandTwentyFourSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEY7GvTLkoij">4.29%. A summary of the warrant activity during the nine months ended July 31, 2024 is presented below: SCHEDULE OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding November 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSdc058Zcy4j" style="width: 14%; text-align: right" title="Number of warrants outstanding, beginning">88,336</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zG2B6iwwUUJ" style="width: 14%; text-align: right" title="Weighted average, exercise price, beginning">22.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4vawIcGfxY9" style="width: 14%; text-align: right" title="Weighted average remaining life in years">7.3</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7gwPVbttGk" style="width: 14%; text-align: right" title="Intrinsic value, beginning">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkEbU0l6CK2i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants issued">103,657</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAjUnqVp40xb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, issued">9.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7WqKuA5fq77" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding, July 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3Kc2A5W52j8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, ending">191,993</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztcBuAzgV7d6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, ending">15.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxfj6tXmVRW1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPdfn2qGVKfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, ending">98,800</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7kn4JRhMfH8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, exercisable">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmccrrKgLbbl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, exercisable">15.20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTZYUc41vE5d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbWwOjMifFzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable ending">98,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> A summary of outstanding and exercisable warrants as of July 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRofXmvguxi9" style="width: 22%; text-align: right" title="Warrant outstanding exercise price">0.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0jPeloosfoh" style="width: 22%; text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zf5ZPm758Rkd" style="width: 21%; text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.7</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDVRVh4SGwFk" style="width: 21%; text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9cjewJlu2Oi" style="text-align: right" title="Warrant outstanding exercise price">30.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwJKEdfAh5m6" style="text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRbODz0PvQFb" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">0.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zER4dEdFMnb7" style="text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0m5qLX4y9e7" style="text-align: right" title="Warrant outstanding exercise price">66.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWouWlMlXbfj" style="text-align: right" title="Warrant outstanding number of shares">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr0tOTSWtVh7" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI7wfQwID2aj" style="text-align: right" title="Warrant exercisable number of shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zibivX3SxPZj" style="text-align: right" title="Warrant outstanding exercise price">24.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zALhEMvJLit6" style="text-align: right" title="Warrant outstanding number of shares">43,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeNnPqOcpMK5" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za1XSx4yGt4b" style="text-align: right" title="Warrant exercisable number of shares">43,336</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxyWQWquvEJi" style="text-align: right" title="Warrant outstanding exercise price">1.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQjEzRu5AMyd" style="text-align: right" title="Warrant outstanding number of shares">4,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQsuYt9embFk" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0skXk4Ck9Pj" style="text-align: right" title="Warrant exercisable number of shares">4,167</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlftuzNt0SM3" style="text-align: right" title="Warrant outstanding exercise price">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWdWZD49fMyd" style="text-align: right" title="Warrant outstanding number of shares">22,279</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuBB4s3kTp9j" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9WEQDqCVKWb" style="text-align: right" title="Warrant exercisable number of shares">22,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHjRqKDZDSqa" style="text-align: right" title="Warrant outstanding exercise price">11.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6qJcCHYxgZe" style="text-align: right" title="Warrant outstanding number of shares">2,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWIbhsaBqIf4" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuxNVvMmTeNk" style="text-align: right" title="Warrant exercisable number of shares">2,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDZGYCE416S8" style="padding-bottom: 1.5pt; text-align: right" title="Warrant outstanding exercise price">8.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjYVujxcnlgf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant outstanding number of shares">74,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlN2PZ6wSi5c" style="padding-bottom: 1.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.9</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfumqBB40Hk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant exercisable number of shares">74,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbODgjaK1Rb8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant outstanding number of shares">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0RFRQ42sdLd" style="padding-bottom: 2.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsyd8Ks2sevj" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable number of shares">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Stock Options A summary of the option activity during the nine months ended July 31, 2024 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding, November 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znPzdiJ01GB1" style="width: 14%; text-align: right" title="Number of stock option, beginning">6,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zO2T8l0DVKM1" style="width: 14%; text-align: right" title="Weighted average, exercise price, beginning">10.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zREmoxWu1oZ" style="width: 14%; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbikfkGOOfKf" style="width: 14%; text-align: right" title="Intrinsic value, beginning">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhQWObB24QS7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLiDjod4ZEcd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedIntrinsicValue_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zDTTGtVGL5s2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding July 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHcFRrp93Co2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock option, beginning">6,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zvJLRsj1Dg43" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, ending balance">10.40</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zP2aZXFU3Kvh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUueg972hgg4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, ending">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsN8Irshz3f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares warrant exercisable, balance">5,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkJryMzhkQ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price excercisable ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zcGzIwXST9Qf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zct4xlKJ8fL7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable issued">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zuaYpXXV0u8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">A summary of outstanding and exercisable options as of July 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Remaining Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCSTcweQvFkd" style="padding-bottom: 1.5pt; width: 22%; text-align: right" title="Options outstanding exercise price">10.40</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIvQHR1pkE5" style="border-bottom: Black 1.5pt solid; width: 22%; text-align: right" title="Options outstanding number of shares">6,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zT7vz9ckCyDj" style="padding-bottom: 1.5pt; width: 21%; text-align: right" title="Options exercisable, weighted average remaining life in years">4.0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUGUlkFqzyG" style="border-bottom: Black 1.5pt solid; width: 21%; text-align: right" title="Options exercisable number of shares">6,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfGbjbjZalk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3M6nGrYltS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> On August 15, 2023, the Company issued five-year options to purchase <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zoz2umAiZ9l9">6,000 shares of the Company’s common stock to a consultant of the Company, pursuant to the Plan. The options have an exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zMQtSSLNpXE9">10.40 per share and vest monthly over a period of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtM_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zLypHgHsig47">24 months, beginning on the vesting commencement date, which is May 1, 2022 per the option agreement. The options have a grant date fair value of $<span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodFairValue1_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_z7lnMw3R0tx">55,711, which will be recognized over the vesting term. The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Risk free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">4.36</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137.1</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividends rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>

10000

9.60

95200

18393

6.80

6.20

5.80

125072 114036 105575 36698 35837 49935

36770

24873

30510

91965

42917

257500

4.80

2.60

2.00

3.40

441428

113300

84117

881165

32247

119796

17576

4.80

12.60

574779

221449

391447

20547

180566

131165

275000

1.03

283250

94417

3.40

3.60

323094

339334

48094

64334

5000

2.20

10500

100000

50000

30000

7.40

368000

37500

9.80

8.00

366000

301500

30000

7.40

220800

4167

38029

11.00

26.40

P5Y

1.3710

4.72

2750

14753

6.40

11.00

P5Y

1.3710

3.93

22279

98708

6.40

10.00

P5Y

1.3710

3.93

37231

7.90500

74461

257701

6.00

7.90500

P5Y

1.3252

4.29

A summary of the warrant activity during the nine months ended July 31, 2024 is presented below: SCHEDULE OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding November 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSdc058Zcy4j" style="width: 14%; text-align: right" title="Number of warrants outstanding, beginning">88,336</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zG2B6iwwUUJ" style="width: 14%; text-align: right" title="Weighted average, exercise price, beginning">22.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4vawIcGfxY9" style="width: 14%; text-align: right" title="Weighted average remaining life in years">7.3</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7gwPVbttGk" style="width: 14%; text-align: right" title="Intrinsic value, beginning">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkEbU0l6CK2i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants issued">103,657</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAjUnqVp40xb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, issued">9.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7WqKuA5fq77" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding, July 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3Kc2A5W52j8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, ending">191,993</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztcBuAzgV7d6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, ending">15.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxfj6tXmVRW1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPdfn2qGVKfe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, ending">98,800</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7kn4JRhMfH8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, exercisable">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmccrrKgLbbl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, exercisable">15.20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTZYUc41vE5d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbWwOjMifFzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable ending">98,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

88336

22.40

P7Y3M18D

103657

9.20

P4Y9M18D

191993

15.20

P4Y

98800

191993 15.20 P4Y 98800 A summary of outstanding and exercisable warrants as of July 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRofXmvguxi9" style="width: 22%; text-align: right" title="Warrant outstanding exercise price">0.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0jPeloosfoh" style="width: 22%; text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zf5ZPm758Rkd" style="width: 21%; text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.7</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDVRVh4SGwFk" style="width: 21%; text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9cjewJlu2Oi" style="text-align: right" title="Warrant outstanding exercise price">30.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwJKEdfAh5m6" style="text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRbODz0PvQFb" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">0.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zER4dEdFMnb7" style="text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0m5qLX4y9e7" style="text-align: right" title="Warrant outstanding exercise price">66.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWouWlMlXbfj" style="text-align: right" title="Warrant outstanding number of shares">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr0tOTSWtVh7" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI7wfQwID2aj" style="text-align: right" title="Warrant exercisable number of shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zibivX3SxPZj" style="text-align: right" title="Warrant outstanding exercise price">24.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zALhEMvJLit6" style="text-align: right" title="Warrant outstanding number of shares">43,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeNnPqOcpMK5" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za1XSx4yGt4b" style="text-align: right" title="Warrant exercisable number of shares">43,336</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxyWQWquvEJi" style="text-align: right" title="Warrant outstanding exercise price">1.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQjEzRu5AMyd" style="text-align: right" title="Warrant outstanding number of shares">4,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQsuYt9embFk" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0skXk4Ck9Pj" style="text-align: right" title="Warrant exercisable number of shares">4,167</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlftuzNt0SM3" style="text-align: right" title="Warrant outstanding exercise price">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWdWZD49fMyd" style="text-align: right" title="Warrant outstanding number of shares">22,279</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuBB4s3kTp9j" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9WEQDqCVKWb" style="text-align: right" title="Warrant exercisable number of shares">22,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHjRqKDZDSqa" style="text-align: right" title="Warrant outstanding exercise price">11.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6qJcCHYxgZe" style="text-align: right" title="Warrant outstanding number of shares">2,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWIbhsaBqIf4" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuxNVvMmTeNk" style="text-align: right" title="Warrant exercisable number of shares">2,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDZGYCE416S8" style="padding-bottom: 1.5pt; text-align: right" title="Warrant outstanding exercise price">8.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjYVujxcnlgf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant outstanding number of shares">74,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlN2PZ6wSi5c" style="padding-bottom: 1.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.9</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfumqBB40Hk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant exercisable number of shares">74,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbODgjaK1Rb8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant outstanding number of shares">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20231101__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0RFRQ42sdLd" style="padding-bottom: 2.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsyd8Ks2sevj" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable number of shares">191,993</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

0.20

20000

P3Y8M12D

20000

30.00

20000

P0Y4M24D

20000

66.00

5000

P3Y8M12D

5000

24.00

43336

P4Y2M12D

43336

1.32

4167

P4Y2M12D

4167

10.00

22279

P4Y4M24D

22279

11.00

2750

P4Y4M24D

2750

8.00

74461

P4Y10M24D

74461

191993

P4Y

191993

A summary of the option activity during the nine months ended July 31, 2024 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding, November 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znPzdiJ01GB1" style="width: 14%; text-align: right" title="Number of stock option, beginning">6,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zO2T8l0DVKM1" style="width: 14%; text-align: right" title="Weighted average, exercise price, beginning">10.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zREmoxWu1oZ" style="width: 14%; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbikfkGOOfKf" style="width: 14%; text-align: right" title="Intrinsic value, beginning">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhQWObB24QS7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLiDjod4ZEcd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedIntrinsicValue_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zDTTGtVGL5s2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, issued">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding July 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHcFRrp93Co2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock option, beginning">6,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zvJLRsj1Dg43" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average, exercise price, ending balance">10.40</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zP2aZXFU3Kvh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average remaining life in years">4.0</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUueg972hgg4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intrinsic value, ending">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, July 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsN8Irshz3f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares warrant exercisable, balance">5,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkJryMzhkQ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price excercisable ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zcGzIwXST9Qf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20231101__20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zct4xlKJ8fL7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable issued">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

6000

10.40

P4Y

6000

10.40

P4Y

5250

10.40 P4Y

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zuaYpXXV0u8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">A summary of outstanding and exercisable options as of July 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Remaining Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCSTcweQvFkd" style="padding-bottom: 1.5pt; width: 22%; text-align: right" title="Options outstanding exercise price">10.40</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIvQHR1pkE5" style="border-bottom: Black 1.5pt solid; width: 22%; text-align: right" title="Options outstanding number of shares">6,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20231101__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zT7vz9ckCyDj" style="padding-bottom: 1.5pt; width: 21%; text-align: right" title="Options exercisable, weighted average remaining life in years">4.0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUGUlkFqzyG" style="border-bottom: Black 1.5pt solid; width: 21%; text-align: right" title="Options exercisable number of shares">6,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfGbjbjZalk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20240731__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3M6nGrYltS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

10.40

6000

P4Y

6000

10.40

P24M

55711

The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Risk free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">4.36</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137.1</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividends rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>

0.0436

P5Y

1.371

NOTE 11 – SUBSEQUENT EVENTS In accordance with ASC 855 - Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events and transactions that occurred after July 31, 2024 through the date the unaudited condensed financial statements are available for issuance. During this period, the Company did not have any material reportable subsequent events, except as disclosed below. August 1, 2024 Financing On August 1, 2024, the Company entered into a Securities Purchase Agreement (the “August 1st SPA”) with an investor, pursuant to which the Company raised gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za5HZ2mF4fJd">134,000 and received net proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromShortTermDebt_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPnctdoTUrPa">110,625; in connection with the financing, the Company issued an unsecured promissory note to the investor in the principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyKSjaT4CKdd">152,000 and an original issue discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlylKWVtZwN">18,000 or approximately <span id="xdx_907_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPJu3kkanxwf">11.8%. Interest accrues on the note at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5Ew5OjLVF5b">12% per annum and the maturity date of the note is <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSzUQIcK5h7">May 30, 2025. The note provides for five payments of principal and accrued interest which are payable: (i) $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250130__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zdaruRsAH2f2">85,120 on January 30, 2025; (ii) $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zOXMXG1Xq78f">21,280 on February 28, 2025; (iii) $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20250330__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zLQ2vSsSgoyd">21,280 on March 30, 2025; (iv) $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20250430__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zyDzijEjvxq5">21,280 on April 30, 2025; and (v) $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20250530__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z4mU3LPBgqB8">21,280 on May 30, 2025. Subject to certain restrictions, the Company may prepay the note, in full and not in part, any time during the 180 day period after the issuance date at a <span id="xdx_902_ecustom--PercentageOfTotalPrincipalAmount_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsh5Jed1SPRf">3% discount to the outstanding amount of principal and interest due and payable; provided, that in the event of a prepayment, the Company will still be required to pay the full amount of interest that would have been payable through the term of the note, in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240801__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7FBS32EF406">18,240. Second Amendment to the Asphalt Ridge Option Agreement On August 5, 2024, the Company and HSO entered into a second amendment to the Asphalt Ridge Option Agreement, pursuant to which the Company and HSO extended the expiration date of the option by two months from August 10, 2024 to February 10, 2025. August 6, 2024 Financing On August 6, 2024, the Company entered into a Securities Purchase Agreement (the “August 6th SPA”) with an investor, pursuant to which the Company raised gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromNotesPayable_c20240806__20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLyw5HsXOG7e">225,000 and received net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromShortTermDebt_c20240806__20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQZOjjfHRppf">199,250; in connection with the Financing, the Company issued an unsecured promissory note to the investor in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zchXGnwE0dL3">255,225, having an original issue discount of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zW6wdkdT2JH">30,225 or approximately <span id="xdx_907_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHS6RXbWrAQf">11.8%. Interest accrues on the note at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5bk1ybzHmHi">12% per annum and the maturity date of the note is <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20240806__20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKe78jHiPBt4">May 30, 2025. The note provides for five payments of principal and accrued interest which are payable: (i) $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250130__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zQcU639PZv7">142,926 on January 30, 2025; (ii) $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20250228__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z7I6qTcv7d61">35,731.50 on February 28, 2025; (iii) $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20250330__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbLILt9xrD84">35,731.50 on March 30, 2025; (iv) $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20250430__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqLFTTUwGzw3">35,731.50 on April 30, 2025; and (v) $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20250530__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zgAhOGp6peO8">35,731.50 on May 30, 2025. Subject to certain restrictions, the Company may prepay the note, in full and not in part, any time during the 180 day period after the issuance date at a <span id="xdx_909_ecustom--PercentageOfTotalPrincipalAmount_iI_pid_dp_uPure_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustOneTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQfROOjbFfm5">3% discount to the outstanding amount of principal and interest due and payable; provided, that in the event of a prepayment, the Company will still be required to pay the full amount of interest that would have been payable through the term of the note, in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1MhkOtBuTu9">30,627. Additionally, in conjunction with two prior investors and the April 2024 Debt Financing, the Company will make two payments of $<span id="xdx_902_eus-gaap--ProceedsFromRepaymentsOfDebt_c20240806__20240806__us-gaap--TypeOfArrangementAxis__custom--AugustSixTwoThousandTwentyFourSPAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4rr9iuV5RAk">25,000 to each of the prior investors from the net proceeds of this financing. Amendment to the April 2024 Debt Financings On August 14, 2024, the Company entered into an amendment to the April 2024 Debt Financings to extend the maturity dates of the notes from August 16, 2024 to September 16, 2024; the amendment also provides for the accrual of interest on the outstanding principal balance of the notes at a rate of 15% per annum from August 16, 2024, until the notes are repaid. Annual Stockholder’s Meeting held on August 15, 2024 On August 15, 2024, the Company held its annual meeting of stockholders; the following actions were taken at the meeting: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Two Class I directors were elected to serve for <span id="xdx_906_ecustom--ExpirationOfTerm_dxL_c20240815__20240815__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--TwoClassOneDirectorsMember_zmDZVD7G8Wih" title="Expiration of term::XDX::P3Y">three-year terms that expire in 2027.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">A proposal was approved to amend the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock-split of its outstanding shares of common stock; the ratio of the split is to be determined by the Board, will be in a range of 1-for-5 to 1-for-20 and will be effective upon the filing of the certificate, the timing of which will also be determined by the Board.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">A proposal was approved to increase the number of shares of common stock reserved for issuance with respect to awards granted under the Plan from 200,000 shares of common stock to 500,000 shares of common stock.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The appointment of the Company’s new independent registered public accounting firm for the year ended October 31, 2024 was ratified.</td></tr> </table>

134000

110625

152000

18000

0.118

0.12

2025-05-30

85120

21280

0.03

18240

225000

199250

255225

30225

0.118

0.12

2025-05-30

142926

35731.50

0.03

30627

25000

0.15

1-for-5 to 1-for-20

200000

500000

1561924

73648

133417

35000

1643881

1695341

1752529

9947742

5836232

1900000

11643083

9488761

609360

1164055

2778

1217597

21651

4403439

1025497

114883

1851386

6710652

9450

48313

45535

48313

54985

1899699

6765637

0.0001

500000

0.0001

24500000

1552328

848640

155

10010

20200121

6635505

-10446882

-3902456

9743384

2723124

11643083

9488761

251743

28669

3311886

768379

1044261

6202

2778

4610668

806028

-4610668

-806028

791811

1661981

1322933 13051 1125000

3896

9450

-1933758

-2994364

-6544426

-3800392

-6544426

-3800392

-5.67

-5.14

-5.67

-5.14

1153988

739889

1153988

739889

848640

-10010

6635505

-3902456

2723124

20000

371998

372000

251946

5164850

5164875

18750 2 1124998 1125000 100000 10 3342616 3342626

4000

122474

1812623

1812635

14275

366658

366659

106250

-11

59993 6 -6

332630

10000

1044260

1044261

-6544426

1552328

155

-10010

20200121

-10446882

9743384

549140

-50545

4203064

-102064

4050510

549140

-50545

4203064

-102064

4050510

4000 535 8 543 225000 22 1322911 1322933

500

40000

20000

60000

994091 994091 15000 2 -2 55000 6 -6 89237 89237

6202

-3800392

848640

-10010

6635505

-3902456

2723124

848640

-10010

6635505

-3902456

2723124

-6544426

-3800392

-9450 9450

25000

2778

1125000 -140000

473240

1218951

80000 89237

1044261

6202

1322933

123417

13846

110180

582543

-4036834

-502144

362022

3749488

1900000

21651

-2189859

738659

60543

4820000

1472512

2920000

6000000

350320

575438

1812635

1013493

888190

2000000

7714969

496915

1488276

-5229

73648

78877

1561924

73648

332630 1108974

213

120 4000

NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS Company Organization Trio Petroleum Corp. (“Trio Petroleum” or the “Company”) is an oil and gas exploration and development company headquartered in Danville, California, with operations in Monterey County, California. The Company was incorporated on July 19, 2021, under the laws of Delaware to acquire, fund and develop oil exploration and production assets in California; it has no revenue-generating operations as of the date of this filing. The Company was formed to acquire Trio Petroleum LLC’s (“Trio LLC”) approximate <span id="xdx_903_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_pid_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zc8sRnLCqXla" title="Business acquisition increase in percentage of working interest">82.75% working interest, which was subsequently increased to an approximate <span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zFw7EPomKtp2" title="Business acquisition percentage of working interest">85.75% working interest, in the large, approximately 9,300-acre South Salinas Project located in Monterey, California, and subsequently partner with certain members of Trio LLC’s management team to develop and operate those assets. (see Note 5 and Note 6). Acquisition of South Salinas Project On September 14, 2021, the Company entered into a Purchase and Sale Agreement (“Trio LLC PSA”) with Trio LLC to acquire an <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zEmbfgcV3rg9">82.75% working interest in the South Salinas Project; the working interest included the purchased percentage of the South Salinas Project’s leases, wells and inventory in exchange for $<span id="xdx_90B_eus-gaap--PaymentsToAcquireBusinessesGross_c20210913__20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zFLRzkQ9O903">300,000 cash, a non-interest-bearing note payable of $<span id="xdx_901_eus-gaap--AccountsPayableInterestBearingCurrentAndNoncurrent_iI_c20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zw6dsMnyi6Ei">3,700,000 due to Trio LLC on December 17, 2021 (see Note 6 and Note 9) and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211216__20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zm1l4vHrrwV4">245,000 shares of the Company’s $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zCtNzjpoIGy3">0.0001 par value common stock (see Note 5 and Note 10). At the time of the acquisition, this share issuance constituted 45% of the total number of issued shares of the Company. The Company accounted for the purchase as an asset acquisition, as prescribed in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 – Business Combinations. The assets and associated asset retirement obligations (“ARO”) were recorded based on relative fair value at the estimated fair value of the consideration paid (see Note 5). In April 2023, the Company purchased an additional <span id="xdx_90D_ecustom--PurchaseOfAdditionalInterestPercentage_iI_dp_uPure_c20230430__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zycJoLh0oSX3">3% working interest in the South Salinas Project; see Note 5 for further information. As of October 31, 2023 and 2022, there were no proved reserves attributable to the approximate 9,300 acres of the property. Initial Public Offering The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold 100,000 shares of its common stock for total gross proceeds of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zUQZHYQy8Um1" title="Sale of stock, consideration received on transaction">6,000,000, which is described more fully in Note 4. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

0.8275

0.8575

0.8275

300000

3700000

245000

0.0001

0.45 0.03

9300

100000

6000000

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, accounts receivable, bad debt expense, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of October 31, 2023 and 2022. Prepaid Expenses Prepaid expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of October 31, 2023 and 2022, the balances of the prepaids account were $133,417 and $35,000, respectively. Deferred Offering Costs Deferred offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the planned IPO (see Note 4). As of October 31, 2023 and 2022, offering costs in the aggregate of $0 and $1,643,881, respectively, were deferred. Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of October 31, 2023 and 2022, the Company recorded $350,320 and $575,438 in debt issuance costs. Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in early development and/or exploration stages and it has not yet realized any revenues from its operations. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. As of October 31, 2023 and 2022, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization. Unproved oil and natural gas properties Unproved oil and natural gas properties consist of costs incurred to acquire unproved leases. Unproved lease acquisition costs are capitalized until the lease expires or when the Company specifically identifies a lease that will revert to the lessor, at which time it charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. All of the Company’s natural gas properties were classified as unproved as of October 31, 2023 and 2022; see further discussion in Note 5. Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties. As of October 31, 2023 and 2022, the Company had no impairment of long-lived assets. Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the South Salinas Project acquisition in future exploration activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO for the years ended October 31, 2022 and 2023 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetRetirementObligation_iS_c20211101__20221031_zhIGguoD1kDc" style="width: 16%; text-align: right" title="ARO, ending balance">45,535</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AccretionExpense_c20211101__20221031_zXgf931TE3Il" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetRetirementObligation_iS_c20221101__20231031_zjOKYXSbp5b9" style="text-align: right" title="ARO, ending balance">48,313</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccretionExpense_c20221101__20231031_zvzkcqREMgH2" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AssetRetirementObligation_iE_c20221101__20231031_z6OhGwbDjKz5" style="text-align: right" title="ARO, ending balance">51,091</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Less: ARO – current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetRetirementObligationCurrent_iI_c20231031_zStxOeYe6Akb" style="border-bottom: Black 1pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20231031_z5xKttCAOEL5" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">48,313</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20210914__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_z0SMVN135VI5">82.75% working interest (which was subsequently increased to an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230430__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zP6vAa3Uvik3">85.75% working interest as of April 2023) in the South Salinas Project from Trio LLC in exchange for cash, a note payable to Trio LLC and the issuance of 245,000 shares of common stock. As of the date of the acquisition, Trio LLC owned 45% of the outstanding shares of the Company and was considered a related party. As of October 31, 2023 and 2022, Trio LLC owned less than 1% and 29%, respectively, of the outstanding shares of the Company. Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company utilizes ASC 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely than not” that a deferred tax asset will not be realized. At October 31, 2023 and 2022, the Company’s net deferred tax asset has been fully reserved. For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations when a determination is made that such expense is likely. The Company is subject to income tax examinations by major taxing authorities since inception. Fair Value Measurements The carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement. As defined in ASC 820, Fair Value Measurements and Disclosures, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent measurement. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">Level 1:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques.</td></tr> </table> There are no assets or liabilities measured at fair value on a recurring basis. Assets and liabilities accounted for at fair value on a non-recurring basis in accordance with the fair value hierarchy include the initial allocation of the asset acquisition purchase price, including asset retirement obligations, the fair value of oil and natural gas properties and the assessment of impairment. The fair value measurements and allocation of assets acquired are measured on a nonrecurring basis on the acquisition date using an income valuation technique based on inputs that are not observable in the market and therefore represent Level 3 inputs. Significant inputs used to determine the fair value include estimates of: (i) reserves; (ii) future commodity prices; (iii) operating and development costs; and (iv) a market-based weighted average cost of capital rate. The underlying commodity prices embedded in the Company’s estimated cash flows are the product of a process that begins with NYMEX forward curve pricing, adjusted for estimated location and quality differentials, as well as other factors that the Company’s management believes will impact realizable prices. These inputs require significant judgments and estimates by the Company’s management at the time of the valuation. The fair value of additions to the asset retirement obligation liabilities is measured using valuation techniques consistent with the income approach, which converts future cash flows to a single discounted amount. Significant inputs to the valuation include: (i) estimated plug and abandonment cost per well for all oil and natural gas wells and for all disposal wells; (ii) estimated remaining life per well; (iii) future inflation factors; and (iv) the Company’s average credit-adjusted risk-free rate. These assumptions represent Level 3 inputs. If the carrying amount of its proved oil and natural gas properties, which are assessed for impairment under ASC 360 – Property, Plant and Equipment, exceeds the estimated undiscounted future cash flows, the Company will adjust the carrying amount of the oil and natural gas properties to fair value. The fair value of its oil and natural gas properties is determined using valuation techniques consistent with the income and market approach. The factors used to determine fair value are subject to management’s judgment and expertise and include, but are not limited to, recent sales prices of comparable properties, the present value of future cash flows, net of estimated operating and development costs using estimates of proved reserves, future commodity pricing, future production estimates, anticipated capital expenditures, and various discount rates commensurate with the risk and current market conditions associated with the expected cash flow projected. These assumptions represent Level 3 inputs. Net Loss Per Share Basic and diluted net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic loss per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, warrants and convertible notes, if dilutive. The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive (see Note 10): SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI-DILUTIVE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants (Note 9, Note 10)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDQp_zPVgahdugzsl" style="width: 16%; text-align: right" title="Warrents">19,813</td><td style="width: 1%; text-align: left">(4)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDEp_z3w9JdthvS37" style="width: 16%; text-align: right" title="Warrents">34,656</td><td style="width: 1%; text-align: left">(1)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible Notes (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zMWEnoSWBWTh" style="text-align: right" title="Convertible Notes">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_fKDIp_zlKdxxT1bia2" style="text-align: right" title="Convertible Notes">138,622</td><td style="text-align: left">(2)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Commitment Shares (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_zHpPXD4HrIDg" style="text-align: right" title="Commitment Shares">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_fKDMp_z7nSIMgSbQV5" style="text-align: right" title="Commitment Shares">16,072</td><td style="text-align: left">(3)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock units and shares (Note 6, Note 10)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zM3gxY3zcD19" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDUp_zFOyg4mcdod7" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">70,000</td><td style="padding-bottom: 1pt; text-align: left">(5)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031_zfIeGWGUkUpc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">19,813</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031_zxmFPjOsVhll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">259,350</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance includes warrants issued per the January 2022 Securities Purchase Agreement (“January 2022 SPA”) with GPL Ventures, LLC (“GPL”), which are exercisable into up to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_ecustom--NumberOfSharesOfCommonStockExercisablePercentage_dp_uPure_c20221101__20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GPLVenturesLLCMember_zbmwkPIxNCFc" title="Number of shares of common stock exercisable percentage">50% of the number of shares of common stock issued upon full conversion of the Notes, with an exercise price equal to the conversion price. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon IPO, the debt will convert into a variable number of shares; the number of conversion shares is equal to the outstanding principal amount divided by the conversion price, which is equal to the lesser of a) the IPO price or b) the opening price of the common stock on the first trading day after the IPO multiplied by the discount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_ecustom--WarrantSharesOfOutstandingPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9cu2mfBUUg" title="Warrant shares of outstanding percentage">50%. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The number of commitment shares to be issued is a variable number of shares for a fixed total dollar amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--CommitmentValue_iI_c20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmF8xH0MflH1" title="Commitment value">1,125,000, which is <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_ecustom--CommitmentSharesIssuedPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMtmOcOcUcj8" title="Commitment shares issued percentage">25% of the aggregate Notes principal balance divided by the offering price of the IPO. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(4)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of potentially dilutive shares based on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20221101__20231031_zzmL7hRRt6nk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,336 outstanding, equity classified warrants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(5)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.</td></tr> </table> Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company. Reclassification of Expenses Certain amounts in the prior periods presented have been reclassified to the current period financial statement presentation. This reclassification has no effect on previously reported net income. Subsequent Events The Company evaluated all events and transactions that occurred after October 31, 2023 through the date of the filing of this report. See Note 11 for such events and transactions.

Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, accounts receivable, bad debt expense, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates.

Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of October 31, 2023 and 2022.

Prepaid Expenses Prepaid expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of October 31, 2023 and 2022, the balances of the prepaids account were $133,417 and $35,000, respectively.

133417

35000

Deferred Offering Costs Deferred offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the planned IPO (see Note 4). As of October 31, 2023 and 2022, offering costs in the aggregate of $0 and $1,643,881, respectively, were deferred.

1643881

Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of October 31, 2023 and 2022, the Company recorded $350,320 and $575,438 in debt issuance costs.

350320

575438

Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in early development and/or exploration stages and it has not yet realized any revenues from its operations. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. As of October 31, 2023 and 2022, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization.

Unproved oil and natural gas properties Unproved oil and natural gas properties consist of costs incurred to acquire unproved leases. Unproved lease acquisition costs are capitalized until the lease expires or when the Company specifically identifies a lease that will revert to the lessor, at which time it charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. All of the Company’s natural gas properties were classified as unproved as of October 31, 2023 and 2022; see further discussion in Note 5.

Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties. As of October 31, 2023 and 2022, the Company had no impairment of long-lived assets.

Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the South Salinas Project acquisition in future exploration activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO for the years ended October 31, 2022 and 2023 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetRetirementObligation_iS_c20211101__20221031_zhIGguoD1kDc" style="width: 16%; text-align: right" title="ARO, ending balance">45,535</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AccretionExpense_c20211101__20221031_zXgf931TE3Il" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetRetirementObligation_iS_c20221101__20231031_zjOKYXSbp5b9" style="text-align: right" title="ARO, ending balance">48,313</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccretionExpense_c20221101__20231031_zvzkcqREMgH2" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AssetRetirementObligation_iE_c20221101__20231031_z6OhGwbDjKz5" style="text-align: right" title="ARO, ending balance">51,091</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Less: ARO – current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetRetirementObligationCurrent_iI_c20231031_zStxOeYe6Akb" style="border-bottom: Black 1pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20231031_z5xKttCAOEL5" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">48,313</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Components of the changes in ARO for the years ended October 31, 2022 and 2023 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">ARO, ending balance – October 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetRetirementObligation_iS_c20211101__20221031_zhIGguoD1kDc" style="width: 16%; text-align: right" title="ARO, ending balance">45,535</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AccretionExpense_c20211101__20221031_zXgf931TE3Il" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetRetirementObligation_iS_c20221101__20231031_zjOKYXSbp5b9" style="text-align: right" title="ARO, ending balance">48,313</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accretion expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccretionExpense_c20221101__20231031_zvzkcqREMgH2" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion expense">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ARO, ending balance – October 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AssetRetirementObligation_iE_c20221101__20231031_z6OhGwbDjKz5" style="text-align: right" title="ARO, ending balance">51,091</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Less: ARO – current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetRetirementObligationCurrent_iI_c20231031_zStxOeYe6Akb" style="border-bottom: Black 1pt solid; text-align: right" title="Less: ARO - current">2,778</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">ARO, net of current portion – October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetRetirementObligationsNoncurrent_iI_c20231031_z5xKttCAOEL5" style="border-bottom: Black 2.5pt double; text-align: right" title="ARO, net of current portion">48,313</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

45535

2778

48313

2778

51091

2778

48313

Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20210914__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_z0SMVN135VI5">82.75% working interest (which was subsequently increased to an <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230430__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zP6vAa3Uvik3">85.75% working interest as of April 2023) in the South Salinas Project from Trio LLC in exchange for cash, a note payable to Trio LLC and the issuance of 245,000 shares of common stock. As of the date of the acquisition, Trio LLC owned 45% of the outstanding shares of the Company and was considered a related party. As of October 31, 2023 and 2022, Trio LLC owned less than 1% and 29%, respectively, of the outstanding shares of the Company.

0.8275

0.8575

245000

0.45 0.01 0.29

Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company utilizes ASC 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely than not” that a deferred tax asset will not be realized. At October 31, 2023 and 2022, the Company’s net deferred tax asset has been fully reserved. For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations when a determination is made that such expense is likely. The Company is subject to income tax examinations by major taxing authorities since inception.

Fair Value Measurements The carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement. As defined in ASC 820, Fair Value Measurements and Disclosures, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies to both initial and subsequent measurement. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">Level 1:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3:</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques.</td></tr> </table> There are no assets or liabilities measured at fair value on a recurring basis. Assets and liabilities accounted for at fair value on a non-recurring basis in accordance with the fair value hierarchy include the initial allocation of the asset acquisition purchase price, including asset retirement obligations, the fair value of oil and natural gas properties and the assessment of impairment. The fair value measurements and allocation of assets acquired are measured on a nonrecurring basis on the acquisition date using an income valuation technique based on inputs that are not observable in the market and therefore represent Level 3 inputs. Significant inputs used to determine the fair value include estimates of: (i) reserves; (ii) future commodity prices; (iii) operating and development costs; and (iv) a market-based weighted average cost of capital rate. The underlying commodity prices embedded in the Company’s estimated cash flows are the product of a process that begins with NYMEX forward curve pricing, adjusted for estimated location and quality differentials, as well as other factors that the Company’s management believes will impact realizable prices. These inputs require significant judgments and estimates by the Company’s management at the time of the valuation. The fair value of additions to the asset retirement obligation liabilities is measured using valuation techniques consistent with the income approach, which converts future cash flows to a single discounted amount. Significant inputs to the valuation include: (i) estimated plug and abandonment cost per well for all oil and natural gas wells and for all disposal wells; (ii) estimated remaining life per well; (iii) future inflation factors; and (iv) the Company’s average credit-adjusted risk-free rate. These assumptions represent Level 3 inputs. If the carrying amount of its proved oil and natural gas properties, which are assessed for impairment under ASC 360 – Property, Plant and Equipment, exceeds the estimated undiscounted future cash flows, the Company will adjust the carrying amount of the oil and natural gas properties to fair value. The fair value of its oil and natural gas properties is determined using valuation techniques consistent with the income and market approach. The factors used to determine fair value are subject to management’s judgment and expertise and include, but are not limited to, recent sales prices of comparable properties, the present value of future cash flows, net of estimated operating and development costs using estimates of proved reserves, future commodity pricing, future production estimates, anticipated capital expenditures, and various discount rates commensurate with the risk and current market conditions associated with the expected cash flow projected. These assumptions represent Level 3 inputs.

Net Loss Per Share Basic and diluted net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic loss per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, warrants and convertible notes, if dilutive. The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive (see Note 10): SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI-DILUTIVE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants (Note 9, Note 10)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDQp_zPVgahdugzsl" style="width: 16%; text-align: right" title="Warrents">19,813</td><td style="width: 1%; text-align: left">(4)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDEp_z3w9JdthvS37" style="width: 16%; text-align: right" title="Warrents">34,656</td><td style="width: 1%; text-align: left">(1)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible Notes (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zMWEnoSWBWTh" style="text-align: right" title="Convertible Notes">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_fKDIp_zlKdxxT1bia2" style="text-align: right" title="Convertible Notes">138,622</td><td style="text-align: left">(2)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Commitment Shares (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_zHpPXD4HrIDg" style="text-align: right" title="Commitment Shares">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_fKDMp_z7nSIMgSbQV5" style="text-align: right" title="Commitment Shares">16,072</td><td style="text-align: left">(3)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock units and shares (Note 6, Note 10)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zM3gxY3zcD19" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDUp_zFOyg4mcdod7" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">70,000</td><td style="padding-bottom: 1pt; text-align: left">(5)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031_zfIeGWGUkUpc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">19,813</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031_zxmFPjOsVhll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">259,350</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance includes warrants issued per the January 2022 Securities Purchase Agreement (“January 2022 SPA”) with GPL Ventures, LLC (“GPL”), which are exercisable into up to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_ecustom--NumberOfSharesOfCommonStockExercisablePercentage_dp_uPure_c20221101__20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GPLVenturesLLCMember_zbmwkPIxNCFc" title="Number of shares of common stock exercisable percentage">50% of the number of shares of common stock issued upon full conversion of the Notes, with an exercise price equal to the conversion price. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon IPO, the debt will convert into a variable number of shares; the number of conversion shares is equal to the outstanding principal amount divided by the conversion price, which is equal to the lesser of a) the IPO price or b) the opening price of the common stock on the first trading day after the IPO multiplied by the discount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_ecustom--WarrantSharesOfOutstandingPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9cu2mfBUUg" title="Warrant shares of outstanding percentage">50%. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The number of commitment shares to be issued is a variable number of shares for a fixed total dollar amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--CommitmentValue_iI_c20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmF8xH0MflH1" title="Commitment value">1,125,000, which is <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_ecustom--CommitmentSharesIssuedPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMtmOcOcUcj8" title="Commitment shares issued percentage">25% of the aggregate Notes principal balance divided by the offering price of the IPO. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(4)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of potentially dilutive shares based on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20221101__20231031_zzmL7hRRt6nk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,336 outstanding, equity classified warrants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(5)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.</td></tr> </table>

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive (see Note 10): SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI-DILUTIVE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants (Note 9, Note 10)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDQp_zPVgahdugzsl" style="width: 16%; text-align: right" title="Warrents">19,813</td><td style="width: 1%; text-align: left">(4)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_fKDEp_z3w9JdthvS37" style="width: 16%; text-align: right" title="Warrents">34,656</td><td style="width: 1%; text-align: left">(1)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible Notes (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zMWEnoSWBWTh" style="text-align: right" title="Convertible Notes">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_fKDIp_zlKdxxT1bia2" style="text-align: right" title="Convertible Notes">138,622</td><td style="text-align: left">(2)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Commitment Shares (Note 9, Note 10)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_zHpPXD4HrIDg" style="text-align: right" title="Commitment Shares">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommitmentSharesMember_fKDMp_z7nSIMgSbQV5" style="text-align: right" title="Commitment Shares">16,072</td><td style="text-align: left">(3)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock units and shares (Note 6, Note 10)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zM3gxY3zcD19" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_fKDUp_zFOyg4mcdod7" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units and share">70,000</td><td style="padding-bottom: 1pt; text-align: left">(5)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20221101__20231031_zfIeGWGUkUpc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">19,813</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20221031_zxmFPjOsVhll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total potentially dilutive securities">259,350</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance includes warrants issued per the January 2022 Securities Purchase Agreement (“January 2022 SPA”) with GPL Ventures, LLC (“GPL”), which are exercisable into up to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_ecustom--NumberOfSharesOfCommonStockExercisablePercentage_dp_uPure_c20221101__20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GPLVenturesLLCMember_zbmwkPIxNCFc" title="Number of shares of common stock exercisable percentage">50% of the number of shares of common stock issued upon full conversion of the Notes, with an exercise price equal to the conversion price. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon IPO, the debt will convert into a variable number of shares; the number of conversion shares is equal to the outstanding principal amount divided by the conversion price, which is equal to the lesser of a) the IPO price or b) the opening price of the common stock on the first trading day after the IPO multiplied by the discount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_ecustom--WarrantSharesOfOutstandingPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9cu2mfBUUg" title="Warrant shares of outstanding percentage">50%. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The number of commitment shares to be issued is a variable number of shares for a fixed total dollar amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--CommitmentValue_iI_c20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmF8xH0MflH1" title="Commitment value">1,125,000, which is <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_ecustom--CommitmentSharesIssuedPercentage_dp_uPure_c20221101__20231031__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMtmOcOcUcj8" title="Commitment shares issued percentage">25% of the aggregate Notes principal balance divided by the offering price of the IPO. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(4)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of potentially dilutive shares based on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgQ09NTU9OIFNIQVJFUyBPVVRTVEFORElORyBBTlRJLURJTFVUSVZFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20221101__20231031_zzmL7hRRt6nk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,336 outstanding, equity classified warrants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(5)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.</td></tr> </table>

19813

34656

138622

16072

70000

19813

259350

0.50 0.50 1125000 0.25

Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Reclassification of Expenses Certain amounts in the prior periods presented have been reclassified to the current period financial statement presentation. This reclassification has no effect on previously reported net income.

Subsequent Events The Company evaluated all events and transactions that occurred after October 31, 2023 through the date of the filing of this report. See Note 11 for such events and transactions.

NOTE 3 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of October 31, 2023, the Company had $1,561,924 in its operating bank account and working capital deficit of $156,045. To date, the Company has been funding operations through proceeds from the issuance of common stock, financing through certain investors and its IPO, which closed with net proceeds of $4,940,000. Upon consummation of the IPO, the Company used the net proceeds to i) repay a non-interest-bearing note payable in the amount of $<span id="xdx_904_ecustom--NonInterestBearingNotePayable_iI_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zugmJJ4Bxseb" title="Non-interest-bearing note payable">1,032,512, and ii) repay a bridge note with three investors with a principal amount of $440,000 (see Notes 7 and 9). Additionally, on October 4, 2023, the Company entered into a securities purchase agreement (“October 2023 SPA”) with an institutional investor for convertible note financing in an aggregate principal amount of up to $<span id="xdx_901_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20231004__20231004__us-gaap--AwardTypeAxis__custom--TwoTranchesMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z06Wr4kFwWV1" title="Debt instrument, issued, principal">3.5 million under two tranches; on that same date, the investor funded the first tranche for approximately $<span id="xdx_906_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20231004__20231004__us-gaap--AwardTypeAxis__custom--FirstTrancheMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zgYVm7DEhlD9" title="Debt instrument, issued, principal">1.9 million (net of original issue discount of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231004__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zIAZKMxTR6b7" title="Original issue discount rate">7%). The accompanying financial statements have been prepared on the basis that the Company will continue as a going concern over the next twelve months from the date of issuance of these financial statements, which assumes the realization of assets and the satisfaction of liabilities in the normal course of business. As of October 31, 2023, the Company has an accumulated deficit of $10,446,882 and has experienced losses from continuing operations. Based on the Company’s cash balance as of October 31, 2023 and projected cash needs for the twelve months following the issuance of these financial statements, management estimates that it will need to generate sufficient sales revenue and/or raise additional capital to cover operating and capital requirements. Management will need to raise the additional funds by issuing additional shares of common stock or other equity securities or obtaining additional debt financing. Although management has been successful to date in raising necessary funding and obtaining financing through investors, there can be no assurance that any required future financing can be successfully completed on a timely basis, or on terms acceptable to the Company. Based on these circumstances, management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements. Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

1561924

156045

4940000

1032512

440000

3500000

1900000

0.07

-10446882

NOTE 4 – INITIAL PUBLIC OFFERING The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold 100,000 shares of common stock at a public offering price of $60.00 per share for gross proceeds of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLQJy7e4cZhi" title="Sale of stock, consideration received on transaction">6,000,000. After deducting the underwriting commissions, discounts and offering expenses payable by the Company, it received net proceeds of approximately $4,940,000. The Company’s common stock is listed on the NYSE American under the symbol TPET. The Company also issued warrants to purchase 5,000 shares of common stock to the underwriters at an exercise price of $66.00 per share (110% of public offering price), the cost of which was offset to additional paid-in capital upon IPO.

100000

60.00

6000000

4940000

5000

66.00

1.10

NOTE 5 – OIL AND NATURAL GAS PROPERTIES The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20231031_zkc7IrriqRre" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20221031_z40WQUIRbAzf" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OilAndGasPropertyFullCostMethodGross_iI_zQVD3USBtx0h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Oil and gas properties – not subject to amortization</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,947,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,836,232</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OilAndGasPropertyFullCostMethodDepletion_iI_zWuDgu6wKld7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OilAndGasPropertyFullCostMethodNet_iI_z9NasNptDZF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Oil and gas properties – not subject to amortization, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,947,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,836,232</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the years ended October 31, 2023 and 2022, the Company incurred aggregate exploration costs of $251,743 and $28,669, respectively. For the current year, these expenses were exploratory, geological and geophysical costs and for the prior year, these costs were mainly for the purpose of the site surveys. All costs were expensed on the statement of operations during the applicable periods. For capitalized costs during the year ended October 31, 2023, the Company incurred $4,111,510, of which $4,011,510 and $100,000 pertained to the South Salinas Project and McCool Ranch Oil Field, respectively. Of the costs incurred during the current period for the South Salinas Project, $3,749,488 relates to the drilling of the HV-1 well and $262,022 relates to acquisition costs and the reserve analysis of the optioned assets (see Optioned Assets below, Note 6). The drilling, reserve analysis and acquisition costs were capitalized and are reflected in the balance of the oil and gas property as of October 31, 2023. During the year ended October 31, 2022, the Company paid a lessor a one-time, non-refundable payment of $252,512 to provide for an extension of the force majeure status of the property at that time; this amount was capitalized and reflected in the balance of the oil and gas property as of October 31, 2022. Leases As of October 31, 2023, the Company holds various leases related to the unproved properties of the South Salinas Project (see Note 6 and Note 7); two of the leases are held with the same lessor. The first lease, which covers 8,417 acres, was amended on May 27, 2022 to provide for an extension of then-current force majeure status for an additional, uncontested twelve months, during which the Company would be released from having to evidence to the lessor the existence of force majeure conditions. As consideration for the granting of the lease extension, the Company paid the lessor a one-time, non-refundable payment of $252,512; this amount was capitalized and reflected in the balance of the oil and gas property as of October 31, 2022. The extension period commenced on June 19, 2022; as of October 31, 2023, the “force majeure” status has been extinguished by the drilling of the HV-1 well, and the validity of the lease is maintained by the drilling of the well, which is in production testing. The second lease covers 160 acres of the South Salinas Project; it is currently held by delay rental and is renewed every three years. Until drilling commences, the Company is required to make delay rental payments of $30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the delay rental payment for the period from October 2022 through October 2023. During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers 360 acres and has a term of 20 years; the Company is required to make rental payments of $25/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period February 2023 through February 2024. The second group of leases covers 307.75 acres and has a term of 20 years; the Company is required to make rental payments of $30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period from March 2023 through March 2024. As of October 31, 2023, the Company assessed the unproved properties of the South Salinas Project and those adjacent to it for impairment, analyzing future drilling plans, leasehold expiration and the existence of any known dry holes in the area. The Company did not record any impairment to the oil and gas property as of October 31, 2023, as all capitalized costs represent costs to acquire unproved property leases pending further development on the balance sheet. There is no depletion related to the oil and gas property as of October 31, 2023, as the Company does not currently have production and the acquired property is not subject to amortization as of that date. Optioned Assets On December 22, 2022, the Company and Trio LLC entered into the Fourth Amendment to the Trio LLC PSA (see Note 6). Per the terms of the Fourth Amendment, the Company was granted a 120-day option (commencing on January 1, 2023) to acquire any or all of the following three assets currently owned in part by Trio LLC (the “Optioned Assets”). The price for this option was $150,000, which was paid by the Company to Trio LLC in April 2023; this amount was capitalized and is reflected in the balance of the oil and gas property. The Optioned Assets are as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The McCool Ranch Oil Field (Hangman Hollow Area) asset with an option to acquire Trio LLC’s <span id="xdx_90C_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--McCoolRanchOilFieldMember_zBRM2YVikAYc" title="Percentage of working interest">44% working interest and their Operatorship;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Kern Front Field asset with an option to acquire Trio LLC’s <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--KenFronFieldMember_zl6vsPthkh0g">22% working interest and their Operatorship; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Union Avenue Field with an option to acquire Trio LLC’s <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--UnionAveFieldMember_zNijsyysXRog">20% working interest and their Operatorship;</td></tr> </table> The Optioned Assets are all located in California. In order to evaluate the Optioned Assets, the Company engaged KLS Petroleum Consulting, LLC (“KLSP”) to perform detailed analyses and estimations of the oil and gas reserves and of the fair market values of each of these three assets. These analyses have been completed, and as of October 31, 2023, the Company has paid approximately $39,000 to KLSP for the reserve analysis of the optioned assets; this amount has been capitalized and is reflected in the balance of the oil and gas properties on the balance sheet. Although 120-day option period has expired as of the fiscal year-end, the Company and Trio LLC are nevertheless continuing to work together cooperatively toward the goal of facilitating the Company’s acquisition of the other Optioned Assets. Union Avenue Field Agreement On May 12, 2023, the Company announced the signing of an Acquisition Agreement to potentially acquire up to <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230512__us-gaap--BusinessAcquisitionAxis__custom--UnionAveFieldMember_z6VdiCx8XFQk" title="Percentage of working interest">100% of the working interest in the Union Avenue Field. However, the Company and Trio LLC did not agree on terms and the transaction did not close. McCool Ranch Oil Field Asset Purchase On October 16, 2023, the Company entered into an agreement (“McCool Ranch Purchase Agreement”) with Trio LLC for purchase of a <span id="xdx_906_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20231016__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RegulatoryAssetAxis__custom--KenFronFieldMember_zPolnrBZdwrk" title="Working interest">21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project (see Note 6); the Assets are situated in what is known as the “Hangman Hollow Area” of the McCool Ranch Oil Field. The acquired property is an oil field developed with oil wells, a water-disposal well, steam generator, boiler, various tanks, in-field steam pipelines, oil pipelines and other facilities. The property is fully and properly permitted for oil and gas production, cyclic- steam injection and water disposal; however, it is currently idle (i.e., not producing), although operations to restart production have begun. The Company initially recorded a payment of $100,000 upon execution of the McCool Ranch Purchase Agreement, at which time Trio LLC began refurbishment operations with respect to the San Ardo WD-1 water disposal well (the “WD-1”) to determine if it is capable of reasonably serving the produced water needs for the assets, which Refurbishment was successfully accomplished. With Refurbishment successfully accomplished, the Company will pay an additional $400,000, which shall be used in restarting production operations on the assets. As of October 31, 2023, the Company has recorded the $100,000 payment as a capitalized cost; the balance is reflected in the balance of the oil and gas property as of year-end. Additional Working Interest – South Salinas Project In April 2023, the Company paid Trio LLC approximately $60,000 to acquire an additional <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230430__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember_zMuxScX5OKs5" title="Percentage of working interest">3.026471% working interest in the South Salinas Project, of which working interest amount is one-half (1/2) of the working interest that was acquired by Trio LLC; this amount was capitalized and is reflected in the balance of the oil and gas property (see Note 6).

The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20231031_zkc7IrriqRre" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20221031_z40WQUIRbAzf" style="border-bottom: Black 1pt solid; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--OilAndGasPropertyFullCostMethodGross_iI_zQVD3USBtx0h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Oil and gas properties – not subject to amortization</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,947,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,836,232</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OilAndGasPropertyFullCostMethodDepletion_iI_zWuDgu6wKld7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OilAndGasPropertyFullCostMethodNet_iI_z9NasNptDZF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Oil and gas properties – not subject to amortization, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,947,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,836,232</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

9947742

5836232

9947742

5836232

251743

28669

4111510

4011510

100000

3749488

262022

252512

8417

252512

160

360

P20Y

307.75

P20Y

150000

0.44

0.22

0.20

39000

0.21918315

100000

400000

100000

60000

0.03026471

NOTE 6 – RELATED PARTY TRANSACTIONS South Salinas Project – Related Party The Company was originally formed to acquire Trio LLC’s working interest in the South Salinas Project, and subsequently partner with certain members of Trio LLC’s management to develop and operate those assets (see Note 1, Note 5). Trio LLC operates the South Salinas on behalf of the Company, and as operator, conducts and has full control of the operations and acts in the capacity of an independent contractor. Trio LLC currently holds a <span id="xdx_906_ecustom--WorkingInterestPercentage_pid_dp_uPure_c20221101__20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SouthSalinasProjectMember_zt7KvegLQrDb" title="Working interest percentage">3.8% working interest in the South Salinas Project and the Company holds an 85.75% working interest. The Company advances funds to Trio LLC to develop and operate the assets in the South Salinas Project; such funds have been classified in the long-term asset section of the balance sheet as Advance to Operators since April 2022, and as of October 31, 2023 and 2022, the balance of this account was $<span id="xdx_906_eus-gaap--AdvancesToAffiliate_iI_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SouthSalinasProjectMember_zoqZgEEmHSef" title="Long term asset advance to operators">0 and $<span id="xdx_904_eus-gaap--AdvancesToAffiliate_iI_c20221031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SouthSalinasProjectMember_zIDj5cS6Uij3" title="Long term asset advance to operators">1,900,000, respectively. Optioned Assets with Related Party On December 22, 2022, the Company and Trio LLC entered into the Fourth Amendment to the Trio LLC PSA. Per the terms of the Fourth Amendment, the Company was granted a 120-day option (commencing on January 1, 2023) to acquire any or all of the following three assets currently owned in part by Trio LLC (the “Optioned Assets”). The price for this option was $150,000, which was paid by the Company to Trio LLC in April 2023; this amount was capitalized and is reflected in the balance of the oil and gas property. The Optioned Assets are as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Hangman Hollow Field asset with an option to acquire Trio LLC’s <span id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RegulatoryAssetAxis__custom--HangmanHollowFieldAssetMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OptionedAssetsRelatedPartyMember_zdMbzi7mIrp4" title="Percentage of working interest">44% working interest and their Operatorship;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Kern Front Field asset with an option to acquire Trio LLC’s <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RegulatoryAssetAxis__custom--KenFronFieldMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OptionedAssetsRelatedPartyMember_zYg9IxL4Jpz8">22% working interest and their Operatorship; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Union Avenue Field with an option to acquire Trio LLC’s <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20221222__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RegulatoryAssetAxis__custom--UnionAveFieldMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OptionedAssetsRelatedPartyMember_zBYxyJg8Cg16">20% working interest and their Operatorship;</td></tr> </table> McCool Ranch Oil Field Asset Purchase – Related Party On October 16, 2023, the Company entered into an agreement (“McCool Ranch Purchase Agreement”) with Trio LLC for purchase of a <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20231016__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RegulatoryAssetAxis__custom--KenFronFieldMember_zviHLtcZ5OHd" title="Working interest">21.918315% working interest in the McCool Ranch Oil Field located in Monterey County near the Company’s flagship South Salinas Project (see Note 6); the Assets are situated in what is known as the “Hangman Hollow Area” of the McCool Ranch Oil Field. The acquired property is an oil field developed with oil wells, a water-disposal well, steam generator, boiler, various tanks, in-field steam pipelines, oil pipelines and other facilities. The property is fully and properly permitted for oil and gas production, cyclic- steam injection and water disposal; however, it is currently idle (i.e., not producing), although operations to restart production have begun. The Company initially recorded a payment of $100,000 upon execution of the McCool Ranch Purchase Agreement, at which time Trio LLC began refurbishment operations with respect to the San Ardo WD-1 water disposal well (the “WD-1”) to determine if it is capable of reasonably serving the produced water needs for the assets, which Refurbishment was successfully accomplished. With Refurbishment successfully accomplished, the Company will pay an additional $400,000, which shall be used in restarting production operations on the assets. As of October 31, 2023, the Company has recorded the $100,000 payment as a capitalized cost; the balance is reflected in the balance of the oil and gas property as of year-end. Additional Working Interest – South Salinas Project – Related Party In April 2023, the Company paid Trio LLC approximately $<span id="xdx_907_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20230401__20230430__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AdditionalWorkingInterestSouthSalinasProjectMember_zelJFh3LPUea" title="Cash paid for additional acquisition">60,000 to acquire an additional <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20230430__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AdditionalWorkingInterestSouthSalinasProjectMember_zflFIYwe8wW6" title="Percentage of working interest">3.026471% working interest in the South Salinas Project, of which working interest amount is one-half (1/2) of the working interest that was acquired by Trio LLC; this amount was capitalized and is reflected in the balance of the oil and gas property. Notes Payable – Related Party On September 14, 2021, the Company entered into a note payable with Trio LLC as part of the agreement for the purchase of an <span id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--TrioLLCMember_zO46nHSfYUs8">82.75% working interest in the South Salinas Project (see Note 1). Per the Third Amendment signed on May 27, 2022, a portion of a previous payment made to Trio LLC was used to fund a lease extension payment to a third-party; as the payment previously made was to be used for other expenditures, the amount used to fund the lease extension was added to the remaining amount due to Trio LLC, increasing it from $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NotesPayableRelatedPartyMember_zQ2SyUiIXgf3">780,000 to $<span id="xdx_902_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NotesPayableRelatedPartyMember_zpgNENEWSFS">1,032,512. Per an extension to the Fourth Amendment to the Trio LLC PSA, the Company made the final payment of $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NotesPayableRelatedPartyMember_zJ47cKPZPJbg" title="Related party transaction amounts of transaction">1,032,512 upon the consummation of the IPO. As of October 31, 2023 and 2022, the balance of the note payable was $0 and $1,025,497, respectively, with interest expense recognized of $7,015 and $120,337 for the years ended October 31, 2023 and 2022, respectively. Total payments made on the note payable for the years ended October 31, 2023 and 2022 were $1,032,512, and $2,920,000, respectively. Restricted Stock Units (“RSUs”) issued to Directors On July 11, 2022, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220710__20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FiveOutsideDirectorMember_zHvZMm5pvle6">3,000 shares of its $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FiveOutsideDirectorMember_z4xCe6zG2Gb4">0.0001 par common stock to each of its five outside Directors with a fair value of $5.80 per share for an aggregate grant date value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220710__20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FiveOutsideDirectorMember_zR4jQdC1IALf">88,200. The fair value was calculated via a third-party valuation performed using income and market methods, as well as a discounted cash flow method, with the terminal value using a market multiples method, adjusted for a lack of marketability. The shares, or RSUs, vest in full upon the six-month anniversary of the IPO, subject to the directors’ continued service on the vesting date; upon issuance, the shares will be fully paid and non-assessable. Upon consummation of the IPO, the vesting period for these shares began and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation in the amount of $88,200 and $0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z0QbqTAszfIf">0 as of the period ended October 31, 2023. On September 2, 2023, the Company issued an aggregate <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230902__20230902__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlGfIJ959V0d">21,250 shares of its $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230902__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zi5Fc0uWGVw">0.0001 par common stock to four outside directors with a fair value of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zK3gvpCFjp19">12.80 per share for a grant date value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230902__20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCT2TQt2PGA5">273,275. The shares, or RSUs, vest in full upon the six-month anniversary of the vesting commencement date (or August 28,2023), subject to the directors’ continued service on the vesting date. For the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation in the amount of $96,016 and $0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzvpUidMEn9i">177,259 as of the period ended October 31, 2023. Restricted Shares issued to Executives and Employees In February 2022, the Company entered into employee agreements with Frank Ingriselli (Chief Executive Officer or “CEO”) and Gregory L. Overholtzer (Chief Financial Officer or “CFO”) which, among other things, provided for the grant of restricted shares in the amounts of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrFrankIngriselliMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zKdlj3n88lu">50,000 and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrGregOverholtzerMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_ziUrCCOj2Ig">5,000, respectively, pursuant to the 2022 Equity Incentive Plan (“the Plan”). Per the terms of the employee agreements, subject to continued employment, the restricted shares vest over a two-year period, under which <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20220201__20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zxkuOczVogH8">25% will vest upon the earlier of three months after the IPO or six months after the grant date. After this date, the remainder vest in equal tranches every six months until fully vested. As the Plan was not adopted until October 17, 2022 (see Note 7), these shares will be recorded as of that date at a fair value of $<span id="xdx_90F_eus-gaap--SharePrice_iI_c20220228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zonJvyfrFCcf">5.880 per share; such value was calculated via a third-party valuation performed using income and market methods, as well as a discounted cash flow method, with the terminal value using a market multiples method, adjusted for a lack of marketability (see Note 10). As of October 31, 2022, the Company recorded <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221001__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zJGk5ITdQsP6">55,000 restricted shares at a fair value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221001__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_z1Y6Y9F0B8t9">323,400, and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_z5ExgTHQzide">161,700 and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zFImW6BE4XAd">6,202, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RestrictedShareIssuedToExecutivesAndEmployeesMember_zOC2jDjGKzEl">155,498 as of October 31, 2023. In May 2023, the Company entered into six employee agreements which, among other things, provided for the grant of an aggregate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zX7cEmfWkTk6">35,000 restricted shares pursuant to the Plan. Per the terms of the employee agreements, subject to continued employment, the restricted shares vest as follows: <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20230501__20230531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zlUFOiYF8qTi">25% of the shares will vest five months after the issuance date, after which the remainder vest in equal tranches every six months until fully vested. The shares were recorded on the date of issuance at a fair value of $43.00 per share for an aggregate fair value of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zDU6rru0sdUl">1,505,000, and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zBY3zPwX9BTd">440,219 and $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zisciBWGmxid">0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--SixEmployeeAgreementMember_zubBo3OgTrPd">1,064,781 as of the period ended October 31, 2023. On July 20, 2023, pursuant to the Ingriselli Employment Agreement (see above), the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230720__20230720__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrIngriselliMember_z6m16edw3Cwe">10,000 restricted shares (subject to the Plan) as a discretionary annual bonus at a fair value of $21.40 per share to Mr. Ingriselli for an aggregate fair value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230720__20230720__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrIngriselliMember_zaW7PnnF5EV3">213,000. The shares vested fully on July 24, 2023 and the Company recognized stock-based compensation of $213,000 within stock-based compensation expenses on the income statement for the period ended July 31, 2023. On October 16, 2023, the Company and Michael L. Peterson entered into an employment agreement (the “Peterson Employment Agreement”), effective as of October 23, 2023, pursuant to which Mr. Peterson will serve as Chief Executive Officer of the Company, replacing Mr. Ingriselli. Pursuant to the Peterson Employment Agreement, Mr. Peterson will be paid an annual base salary of $350,000. In addition, Mr. Peterson is entitled to receive, subject to his continuing employment with the Company on the applicable date of the bonus payout, an annual target discretionary bonus of up to 100% of his annual base salary, payable at the discretion of the Compensation Committee of the Board based upon the Company’s and Mr. Peterson’s achievement of objectives and milestones to be determined on an annual basis by the Board. Pursuant to the Peterson Employment Agreement, the Company issued Mr. Peterson is a grant of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zqbnQnizakb5">50,000 shares of restricted stock pursuant to the Company’s Omnibus Incentive Compensation Plan (the “Plan”) at a fair value of $5.40 per share for a grant date fair value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zhcXdkQJoXgj" title="Stock issued during period, value, restricted stock award, gross">271,000. The restricted stock grant vests over a period of two years, with <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20231023__20231023__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrPetersonMember_zNfzk1e1FrR">25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement. As of October 31, 2023, the Company recognized stock-based compensation of $3,341 within stock-based compensation expenses on the income statement, with unrecognized expense of $267,659. Consulting Agreement – Related Party On October 6, 2023, Mr. Ingriselli delivered notice of his resignation as the Company’s Chief Executive Officer, effective on October 23, 2023. Upon his resignation, Mr. Ingriselli will continue as a director and hold the title of “Vice Chairman” of the Board of Directors of the Company. In addition, on October 16, 2023, the Company and Global Venture Investments LLC (“Consultant”), a Delaware Limited Liability Company and a wholly owned consulting firm owned <span id="xdx_90F_ecustom--ConsultingAgreementPercentage_dp_uPure_c20231016__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultingAgreementRelatedPartyMember_zNK2oAvXKbK" title="Consulting agreement percentage">100% by Mr. Ingriselli, entered into a consulting agreement, effective as of the date of resignation and continuing through December 31, 2023. Pursuant to the Consulting Agreement, the Company will pay Mr. Ingriselli a cash consulting fee equal to $<span id="xdx_900_ecustom--ConsultingAgreementFee_c20231016__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultingAgreementRelatedPartyMember_zHN1X2MtT2U" title="Consulting agreement fee">10,000 per month, payable within five business days after the commencement of each calendar month during the term of the Consulting Agreement. The Consulting Agreement terminated on December 31, 2023, in accordance with its terms.

0.038 0.8575

1900000

150000

0.44

0.22

0.20

0.21918315

100000

400000

100000

60000

0.03026471

0.8275

780000

1032512

1025497

7015

120337

1032512

2920000

3000

0.0001

5.80

88200

21250

0.0001

12.80

273275

96016

177259

50000

5000

0.25

5.880

55000

323400

161700

6202

155498

35000

0.25

43.00

1505000

440219

1064781

10000

21.40

213000

350000 1

50000

5.40

271000

0.25

3341

267659

1 10000

NOTE 7 – COMMITMENTS AND CONTINGENCIES From time to time, the Company is subject to various claims that arise in the ordinary course of business. Management believes that any liability of the Company that may arise out of or with respect to these matters will not materially adversely affect the financial position, results of operations, or cash flows of the Company. Unproved Property Leases As of October 31, 2023, the Company holds various leases related to the unproved properties of the South Salinas Project (see Note 5); two of the leases are held with the same lessor. The first lease, which covers <span id="xdx_905_eus-gaap--AreaOfLand_iI_uAcre_c20231031__us-gaap--LeaseContractualTermAxis__custom--FirstAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zMHPabJrKXc9" title="Area of land">8,417 acres, was amended on May 27, 2022 to provide for an extension of then-current force majeure status for an additional, uncontested twelve months, during which the Company would be released from having to evidence to the lessor the existence of force majeure conditions. As consideration for the granting of the lease extension, the Company paid the lessor a one-time, non-refundable payment of $<span id="xdx_908_ecustom--NonRefundablePayment_iI_c20221031__us-gaap--LeaseContractualTermAxis__custom--FirstAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zdICqj1Aruy3" title="Non refundable payment">252,512; this amount was capitalized and reflected in the balance of the oil and gas property as of October 31, 2022. The extension period commenced on June 19, 2022; as of October 31, 2023, the “force majeure” status has been extinguished by the drilling of the HV-1 well, and the validity of the lease is maintained by the drilling of the well, which is in production testing. The second lease covers <span id="xdx_90E_eus-gaap--AreaOfLand_iI_uAcre_c20231031__us-gaap--LeaseContractualTermAxis__custom--SecondAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zRRtMPQYCuXk" title="Area of land">160 acres of the South Salinas Project; it is currently held by delay rental and is renewed every three years. Until drilling commences, the Company is required to make delay rental payments of $<span id="xdx_906_ecustom--DelayRentalPayments_iI_uAcre_c20231031__us-gaap--LeaseContractualTermAxis__custom--SecondAforementionedMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zqILJQIdxRig" title="Delay rental payments">30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the delay rental payment for the period from October 2022 through October 2023. During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers <span id="xdx_90F_eus-gaap--AreaOfLand_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zNaRd7uh7TXg" title="Area of land"><span id="xdx_90D_eus-gaap--AreaOfLand_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zcEdQsATckO3" title="Area of land">360 acres and has a term of <span id="xdx_90D_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zVa5zwQrtGn7" title="Lease, term"><span id="xdx_903_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zMTbkisYV4l6" title="Lease, term">20 years; the Company is required to make rental payments of $<span id="xdx_901_eus-gaap--NetRentableArea_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zml9HKNASCY9" title="Delay rental payments"><span id="xdx_904_eus-gaap--NetRentableArea_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--FirstGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zEcJ2EFXElL8" title="Delay rental payments">25/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period February 2023 through February 2024. The second group of leases covers <span id="xdx_90D_eus-gaap--AreaOfLand_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zkxUI0T0n6P1" title="Area of land"><span id="xdx_90E_eus-gaap--AreaOfLand_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zR2K3qQ9i6hc" title="Area of land">307.75 acres and has a term of <span id="xdx_90A_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zV3sZ9HboAY6" title="Lease, term"><span id="xdx_90D_eus-gaap--LessorOperatingLeaseRenewalTerm_iI_dtYp_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_z23eDbVITXr9" title="Lease, term">20 years; the Company is required to make rental payments of $<span id="xdx_90C_ecustom--DelayRentalPayments_iI_uAcre_c20230228__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zL4Q1MVDoJ46" title="Delay rental payments"><span id="xdx_907_ecustom--DelayRentalPayments_iI_uAcre_c20230331__us-gaap--LeaseContractualTermAxis__custom--SecondGroupMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--UnprovedPropertyLeaseMember_zgjeUH4AHODk" title="Delay rental payments">30/acre per year. The Company is currently in compliance with this requirement and has paid in advance the rental payment for the period from March 2023 through March 2024. As of October 31, 2023, the Company assessed the unproved properties of the South Salinas Project and those adjacent to it for impairment, analyzing future drilling plans, leasehold expiration and the existence of any known dry holes in the area. Management concluded there is no impairment allowance required as of the balance sheet date. Board of Directors Compensation On July 11, 2022, the Company’s Board of Directors approved compensation for each of the non-employee directors of the Company, which would be effective upon the consummation of the IPO. Such compensation is structured as follows: an annual retainer of $50,000 cash plus an additional $10,000 for each Board committee upon which the Director serves, each paid quarterly in arrears. Payment for this approved compensation commenced upon successful completion of the Company’s IPO and as of October 31, 2023, the Company has recognized $156,154 in directors’ fees. Agreements with Advisors On July 28, 2022, the Company entered into an agreement with Spartan Capital Securities, LLC (“Spartan”) whereby Spartan will serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company for the term of the agreement, which is one year. The agreement provides for a $25,000 non-refundable advance upon execution of the agreement and completion of a bridge offering to be credited against the accountable expenses incurred by Spartan upon successful completion of the IPO, a cash fee or an underwriter discount of 7.5% of the aggregate proceeds raised in the IPO, warrants to purchase a number of common shares equal to 5% of the aggregate number of common shares placed in the IPO, an expense allowance of up to $150,000 for fees and expenses of legal counsel and other out-of-pocket expenses and 1% of the gross proceeds of the IPO to Spartan for non-accountable expenses. The agreement also provides for an option to Spartan that is exercisable within 45 days after the closing of the IPO to purchase up to an additional 15% of the total number of securities offered by the Company in the IPO. For a period of 18 months following the July 28, 2023 expiration of the agreement, Spartan shall be entitled to receive the same 7.5% cash fee and 5% warrant coverage compensation under the “tail” terms of the agreement with respect to financing transactions the Company consummates with any party contacted or introduced by Spartan to the Company prior to the expiration of the Spartan agreement. On April 20, 2023, pursuant to the agreement above, the Company issued representative warrants to Spartan to purchase up to an aggregate of 50,000 shares of common stock; these warrants may be exercised commencing from the closing of the Offering and expiring five years from the effective date of the registration statement at an exercise price of $66.00 (<span id="xdx_90C_ecustom--PublicOfferingPricePercentage_pid_dp_uPure_c20230420__20230420__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__us-gaap--IPOMember_zw5hWeLLJjja">110% of the public offering price of the common stock). Trio LLC – Monthly Consulting Fee Pursuant to the Fourth Amendment to the Trio LLC PSA, the Company agreed, retroactively commencing on May 1, 2022, to accrue a monthly consulting fee of $35,000, due and payable by the Company to Trio LLC. This fee is intended to cover the work being done for the Company by Trio LLC’s employees prior to the closing date of the Company’s IPO. As of October 31, 2023, the Company has accrued and paid $406,000 in fees for these services. On May 1, 2023, the Company entered into six employment agreements with Trio LLC employees; the agreements provide for compensation and restricted shares pursuant to the Plan (see Note 10) with a start date of May 1, 2023, provided that each individual continues to serve as an employee of Trio LLC on a part-time basis.

8417

252512

160

360

P20Y

307.75

P20Y

30 30

50000

10000

156154 25000

150000

50000

P5Y

66.00

1.10

35000

406000

NOTE 8 – INCOME TAXES The Company accounts for income taxes under ASC 740-10, which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. Significant components of the Company’s deferred tax assets are summarized below. SCHEDULE OF DEFERRED TAX ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20231031_zueldGDiA6l8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20221031_zmouszmRCr0l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzbzC_zVmUlhJOoPQ3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1pt">Net operating loss carry forwards</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">1,095,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">797,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzbzC_maDTANzE8j_zsZIZMyvvuqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total deferred tax asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,095,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">797,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzE8j_zkphJxhVCtr9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,095,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(797,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzE8j_zk1F0OuOgOS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Deferred tax asset, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of October 31, 2023 and 2022, the Company had approximately $1,095,000 and $797,000, respectively, in net operating loss carry-forwards for federal and state income tax reporting (tax effected) purposes. As a result of the Tax Cuts Job Act 2017 (the “Act”), certain future carryforwards do not expire. The Company has not performed a formal analysis but believes its ability to use such net operating losses and tax credit carryforwards in the future is subject to annual limitations due to change of control provisions under Sections 382 and 383 of the Internal Revenue Code, which will significantly impact its ability to realize these deferred tax assets. The Company recorded a valuation allowance in the full amount of its net deferred tax assets since realization of such tax benefits has been determined by the Company’s management to be less likely than not. The valuation allowance increased $298,000 and $776,000 during the years ended October 31, 2023 and 2022, respectively. A reconciliation of the statutory federal income tax benefit to actual tax benefit is as follows: SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20221101__20231031_z5TFpXInAU6a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20211101__20221031_zMgu5s54tlFa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_maTET_zocO7wrPbqad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Federal statutory blended income tax rates</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(21</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(21</td><td style="width: 1%; text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_maTET_zkafElZlNJg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State statutory income tax rate, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_maTET_zIv2xn3dCBPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_mtTET_zVVX5tfktXy1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> As of the date of this filing, the Company has not filed its 2023 federal and state corporate income tax returns. The Company expects to file these documents as soon as practicable. The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense.

Significant components of the Company’s deferred tax assets are summarized below. SCHEDULE OF DEFERRED TAX ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20231031_zueldGDiA6l8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20221031_zmouszmRCr0l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzbzC_zVmUlhJOoPQ3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1pt">Net operating loss carry forwards</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">1,095,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">797,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzbzC_maDTANzE8j_zsZIZMyvvuqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total deferred tax asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,095,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">797,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzE8j_zkphJxhVCtr9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,095,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(797,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzE8j_zk1F0OuOgOS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Deferred tax asset, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1095000

797000

1095000

797000

1095000

797000

1095000

797000

298000

776000

A reconciliation of the statutory federal income tax benefit to actual tax benefit is as follows: SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20221101__20231031_z5TFpXInAU6a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20211101__20221031_zMgu5s54tlFa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_maTET_zocO7wrPbqad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Federal statutory blended income tax rates</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(21</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(21</td><td style="width: 1%; text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_maTET_zkafElZlNJg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State statutory income tax rate, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_maTET_zIv2xn3dCBPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_mtTET_zVVX5tfktXy1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table>

0.21

-0.21

NOTE 9 – NOTES PAYABLE Notes payable as of October 31, 2023 and 2022 consisted of the following: SCHEDULE OF NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49A_20231031_z52UUJ8qgiaf" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">As of October 31,</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_496_20221031_zz2HAxTbjhkh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">As of October 31,</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdeUcjgRdQm7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Notes payable – related party, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,025,497</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--NotesPayable_iI_hsrt--TitleOfIndividualAxis__custom--InvestorsMember_zg5WRKgk28T8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Notes payable – investors, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,137,720</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__us-gaap--BridgeLoanMember_z4ocFOHA5KU6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Bridge note, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">265,719</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayableCurrent_iI_zwBDs6GeW0C2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Convertible note, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,217,597</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_zts7SHjnAukf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Total Notes payable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,217,597</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,428,936</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> Notes Payable – Related Party On September 14, 2021, the Company entered into a note payable with Trio LLC as part of the agreement for the purchase of an <span id="xdx_906_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zlM1Upu2EYMe">82.75% working interest in the South Salinas Project (see Note 1). Per the Third Amendment signed on May 27, 2022, a portion of a previous payment made to Trio LLC was used to fund a lease extension payment to a third-party; as the payment previously made was to be used for other expenditures, the amount used to fund the lease extension was added to the remaining amount due to Trio LLC, increasing it from $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zDHvKhqQMKBd">780,000 to $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyb0Q84QmNt6">1,032,512. Per an extension to the Fourth Amendment to the Trio LLC PSA, the Company made the final payment of $<span id="xdx_90B_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220526__20220527__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z40pk68j3Wfe">1,032,512 upon the consummation of the IPO. As of October 31, 2023 and 2022, the balance of the note payable was $0 and $1,025,497, respectively, with interest expense recognized of $7,015 and $120,337 for the years ended October 31, 2023, respectively. Total payments made on the note payable for years ended October 31, 2023 and 2022 were $1,032,512 and $2,920,000, respectively. Notes Payable – Investors (January 2022 SPA) On January 28, 2022, the Company entered into the January 2022 SPA with GPL, pursuant to which (i) in exchange for $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember_z7iGDImCjDsc" title="Business combination, consideration transferred">4,500,000 in consideration, the Company issued senior secured convertible promissory notes (the “January 2022 Notes”) with an aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwoThousandAndTwentyTwoNotesMember_zBMiK4IWFwph">4,500,000 (ii) the Company issued warrants to purchase up to 50% of the number of shares of Common Stock issued upon the full conversion of the January 2022 Notes, and (iii) conditional upon a successful IPO, the Company agreed to issue commitment shares (“Commitment Shares”) to the investors (“GPL Investors”) upon the date of the Company’s IPO. The Notes were collateralized with a security interest in the oil and gas properties, which was to be perfected by April 28, 2022. In the event the collateral was not perfected by April 28, 2022, the Company was required to deliver 225,000 shares (“Default Shares”) to the investors. The Default Shares were initially held in escrow until the earlier of a) the granting and perfection of the security interest, b) the conversion of the January 2022 Notes upon the IPO or c) April 28, 2022. As the Company failed to perfect the security interest and no IPO occurred by April 28, 2022, the Default Shares were delivered to the investors on April 28, 2022. The shares were issued at a fair value of $5.80 per share for an aggregate value of $1,322,933, and this amount was recognized as penalty fees related to debt on the income statement. The January 2022 Notes have a maturity date on the earlier of April 30, 2023 (such maturity date being extended initially from January 28, 2023 pursuant to the amendment to the January 2022 Notes signed on January 23, 2023 and again from February 28, 2023 pursuant to the second amendment to the January 2022 Notes signed on February 23, 2023) or the IPO and bear interest at a rate of 8% per annum, which is to be accrued and paid on the maturity date. Because the Company’s IPO did not occur by August 1, 2022 and the Company did not default on the January 2022 Notes, the interest percentage increased to <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__srt--RangeAxis__srt--MaximumMember_zgipqA688eEb" title="Debt instrument, interest rate">15% per annum. The principal and interest payable on the January 2022 Notes will automatically convert into shares upon the IPO. The conversion price is the lesser of <span id="xdx_900_eus-gaap--DebtConversionDescription_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZhU5K4YsOTj" title="Conversion price, description">i) the IPO price multiplied by the discount of 50% or ii) the opening price of the shares of Common Stock on the trading day following the date of the consummation of the IPO multiplied by the discount of 50%. The number of conversion shares is the outstanding principal amount divided by the conversion price. Upon the consummation of the IPO, the debt will convert into a fixed dollar amount of $9,000,000 of a variable number of shares. Upon consummation of its IPO, the Company converted the aggregate outstanding principal and accrued interest balances of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHN5FPpK3cRh">4,500,000 and $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbOSi3y5NT8j">664,875, respectively, into <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z0jCxUB1CWEb">251,946 shares of common stock; the number of conversion shares was calculated by dividing the aggregate balance of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pid_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzgjNN8QGsY3">5,164,875 by the opening trading price of its common stock on April 19, 2023 of $41.00, with a discount applied of 50%. The Company also issued <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesRelatedToTheSPAShares_pid_c20220126__20220128__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziRqrVSKqV85">18,750 commitment shares, the number of which was calculated by taking 25% of the outstanding principal balance of $4,500,000 and dividing it by the IPO price of $60.00 per share, with the expense for issuing the commitment shares being recognized as a loss on the income statement as of April 30, 2023. As of October 31, 2023 and 2022, the balance of the Notes payable was $0 and $4,137,720, with interest expense of $674,405 and $1,136,811 for the years ended October 31, 2023 and 2022, respectively. Bridge Note During September 2022, the Company entered into an agreement or bridge note (“Bridge Note”) with three investors; the Bridge Note includes original issue discount senior notes (“Notes”) with gross proceeds of $444,000, a 10% Original Issue Discount (“OID”) of $44,000 and debt issuance costs of $70,438, for net proceeds of $329,562 to the Company. The Bridge Note included pre-funded warrants that permit the investors to purchase a number of shares of the Company’s common stock (equal to 100% of the original principal amount of the Notes), which can be exercised from the date of the warrant agreement to five years from the date of the Company’s IPO at an exercise price of $0.20. The Notes had a maturity date of the earlier of i) April 30, 2023 or ii) the completion of the IPO. The Notes bore interest at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220930__us-gaap--ShortTermDebtTypeAxis__us-gaap--BridgeLoanMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2ZkX6MmvU04">8% per annum, which would waived if the Company completed a successful IPO within 90 days of the closing of financing; in the event of default, the interest percentage would increase to <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220930__us-gaap--ShortTermDebtTypeAxis__us-gaap--BridgeLoanMember__srt--RangeAxis__srt--MaximumMember_zpoDreh452Uh">15% per annum. The Company also issued pre-funded warrants in connection with the Bridge Note to purchase a number of shares equal to the number of dollars of the Notes, or 20,000, at an exercise price of $0.20 per share; the Company determined the warrants are equity classified and can be exercised at any time from the date of the warrant agreement to five years from the date of the completion of the IPO. The Company also incurred debt issuance costs of $70,438 in connection with the issuance of the Notes and warrants. The values of the OID, warrants and debt issuance costs are recorded as debt discounts and amortized over the life of the Notes as interest expense. Upon consummation of its IPO, the Company repaid the Bridge Note in the amount of $440,000 and interest was waived by the investors. As of October 31, 2023 and 2022, the balance of the Bridge Note (which is included within the Notes payable – investors, net of discounts line item on the balance sheet) is $0 and $265,719, respectively, with interest expense of $174,281 and $51,040 for the years ended October 31, 2023 and 2022, respectively. Convertible note – investors (October 2023 SPA) On October 4, 2023, the Company entered into a securities purchase agreement (the “October 2023 SPA”) with an investor; the October 2023 SPA provides for loans in an aggregate principal amount of up to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z5likAVjVQWf" title="Aggregate principal amount">3.5 million under two tranches, with first and second tranche fund amounts of $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtInstrumentAxis__custom--FirstTrancheMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zqM0hbcFGIzc" title="Proceeds from convertible debt">2.0 million and $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtInstrumentAxis__custom--SecondTrancheMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zCE3cYQ7xlDk" title="Proceeds from convertible debt">1.5 million, respectively. The first tranche will be immediately funded upon closing and the second tranche will be funded after the Company provides written confirmation to the investor and subject to the mutual consent of the investor and the Company that (i) stockholder approval of the transactions has been obtained for the purpose of complying with the NYSE/NYSE American Rules; (ii) that a resale Registration Statement on Form S-1 (the “Resale Registration Statement”) has been declared effective by the SEC for the registration of the shares of Common Stock issuable upon conversion of the Note and the Warrant and (iii) there is no Event of Default (as defined in the October 2023 SPA that has occurred or will occur as a result of such additional funding and in full force and effect). In consideration for the investor’s funding of the first tranche, the Company issued and sold to the investor, in a private placement, i) a senior secured convertible promissory note in the aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zFNNcf9GOSCe">2,000,000 (the “Note”) and ii) a warrant to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z5LCrifcrxe7">43,336 shares of Common Stock at an initial exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zHz5XpN4YA22">24.00 per share of Common Stock, subject to certain adjustments (the “Common Warrant”). The Note is initially convertible into shares of Common Stock at conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zNMF8Ia6osll">24.00, subject to certain adjustments (the “Conversion Price”), provided that the Conversion Price shall not be reduced below $<span id="xdx_90F_ecustom--DebtInstrumentFloorPrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zPSDUmfeT5wc">7.00 (the “Floor Price”). The Note does not bear any interest and matures on April 4, 2025. Upon the initial funding on October 4, 2023, the Company recorded gross proceeds of approximately $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zUiXCKydYi0b">2.0 million, a <span id="xdx_900_ecustom--DebtInstrumentOriginalIssueDiscountPercentage_iI_pid_dp_uPure_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z9Wkr1rLKWA2" title="Debt instrument original issue discount percentage">7% original issue discount of $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zouFuza8ZN4g">140,000 and debt issuance costs of $<span id="xdx_901_eus-gaap--PaymentsOfDebtIssuanceCosts_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zD9qxJSaW1gj">350,320, for net proceeds of approximately $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zB6dN0FCezWa">1.5 million. The Company also issued a warrant to purchase up to <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zJKtzBQlWd6k">43,335 shares of common stock with an aggregate relative fair value of $<span id="xdx_906_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_z9XsYZfiH2Ii">332,630; the factors used to determine fair value were a share price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zC5qnmhYzY9i">11.00, an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_ziLY5DDLnVgd">24.00, an expected term of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zAX8fByI7kRd">5 years, annualized volatility of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zDX3Z1cWzQrg">137.10%, a dividend rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dcp_uPure_c20231004__20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z2PEhqJ6MpG6">zero percent and a discount rate of <span id="xdx_90F_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zN30bUI8mZvk">4.72%. Commencing on the earlier of (i) the day that is the four months after October 4, 2023 and (ii) the date on which the first Resale Registration Statement shall have been declared effective by the SEC, the Company is required to pay to the investor the outstanding principal balance under the Note in monthly installments, on such date and each one (1) month anniversary thereof, in an amount equal to <span id="xdx_900_ecustom--PercentageOfTotalPrincipalAmount_iI_pid_dp_uPure_c20231004__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoThousandTwentyThreeSPAMember_zCaSX5smHS2b" title="Percentage of total principal amount">103% of the total principal amount multiplied by the quotient determined by dividing one by the number of months remaining until the maturity date of the Note, until the outstanding principal amount has been paid in full or, if earlier, upon acceleration, conversion or redemption of the Note in accordance with its terms. All monthly payments are payable by the Company, in cash, provided that under certain circumstances, as provided in the Note, the Company may elect to pay in shares of Common Stock. As collateral for the obligations under the October 2023 SPA, the Company has granted to the investor a senior security interest in all of the Company’s assets (inclusive of intellectual property), subject to certain exceptions, as set forth in the Security Agreement (as defined in the October 2023 SPA). The Company has also entered into a Mortgage, Deed of Trust, Assignment of Production, Security Agreement and Financing Statement (the “Deed of Trust”) with the Investor granting to the Investor a security interest in certain oil and gas interests held by the Company in California (the “Deed of Trust”). In connection with the October 2023 SPA, on October 4, 2023, the Company entered into voting agreements (collectively, the “Voting Agreements”) with certain Company stockholders, directors and officers, representing any aggregate of 201,250 shares of Common Stock, including Frank Ingriselli, the Company’s Chief Executive Officer, and a certain entity affiliated with Mr. Ingriselli. Pursuant to the Voting Agreements, each stockholder party thereto has agreed to vote its shares of Common Stock to approve the issuance of the securities under the Securities Purchase Agreement for the purpose of complying with the applicable NYSE/NYSE American Rules requiring stockholder approval for the Company’s issuance of shares of Common Stock, in connection with the transactions contemplated under the October 2023 SPA, in excess of 20% of the number of shares of Common Stock outstanding on the date hereof. Each Voting Agreement will terminate upon the sufficient stockholder vote required to approve the stockholder proposals in connection with respect to the transactions contemplated in the October 2023 SPA (the “Voting Agreement Expiration Date”). In connection with the October 2023 SPA, on October 4, 2023, the Company entered into a registration rights agreement (the “October 2023 RRA”) with the investor pursuant to which the Registrable Securities (as defined therein) held by the investor, subject to certain conditions, are entitled to registration under the Securities Act. Pursuant to October 2023 RRA, the Company is required to, within 30 days after the date thereof, and within 10 days after the Closing of the Second Tranche (as such term is defined in the October 2023 SPA), file with the SEC (at the Company’s sole cost and expense) a Resale Registration Statement and to cause such Resale Registration Statement to be effective within 60 days after the applicable filing date, covering the resale by the Investor of the Registrable Securities. Under the terms of the October 2023 SPA, the October 2023 RRA and the Note, the Company is required to reserve and register 658,099 shares of Common Stock in a Resale Registration Statement which such number represents 200% of the number of shares on the exercise of the Common Warrants and 200% of the number of shares upon the conversion of the Note.

Notes payable as of October 31, 2023 and 2022 consisted of the following: SCHEDULE OF NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49A_20231031_z52UUJ8qgiaf" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">As of October 31,</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_496_20221031_zz2HAxTbjhkh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">As of October 31,</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--NotesPayable_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdeUcjgRdQm7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Notes payable – related party, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,025,497</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--NotesPayable_iI_hsrt--TitleOfIndividualAxis__custom--InvestorsMember_zg5WRKgk28T8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Notes payable – investors, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,137,720</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__us-gaap--BridgeLoanMember_z4ocFOHA5KU6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Bridge note, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">265,719</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayableCurrent_iI_zwBDs6GeW0C2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Convertible note, net of discounts</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,217,597</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_zts7SHjnAukf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Total Notes payable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,217,597</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,428,936</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

1025497

4137720

265719

1217597

5428936

0.8275

780000

1032512

1025497

7015

120337

1032512

2920000

4500000

0.50 225000

5.80

1322933

0.08

0.15

i) the IPO price multiplied by the discount of 50% or ii) the opening price of the shares of Common Stock on the trading day following the date of the consummation of the IPO multiplied by the discount of 50%.

9000000

4500000

664875

251946

5164875

41.00

18750

4500000

60.00

4137720

674405

1136811

444000

0.10

44000

70438

329562

0.20

0.08

0.15

20000

0.20

70438

440000

265719

174281

51040

3500000

2000000.0

1500000

2000000

43336

24.00

7.00

2000000.0

0.07

140000

350320

1500000

43335

332630

11.00

24.00

P5Y

1.3710

4.72

1.03 201250 0.20 658099 2 2

NOTE 10 – STOCKHOLDERS’ EQUITY Common Shares The Company is authorized to issue an aggregate of 25,000,000 shares. The authorized capital stock is divided into: (i) 24,500,000 shares of common stock having a par value of $0.0001 per share and (ii) 500,000 shares of preferred stock having a par value of $0.0001 per share. In January 2022, the Company entered into the January 2022 SPA with GPL, which has warrants attached that are exercisable into up to <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_uPure_c20220101__20220131__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLiKkNTXib3e" title="Warrant exercisable, rate">50% of the number of shares of common stock issued upon full conversion of the Notes. The Company determined the warrants are equity classified and used a third party to perform a valuation to estimate their fair market value at January 28, 2022, which was $994,091. On April 28, 2022, the Company issued 225,000 shares of its $0.0001 par common stock at a price of $5.80 per share for a total aggregate fair value of $1,322,933 to GPL as default shares in connection with the January 2022 SPA (see Note 3, Note 6 and Note 9). On July 11, 2022, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220710__20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zjd7JiFuFpid">3,000 shares of its $0.0001 par common stock to each of its five outside Directors for a total aggregate amount of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220710__20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zXjPyxwLGEUd">15,000 shares. The shares, or RSUs, vest in full upon the six-month anniversary of the IPO, subject to the directors’ continued service on the vesting date; upon issuance, the shares will be fully paid and non-assessable. The RSUs were recorded at a fair value of $5.80 per share for a total value of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c20220710__20220711__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zvdy9ZTCAcB9">88,200. Upon consummation of the IPO, the vesting period for these shares began and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation in the amount of $88,200 and $0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zmgLh0rDPlsk">0 as of the period ended October 31, 2023. On October 17, 2022, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221017__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember_zMGybhtUim12">55,000 restricted shares to two of its executives pursuant to the Plan. As the Plan was not adopted until October 17, 2022, these shares were recorded as of that date at a fair value of $5.80 per share; such value was calculated via a third-party valuation performed using income and market methods, as well as a discounted cash flow method, with the terminal value using a market multiples method, adjusted for a lack of marketability. As of October 31, 2022, the Company recorded <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember_zVyNYzE4u13e">55,000 restricted shares at a fair value of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember_zQwwGmAPA3hk">323,400 and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation of $161,700 and $6,202, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--TitleOfIndividualAxis__custom--ExecutivesMember_zmQGf6WJ62H2">155,498 as of October 31, 2023. In December 2022, the Company entered into subscription agreements with two accredited investors for the aggregate issuance of 20,000 common shares for aggregate gross cash proceeds of $400,000. The common shares are $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8jhGSygnVVk" title="Common stock, par or stated value per share">0.0001 par value and have a purchase price of $20.00 per share. In April 2023, the Company consummated its IPO and sold 100,000 shares of common stock at a public offering price of $60.00 per share for gross proceeds of $6,000,000. In April 2023, upon consummation of its IPO, the Company also issued 18,750 commitment shares, the number of which was calculated by taking 25% of the outstanding principal balance of the January 2022 Notes of $4,500,000 and dividing it by the IPO price of $60.00 per share On April 20, 2023, the Company issued 625 shares of common stock at a fair value of $40.00 per share to consultants in exchange for services rendered; the aggregate amount of $25,000 was recorded as fees for professional services as of the end of the period. On May 1, 2023, the Company issued 35,000 restricted shares to six of its employees pursuant to the Plan (see Note 6); the shares were recorded at a fair value of $43.00 per share for an aggregate grant date fair value of $1,505,000, and for the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation of $440,219 and $0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zt8PF8lbKmG7">1,064,781 as of the period ended October 31, 2023. On May 2, 2023, June 23, 2023 and July 11, 2023, the Company issued 1,250, 5,000 and 5,000 shares of common stock, par value of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230711__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq3G3hkC8ftl" title="Common stock, par or stated value per share">0.0001, respectively, at a fair value of $42.00, $17.60 and $24.20, respectively, to consultants in exchange for services rendered; the aggregate amounts of $52,500, $88,000 and $121,000, respectively, were recorded as fees for professional services as of the end of the period. On June 30, 2023, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230630__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--MarcumLlpMember_zC1qukpD7lj4">2,400 shares of common stock, par value of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--MarcumLlpMember_zp1eloxumsA5" title="Common stock, par or stated value per share">0.0001, at a fair value of $33.40 to Marcum, LLP for an aggregate amount of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230630__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--MarcumLlpMember_zunpmbSdHEra">80,159 for partial satisfaction of an account payable. On June 30, 2023, the Company issued a Form S-1/A, which registered for resale (i) up to 157,466 shares of common stock, par value $0.0001 per share which the selling stockholders may acquire upon the exercise of outstanding common warrants and (ii) up to 25,000 shares of common stock, which the selling stockholders may acquire upon the exercise of outstanding pre-funded warrants. Such warrants were issued to the selling stockholders in connection with securities purchase agreements entered into on January 28, 2022 and September 20, 2022. The Company recorded 34,993 shares of common stock that are not exercised but registered in accordance with their common warrant agreements and 25,000 shares of common stock that are not exercised but registered in accordance with their pre-funded warrant agreements upon the filing of this Form S-1/A. On July 20, 2023, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230720__20230720__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrFrankIngriselliMember_zkvxxd4RKs12">10,000 restricted shares pursuant to the Plan to Mr. Ingriselli (see Note 6) at a fair value of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230720__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrFrankIngriselliMember_zvFOxLbqBZP3">21.40 per share for an aggregate fair value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230720__20230720__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--MrFrankIngriselliMember_zNgic33hKmX4">213,000. The shares vested fully on July 24, 2023 and the Company recognized stock-based compensation for the full value of the shares as of the end of the period. On September 2, 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230902__20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_zkzESntuqdr">21,250 shares of its $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_z0jTFhCG7tF3">0.0001 par common stock to four outside Directors with a fair value of $12.80 per share for a grant date value of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230902__20230902__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_zFgsjddx08f9">273,275. The shares, or RSUs, vest in full upon the six-month anniversary of the vesting commencement date (or August 28,2023), subject to the directors’ continued service on the vesting date. For the years ended October 31, 2023 and 2022, the Company recognized stock-based compensation in the amount of $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_zIPiYSUhotSd">96,016 and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_zqXnTEWvr1Xi" title="Share-based payment arrangement, noncash expense">0, respectively, within stock-based compensation expenses on the income statement, with unrecognized expense of $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231031__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--FourOutsideDirectorMember_zBbLLtDVIlO3">177,259 as of the period ended October 31, 2023. On October 16, 2023, pursuant to the Peterson Employment Agreement, the Company issued Mr. Peterson is a grant of 50,000 shares of restricted stock pursuant to the Plan at a fair value of $5.40 per share for a grant date fair value of $271,000. The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement. As of October 31, 2023, the Company recognized stock-based compensation of $3,341 within stock-based compensation expenses on the income statement, with unrecognized expense of $267,659. Warrants January 2022 SPA with GPL Warrants In January 2022, the Company entered into the January 2022 SPA with GPL, which had warrants attached that were exercisable into up to <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_uPure_c20220101__20220131__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zk8asPiPQH17" title="Warrant exercisable, rate">50% of the number of shares of common stock issued upon full conversion of the Notes. The Company determined the warrants were equity classified and used a third party to perform a valuation to estimate their fair market value at January 28, 2022, which was $994,091. The factors used to determine their fair value were a term of 3 years, volatility of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220131__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_z8w7Fcht4LE4" title="Warrant measurement input">92%, a share price based on comparable companies and an exercise price of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220131__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zvH5hPVKuct2" title="Warrant measurement input">50% of the stock price upon the Company’s IPO. Upon consummation of the IPO, the Company issued an aggregate of 125,973 warrants to the GPL investors at an exercise price of $20.60 and an expiration date of 3 years from the date of the IPO; on July 10, 2023, the Company entered into amendments to the warrant agreements with five of the six investors, whereby i) the exercise price was reduced from $20.60 to $16.00 and ii) the number of warrants was increased by a factor of 1.25 or 24,495 warrants in order to induce full, immediate exercise. Accordingly, 122,474 warrants (original number of warrants was 97,979) were exercised at an exercise price of $16.00 per share for aggregate proceeds (net of equity issuance costs of $146,938) of $1,812,635. The shares issued for the exercise of these warrants were registered for resale as part of the Form S-1/A filed on June 30, 2023. The Company accounted for the amendments as warrant modifications, whereby the effect of the modifications is measured as the difference in relative fair value immediately before the modification and after the modification; and any increase to the relative fair value is recognized as equity issuance costs. To assess for the change in relative fair value, the Company performed a Black Scholes Option Model calculation to quantify the fair value of 97,979 common warrants under their original terms as of the modification date using the following assumptions: a share price of $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zbOMXAgyRH96">28.60, an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zSEqUPak1j7i">20.60, an expected term of <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zBt3mrG1Ukhd">3.0 years, volatility of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zPX5CkdorrNf">136%, a dividend rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zN3DIx0mZ2Yf">0% and a discount rate of <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zdAfCc6anxyi">4.54%. The Company then performed a Black Scholes Option Model calculation to quantify the fair value of 122,474 common warrants with their new modified terms as of the modification date using the following assumptions: a share price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_z3reyV7dFMIb">30.60, an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zcfvqdeKERmi">16.00, an expected term of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zmE5u2GlYuD">3.0 years, volatility of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zZv26pK7Zppi">136%, a dividend rate of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230710__20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zBs76LWduvzd">0% and a discount rate of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230710__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zyJkLZfT66wh">4.54%. The aggregate difference of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230710__20230710__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zMOfWaKamiBi">0.3 million between the two calculated amounts was recorded as an equity issuance cost within equity during the period to account for the change in relative fair value. On September 20, 2023, the Company and the sixth GPL investor entered into an amendment to their particular warrant agreement, pursuant to which the Company agreed to amend the warrant held by the holder in order to (i) reduce the exercise price of the warrant from an exercise price of $20.60 per share to $2.20 per share and (ii) add a customary cashless exercise provision to the warrant. On September 21, 2023, the holder delivered a notice of exercise to the Company exercising the Warrant, in full, on a “cashless basis,” pursuant to which an aggregate of 22,592 shares of common stock were issued to the holder on or before September 25, 2023. The Company accounted for the amendments as warrant modifications, whereby the effect of the modifications is measured as the difference in relative fair value immediately before the modification and after the modification; and any increase to the relative fair value is recognized as equity issuance costs. To assess for the change in relative fair value, the Company performed a Black Scholes Option Model calculation to quantify the fair value of 27,994 common warrants under their original terms as of the modification date using the following assumptions: a share price of $<span id="xdx_905_eus-gaap--SharePrice_iI_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zhyRZcen0yD">11.40, an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zZuxyIUMqzB">20.60, an expected term of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zsglooc1Wnq9">3.0 years, volatility of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zKXq6S70rB6e">148%, a dividend rate of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zYHXbrDyXPv2">0% and a discount rate of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--OriginalIssueTermsMember_zjH95CQa2VIa">4.82%. The Company then performed a Black Scholes Option Model calculation to quantify the fair value of 22,592 common warrants with their new modified terms as of the modification date using the following assumptions: a share price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_z1lwNN9cdZtd">11.40, an exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zAvTyGetOtX4">2.20, an expected term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zR3qi19Irjfi">3.0 years, volatility of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_z81Yu3LwWCv7">148%, a dividend rate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230920__20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zEQ3YJGeIUYk">0% and a discount rate of <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230920__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zpvkqcPdTeJ2">4.82%. The aggregate difference of less than $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230920__20230920__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewModifiedTermsMember_zw9BQemkcZ3a">1,000 between the two calculated amounts was recorded as an equity issuance cost within equity during the period to account for the change in relative fair value. Other Warrants In December 2022, the Company entered into subscription agreements with two accredited investors for the aggregate issuance of <span id="xdx_907_eus-gaap--SharesIssued_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoAccreditedInvestorsMember_zlLrA00Mga9e">20,000 common shares, as well as warrants to purchase additional shares up to the initial subscription amount; the warrants are exercisable for two years and have an exercise price equal to fifty percent of the price per share the Company sells its common shares in its IPO. The warrants were determined to be equity classified and were recorded at fair value in additional paid-in capital on the balance sheet for the period. Their fair value was based on the price the third-party investors paid for the original subscription agreements described above. The Company also issued warrants to purchase 5,000 shares of common stock to the underwriters at an exercise price of $66.00 per share (110% of public offering price). A summary of the warrant activity during the years ended October 31, 2023 and 2022 is presented below: SCHEDULE OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Life in Years</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20211101__20221031_zAd9AA1N3REd" style="text-align: right" title="Number of warrants outstanding, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031_zuCH1AMVrrm9" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c20201101__20211031_zwvPICpNENJg" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20211101__20221031_zNtJ2NJlGNGe" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Issued</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20211101__20221031_zKSh5rnnbE24" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20211101__20221031_zIieBLlwl9R" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_c20211101__20221031_zCR8gXMxETxc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average remaining life in years">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20221101__20231031_zFUT8UZIDI3e" style="text-align: right" title="Number of warrants outstanding, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031_zkGNs7SjHYP9" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c20211101__20221031_zZcT0xFWLZkb" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20221101__20231031_zpCNZxlM249g" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20221101__20231031_zSlQyBOEtg1g" style="width: 10%; text-align: right" title="Number of warrants issued">238,803</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_z5WUutkU3Ac1" style="width: 10%; text-align: right" title="Weighted average, exercise price, issued">20.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20221101__20231031_zKsA8kLnudaj" style="width: 10%; text-align: right" title="Weighted average remaining life in years">3.1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20221101__20231031_zJj4YYmvAwc" style="text-align: right" title="Number of warrants exercised">(145,065</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zOjjs5oBZzTl" style="text-align: right" title="Weighted average, exercise price, exercised">20.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_c20221101__20231031_zjKVAqL7hhcd" style="text-align: right" title="Weighted average remaining life in years, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20221101__20231031_z2YA1q1219h" style="text-align: right" title="Number of warrants cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zuA5BAjkgh9j" style="text-align: right" title="Weighted average, exercise price, cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20221101__20231031_zHB0RxqMqJ62" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants expired">(5,402</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zCyWFWD5kZG5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20221101__20231031_zOkUfou7BZu6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20221101__20231031_zazQ8oJVv6L2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, ending">22.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20231031_zrUoU7lqitXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20221101__20231031_zywaOGo7dk2a" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, ending">211,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20221101__20231031_zndoyscvomf6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, exercisable">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20221101__20231031_zHAIpYwGLX0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, exercisable">22.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20221101__20231031_zzwsJODtXu36" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20221101__20231031_zuPlj20C5f41" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable ending">211,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> A summary of outstanding and exercisable warrants as of October 31, 2023 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjqj6ZCwNyK5" style="width: 22%; text-align: right" title="Warrant outstanding exercise price">0.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZ0GALWayT6h" style="width: 22%; text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyp4oaCjO0Ei" style="width: 22%; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdfA9baw0xkg" style="width: 20%; text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zksKIj25ewN7" style="text-align: right" title="Warrant outstanding exercise price">30.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z20GWmWDVH34" style="text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZRBxgkGAN55" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrPYKHytUaN9" style="text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcHmIucraPFk" style="text-align: right" title="Warrant outstanding exercise price">66.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMJEQzhbavDl" style="text-align: right" title="Warrant outstanding number of shares">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNLeAzMvJIgl" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zquuWJCpzUp8" style="text-align: right" title="Warrant exercisable number of shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD4xr8HmxTMl" style="padding-bottom: 1pt; text-align: right" title="Warrant outstanding exercise price">24.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEy7JmL0FUTb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding number of shares">43,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOx0NN57uv8a" style="padding-bottom: 1pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.9</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj654MHFGv81" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant exercisable number of shares">43,336</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhShvwXccJ93" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant outstanding number of shares">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgtDAzIczOsc" style="padding-bottom: 2.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zz8L2ruodLi5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable number of shares">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Stock Options A summary of the option activity during the years ended October 31, 2023 and 2022 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Life in Years</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8srA57ibdhj" style="text-align: right" title="Number of stock option, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWK1ssR0eQCj" style="text-align: right" title="Weighted average, exercise price, beginning balance">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYpyVqFMtrF2" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znkunRAUnlRc" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Issued</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIrAHaoxnET7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwe78hebcT52" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVz22aln6VN1" style="text-align: right" title="Number of stock option, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zrzf5qEos7wj" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQDHutQJQsl9" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zvF2FH33aMl" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHAbNf0Fvxg8" style="width: 10%; text-align: right" title="Number of options issued">6,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq1iZxu6jkBl" style="width: 10%; text-align: right" title="Weighted average, exercise price, issued">10.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYOeCGiwg3Hj" style="width: 10%; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedIntrinsicValue_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLiEAQhPcefi" style="width: 10%; text-align: right" title="Intrinsic value, issued">1,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkgRFTmWWb81" style="text-align: right" title="Number of options exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXsb7uWrIU6a" style="text-align: right" title="Weighted average, exercise price, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIkzYhql18o2" style="text-align: right" title="Number of options cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkqUrc9J5dg9" style="text-align: right" title="Weighted average, exercise price, cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2wpr9lqLRi3" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUGGbwWRgdCa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGc038rDvfE2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock option, beginning">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zoYY73eVyWcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLQo2H4MMhG4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHUw4qtXfRp8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, ending">1,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwRinSceAn0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares warrant exercisable, balance">4,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5ygKTv2CCV6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price excercisable ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zJoESwG8TTTd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zKbYy44UuIs5" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable issued">1,350</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_za3ioH2JtJCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">A summary of outstanding and exercisable options as of October 31, 2023 and 2022 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy1TuWnUGgAc" style="padding-bottom: 1pt; width: 22%; text-align: right" title="Options outstanding exercise price">10.40</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB8c4BwMZ4u6" style="border-bottom: Black 1pt solid; width: 22%; text-align: right" title="Options outstanding number of shares">6,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPsMWnic7Ega" style="padding-bottom: 1pt; width: 22%; text-align: right" title="Options exercisable, weighted average remaining life in years">4.8</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYICfpRot8zh" style="border-bottom: Black 1pt solid; width: 20%; text-align: right" title="Options exercisable number of shares">4,500</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z95MO5aZ4gw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNr1jrX4qdJg" style="padding-bottom: 2.5pt; text-align: right" title="Options exercisable, weighted average remaining life in years">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zKpL4yD0g6d9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable number of shares">4,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> On August 15, 2023, the Company issued five-year options to purchase <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zfIcL7YHDikc">6,000 shares of the Company’s common stock to a consultant of the Company, pursuant to the Plan. The options have an exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_ziYRPHg7sC4j">10.40 per share and vest monthly over a period of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtM_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zPhG01RtukS5">24 months, beginning on the vesting commencement date. The options have a grant date fair value of $<span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodFairValue1_c20230815__20230815__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zYxqXDJg1bI1">55,711, which will be recognized over the vesting term. The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%">Risk free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">4.36%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Expected term (years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5.0</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Expected volatility</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">137.1%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Expected dividends</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">0%</td></tr> </table>

25000000

24500000

0.0001

500000

0.0001

994091

225000

0.0001

5.80

1322933

3000

0.0001

15000

5.80

88200

55000

5.80

55000

323400

161700

6202

155498

20000

400000

0.0001

20.00

100000

60.00

6000000

18750

0.25

4500000

60.00

625

40.00

25000

35000

43.00

1505000

440219

1064781

1250

5000

0.0001

42.00

17.60

24.20

52500

88000

121000

2400

0.0001

33.40

80159

the Company issued a Form S-1/A, which registered for resale (i) up to

10000

21.40

213000

21250

0.0001

12.80

273275

96016

177259

50000

5.40

271000

The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement

3341

267659

994091

P3Y

125973

20.60

P3Y

i) the exercise price was reduced from

122474

97979

16.00

146938

1812635

97979

28.60

20.60

P3Y

1.36

4.54

122474

30.60

16.00

P3Y

1.36

4.54

300000

(i) reduce the exercise price of the warrant from an exercise price of

22592

27994

11.40

20.60

P3Y

1.48

4.82

22592

11.40

2.20

P3Y

1.48

4.82

1000

20000

5000

66.00

1.10

A summary of the warrant activity during the years ended October 31, 2023 and 2022 is presented below: SCHEDULE OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Life in Years</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20211101__20221031_zAd9AA1N3REd" style="text-align: right" title="Number of warrants outstanding, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031_zuCH1AMVrrm9" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c20201101__20211031_zwvPICpNENJg" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20211101__20221031_zNtJ2NJlGNGe" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Issued</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20211101__20221031_zKSh5rnnbE24" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20211101__20221031_zIieBLlwl9R" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_c20211101__20221031_zCR8gXMxETxc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average remaining life in years">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20221101__20231031_zFUT8UZIDI3e" style="text-align: right" title="Number of warrants outstanding, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031_zkGNs7SjHYP9" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c20211101__20221031_zZcT0xFWLZkb" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20221101__20231031_zpCNZxlM249g" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20221101__20231031_zSlQyBOEtg1g" style="width: 10%; text-align: right" title="Number of warrants issued">238,803</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_z5WUutkU3Ac1" style="width: 10%; text-align: right" title="Weighted average, exercise price, issued">20.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20221101__20231031_zKsA8kLnudaj" style="width: 10%; text-align: right" title="Weighted average remaining life in years">3.1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20221101__20231031_zJj4YYmvAwc" style="text-align: right" title="Number of warrants exercised">(145,065</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zOjjs5oBZzTl" style="text-align: right" title="Weighted average, exercise price, exercised">20.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_c20221101__20231031_zjKVAqL7hhcd" style="text-align: right" title="Weighted average remaining life in years, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20221101__20231031_z2YA1q1219h" style="text-align: right" title="Number of warrants cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zuA5BAjkgh9j" style="text-align: right" title="Weighted average, exercise price, cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20221101__20231031_zHB0RxqMqJ62" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants expired">(5,402</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031_zCyWFWD5kZG5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20221101__20231031_zOkUfou7BZu6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20221101__20231031_zazQ8oJVv6L2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, ending">22.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20231031_zrUoU7lqitXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20221101__20231031_zywaOGo7dk2a" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, ending">211,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20221101__20231031_zndoyscvomf6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, exercisable">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20221101__20231031_zHAIpYwGLX0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, exercisable">22.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20221101__20231031_zzwsJODtXu36" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20221101__20231031_zuPlj20C5f41" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable ending">211,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

238803

20.80

P3Y1M6D

145065

20.60

5402

88336

22.40

P3Y10M24D

211200

88336

22.40 P3Y10M24D 211200 A summary of outstanding and exercisable warrants as of October 31, 2023 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjqj6ZCwNyK5" style="width: 22%; text-align: right" title="Warrant outstanding exercise price">0.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZ0GALWayT6h" style="width: 22%; text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyp4oaCjO0Ei" style="width: 22%; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdfA9baw0xkg" style="width: 20%; text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zksKIj25ewN7" style="text-align: right" title="Warrant outstanding exercise price">30.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z20GWmWDVH34" style="text-align: right" title="Warrant outstanding number of shares">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZRBxgkGAN55" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrPYKHytUaN9" style="text-align: right" title="Warrant exercisable number of shares">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcHmIucraPFk" style="text-align: right" title="Warrant outstanding exercise price">66.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMJEQzhbavDl" style="text-align: right" title="Warrant outstanding number of shares">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNLeAzMvJIgl" style="text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zquuWJCpzUp8" style="text-align: right" title="Warrant exercisable number of shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD4xr8HmxTMl" style="padding-bottom: 1pt; text-align: right" title="Warrant outstanding exercise price">24.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEy7JmL0FUTb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding number of shares">43,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOx0NN57uv8a" style="padding-bottom: 1pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">4.9</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj654MHFGv81" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant exercisable number of shares">43,336</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhShvwXccJ93" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant outstanding number of shares">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgtDAzIczOsc" style="padding-bottom: 2.5pt; text-align: right" title="Warrant exercisable, weighted average remaining life in years">3.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zz8L2ruodLi5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable number of shares">88,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

0.20

20000

P4Y6M

20000

30.00

20000

P1Y1M6D

20000

66.00

5000

P4Y6M

5000

24.00

43336

P4Y10M24D

43336

88336

P3Y10M24D

88336

A summary of the option activity during the years ended October 31, 2023 and 2022 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Life in Years</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8srA57ibdhj" style="text-align: right" title="Number of stock option, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWK1ssR0eQCj" style="text-align: right" title="Weighted average, exercise price, beginning balance">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c20201101__20211031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYpyVqFMtrF2" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znkunRAUnlRc" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Issued</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIrAHaoxnET7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwe78hebcT52" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, issued">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, November 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVz22aln6VN1" style="text-align: right" title="Number of stock option, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zrzf5qEos7wj" style="text-align: right" title="Weighted average, exercise price, beginning">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c20211101__20221031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQDHutQJQsl9" style="text-align: right" title="Weighted average remaining life in years">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zvF2FH33aMl" style="text-align: right" title="Intrinsic value, beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Issued</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHAbNf0Fvxg8" style="width: 10%; text-align: right" title="Number of options issued">6,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq1iZxu6jkBl" style="width: 10%; text-align: right" title="Weighted average, exercise price, issued">10.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYOeCGiwg3Hj" style="width: 10%; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIssuedIntrinsicValue_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLiEAQhPcefi" style="width: 10%; text-align: right" title="Intrinsic value, issued">1,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkgRFTmWWb81" style="text-align: right" title="Number of options exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXsb7uWrIU6a" style="text-align: right" title="Weighted average, exercise price, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIkzYhql18o2" style="text-align: right" title="Number of options cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkqUrc9J5dg9" style="text-align: right" title="Weighted average, exercise price, cancelled">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2wpr9lqLRi3" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUGGbwWRgdCa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average, exercise price, expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGc038rDvfE2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock option, beginning">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zoYY73eVyWcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average, exercise price, ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLQo2H4MMhG4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHUw4qtXfRp8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, ending">1,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, October 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwRinSceAn0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares warrant exercisable, balance">4,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice_iE_pid_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5ygKTv2CCV6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price excercisable ending balance">10.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zJoESwG8TTTd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average remaining life in years, Exercisable">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable_iE_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zKbYy44UuIs5" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value, exercisable issued">1,350</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

6000

10.40

P4Y9M18D 1800

6000

10.40

P4Y9M18D

1800

4500

10.40 P4Y9M18D 1350

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_za3ioH2JtJCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">A summary of outstanding and exercisable options as of October 31, 2023 and 2022 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1pt; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options Exercisable</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life in Years</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy1TuWnUGgAc" style="padding-bottom: 1pt; width: 22%; text-align: right" title="Options outstanding exercise price">10.40</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zB8c4BwMZ4u6" style="border-bottom: Black 1pt solid; width: 22%; text-align: right" title="Options outstanding number of shares">6,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20221101__20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPsMWnic7Ega" style="padding-bottom: 1pt; width: 22%; text-align: right" title="Options exercisable, weighted average remaining life in years">4.8</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYICfpRot8zh" style="border-bottom: Black 1pt solid; width: 20%; text-align: right" title="Options exercisable number of shares">4,500</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z95MO5aZ4gw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding number of shares">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_pid_dtY_c20221101__20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNr1jrX4qdJg" style="padding-bottom: 2.5pt; text-align: right" title="Options exercisable, weighted average remaining life in years">4.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20231031__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zKpL4yD0g6d9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable number of shares">4,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

10.40

6000

P4Y9M18D

4500

6000

P4Y9M18D

4500

6000

10.40

P24M

55711

The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%">Risk free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">4.36%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Expected term (years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5.0</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif">Expected volatility</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">137.1%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif">Expected dividends</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">0%</td></tr> </table>

0.0436

P5Y

1.371

NOTE 11 – SUBSEQUENT EVENTS In accordance with ASC 855 – Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events and transactions that occurred after October 31, 2023, through the date the financial statements were issued. Except for the following, there are no subsequent events identified that would require disclosure in the financial statements. Resale Form S-1 On November 11, 2023, the Company filed a Form S-1 for the resale of i) up to <span id="xdx_908_ecustom--NumberOfSharesIssuable_iI_pid_c20231111__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredConvertiblePromissoryNoteMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zY6c8RD7Zwv7">571,429 shares of common stock issuable upon conversion of a senior secured convertible promissory note, ii) up to <span id="xdx_90D_ecustom--NumberOfSharesIssuable_iI_pid_c20231111__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSmPRs4OB3t8">86,671 shares of common stock issuable upon exercise of a common warrant, and iii) up to <span id="xdx_908_ecustom--NumberOfSharesIssuable_iI_pid_c20231111__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5u4ZzZFDYDk">4,167 shares of common stock issuable upon exercise of a placement agent warrant. First Amendment to the Resales Form S-1 On December 6, 2023, the Company filed the first amendment to the Form S-1 filed with the SEC on November 3, 2023. Asphalt Ridge Option Agreement and Amendment On November 10, 2023, the Company entered into a leasehold acquisition and development option agreement (“AR Agreement”) with Heavy Sweet Oil LLC (“Heavy Sweet”) to purchase up to a <span id="xdx_90F_ecustom--PercentageOfProductionShare_pid_dp_uPure_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsxNd4R1fgJc">20% production share (“Asphalt Ridge Option”) in certain leases in eastern Utah totaling 960 acres. The Asphalt Ridge Option had an original term of nine months, through August 10, 2024, which has been extended through February 10, 2025, and gives the Company the exclusive right, but not the obligation, to acquire up to a <span id="xdx_901_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCiQNO1Oul0b">20% working interest in the leases for $<span id="xdx_905_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_pid_c20231110__20231110__us-gaap--TypeOfArrangementAxis__custom--ARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqIciFmbWZk6">2,000,000, which may be invested in tranches, provided that the initial tranche closing occurs during the option period and subsequent tranches occur as soon thereafter as practical within the Asphalt Ridge Option period, with each tranche providing the Company a portion of the ownership of the leases. Upon receipt of any funding from the Company pursuant to the Asphalt Ridge Option, Heavy Sweet is required to pay that amount to the named operator of the properties, to pay for engineering, procurement, operations, sales, and logistics activities on the properties. On December 29, 2023, the Company and Heavy Sweet entered into an Amendment to the AR Agreement (the “AR Amendment”), pursuant to which the Company and Heavy Sweet amended the AR Agreement to provide that, within three business days of the effective date of the AR Amendment, the Company would fund $<span id="xdx_90E_ecustom--AmountAgreedToFundAsPerAmendedAgreement_iI_c20231229__us-gaap--TypeOfArrangementAxis__custom--AmendedARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8hq2JP7kMW1" title="Amount agreed to fund">200,000 of the $<span id="xdx_908_ecustom--TotalPurchasePriceOfLease_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--AmendedARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwxQhaxfEkpd" title="Purchase price of lease, total">2,000,000 total purchase price in exchange for the Company receiving an immediate <span id="xdx_906_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--AmendedARAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8PYOT7trQ7c" title="Percentage of interest">2% interest in the leases, which advanced funds would be used solely for the building of roads and related infrastructure in furtherance of the development plan. On December 29, 2023, the Company paid the $<span id="xdx_908_eus-gaap--PaymentsToAcquireLoansAndLeasesHeldForInvestment_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--AmendedARAgreementMember__dei--LegalEntityAxis__custom--HeavySweetOilLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2ZLa6QLZ4n2" title="Payments to acquire loans and leases">200,000 advance to Heavy Sweet and was assigned a <span id="xdx_906_ecustom--PercentageOfInterestToAcquireInLeases_pid_dp_uPure_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--AmendedARAgreementMember__dei--LegalEntityAxis__custom--HeavySweetOilLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8M7EMquLYKi" title="Percentage of interest">2% interest in the leases. Amendment to October 2023 SPA and Second Tranche Financing On December 29, 2023, the Company and an investor entered into an Amendment to the October 2023 SPA (see Note 9), whereby in connection with the closing of the second tranche, (i) the fixed conversion price of the convertible promissory note issued and (ii) the exercise price of the warrant issued in connection with the second tranche were both reduced from $24.00 to $10.00. The closing of the second tranche will be in the principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231229__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToOctoberTwentyTwentyThreeSPAMember_z767d5pGR0Je">550,000. On January 2, 2024, the Company closed on the second tranche and received gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromNotesPayable_c20240102__20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToSecondTrancheFinancingMember_zN0VIn7LNbj7">511,500; in consideration for the funding, the Company issued to the investor a note in the principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToSecondTrancheFinancingMember_zbymIt9uQw48">550,000 with a conversion price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToSecondTrancheFinancingMember_z6hbo6FPOouf">10.00, subject to certain adjustments and a warrant to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToSecondTrancheFinancingMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zApIjEzEdTj1">22,279 shares of common stock at an initial exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--AmendmentToSecondTrancheFinancingMember_zBYtDydPXGtk">10.00 per share, subject to certain adjustments.

571429 86671 4167 0.20 0.20

2000000

200000 2000000 0.02

200000

0.02

24.00

10.00

550000

511500

550000

10.00

22279

10.00

Amount is for an adjustment for shares recorded as not exercised but registered in accordance with their warrant agreements. Balance includes warrants issued per the January 2022 Securities Purchase Agreement (“January 2022 SPA”) with GPL Ventures, LLC (“GPL”), which are exercisable into up to 50% of the number of shares of common stock issued upon full conversion of the Notes, with an exercise price equal to the conversion price. Upon IPO, the debt will convert into a variable number of shares; the number of conversion shares is equal to the outstanding principal amount divided by the conversion price, which is equal to the lesser of a) the IPO price or b) the opening price of the common stock on the first trading day after the IPO multiplied by the discount of 50%. The number of commitment shares to be issued is a variable number of shares for a fixed total dollar amount of $1,125,000, which is 25% of the aggregate Notes principal balance divided by the offering price of the IPO. Balance consists of potentially dilutive shares based on Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.